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Résumé 
Staphylococcus aureus est un agent pathogène humain responsable d'une grande variété de 
maladies allant d'infections bénignes de la peau comme des furoncles, à des infections plus sévères 
telles que des septicémies ou des endocardites infectieuses. Il est également responsable 
d’intoxications alimentaires et du syndrome de choc toxique. Cette hétérogénéité des infections et la 
capacité de S. aureus à développer des résistances à la plupart des antibiotiques disponibles, reflète 
son extraordinaire capacité à s'adapter et à survivre dans une grande variété d'environnements. La 
pathogénie de l'infection à S. aureus implique un large éventail d’adhésines associées à la paroi 
cellulaire et de toxines extracellulaires qui favorisent la colonisation et l'invasion de l'hôte. De plus, S. 
aureus est extrêmement bien équipé de systèmes de régulation qui détectent les conditions 
environnementales et répondent de manière très fine par des modifications de l'expression des 
déterminants métaboliques et des facteurs de virulence. Les adhésines de surface ou MSCRAMMs 
(Composants de la Surface Microbienne qui Reconnaissent les Molécules d’Adhérence de la Matrice 
extracellulaire) permettent la liaison à la matrice extracellulaire de l’hôte ou à des composants du 
sérum, comme notamment le fibrinogène, la fibronectine, le collagène et l'élastine, afin de promouvoir 
la colonisation et l'invasion des tissus. Les principales MSCRAMMs incluent une famille de protéines 
de surface liées de manière covalente au peptidoglycane de la paroi cellulaire par l'intermédiaire d’un 
motif LPXTG conservé. Des analyses génomiques indiquent qu’il existe jusqu'à 22 protéines à LPXTG 
chez S. aureus qui peuvent agir individuellement ou en synergie pour favoriser l'infection. 
Dans la première partie de cette étude, nous avons comparé les phénotypes d’adhérence au 
fibrinogène et la fibronectine de 30 isolats de S. aureus provenant de porteurs sains avec les 
phénotypes d'adhérence de 30 isolats d’endocardites infectieuses et de 30 isolats d'hémoculture. 
Dans l'ensemble, une grande variation des phénotypes d’adhérence a été obtenue in vitro, mais 
aucune différence significative n'a été observée entre les souches de porteurs sains et d'infections. 
Nous avons également étudié la relation entre l'adhérence in vitro et l’infectivité in vivo dans un 
modèle expérimental d’endocardite chez le rat, en utilisant 4 isolats qui présentaient soit des 
phénotypes d'adhérence extrêmement bas, soit très élevés. Contre toute attente, aucune différence 
n'a été observée entre le pouvoir infectieux in vivo des isolats qui étaient peu ou très adhérents in 
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vitro. Nous avons conclu que la variabilité d’adhérence au fibrinogène et à la fibronectine in vitro 
n'était pas corrélée avec le pouvoir infectieux in vivo, et que les différences de pouvoir infectieux entre 
les différentes souches ne pouvaient être exprimées qu’ in vivo. Par conséquent, compte tenu de 
l'importance de l'expression des adhésines lors de l'infection, des analyses semi-quantitatives de la 
présence de ces adhésines à la surface bactérienne ont été réalisées par une approche protéomique. 
Dans la deuxième série d’expériences, la présence physique des protéines à LPXTG a été 
mesurée à la surface cellulaire à différents temps au cours de la croissance bactérienne et dans 
différents milieux de culture. S. aureus Newman a été cultivé dans du bouillon de soja tryptique (TSB) 
ou du RPMI (Roswell Park Memorial Institut) et des échantillons de cellules ont été prélevés au cours 
de la phase exponentielle de croissance et jusqu’en phase stationnaire tardive. Les expériences ont 
été réalisées avec des mutants du régulateur global agr, ainsi que de la protéine A ou du facteur 
d’agglutination A, ClfA. Les peptides des adhésines ont été générés par une méthode de digestion 
enzymatique à la trypsine permettant un “rasage” de la surface des bactéries vivantes. Les analyses 
protéomiques semi-quantitatives ont été réalisées en tandem par chromatographie liquide et 
spéctrométrie de masse (LC-MS). Nous avons également déterminé en parallèle l’expression des 
ARNm correspondants par analyse de puces à ADN et le phénotype d’adhérence des bactéries au 
fibrinogène in vitro. Le protéome de surface obtenu était très complexe et contenait de nombreuses 
protéines qui théoriquement n'appartenaient pas à l'enveloppe bactérienne, y compris des protéines 
ribosomales et des enzymes métaboliques. Seize des 22 protéines à LPXTG connues ont été 
détectées, mais étaient exprimées de façon différentielle. Comme supposé, 9 protéines connues pour 
être régulées par agr (par exemple : Spa, FnBPA, ClfA, IsdA, IsdB, SasH, SasD, SasG et FmtB) ont 
augmenté jusqu'à la phase de croissance exponentielle tardive puis ont diminué en phase 
stationnaire. Cependant, cette expression “en cloche” a été annihilée avec le mutant agr-. Toutefois, 
seuls la protéine A et SasH ont modifié leur profil protéomique et ARNm en parallèle, dans la souche 
parental et le mutant agr-, tandis que toutes les autres protéines LPXTG ont modifié leurs profils 
protéomiques indépendamment de leur ARNm durant la croissance. De plus, ClfA a hautement été 
transcrit et actif dans les tests d’adhérence au fibrinogène in vitro en phase tardive de croissance 
(24h), alors qu'il a été très peu détecté en protéomique. Cette expression différentielle a aussi bien été 
détectée en milieu riche en fer dans le TSB qu’en milieu pauvre dans le RPMI. Les déterminants de 
surface du système régulés par le fer (isd), notamment IsdA, IsdB et IsdH étaient très peu exprimés 
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dans le TSB alors qu'ils ont augmenté leur expression par 10 dans le RPMI. Nous en avons conclu 
que des analyses protéomiques semi-quantitatives de protéines spécifiques étaient réalisables chez 
S. aureus et que les analyses protéomiques, transcriptomiques ainsi que les tests phénotypiques 
d’adhérence montraient des profils différentiels chez cette bactérie. De plus, les signatures 
peptidiques libérées par le rasage à la trypsine suggèrent des expositions différentielles des domaines 
de ces protéines dans des environnements différents, qui pourraient être pertinents pour 
l’établissement de vaccins anti-adhésines. Une compréhension approfondie de la physiologie de S. 
aureus doit donc intégrer toutes ces approches. 
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Summary 
Staphylococcus aureus is a highly successful pathogen responsible of a wide variety of 
diseases, from minor skin infection to life-threatening sepsis or infective endocarditis, as well as food 
poisoning and toxic shock syndrome. This heterogeneity of infections and the ability of S. aureus to 
develop antibiotic-resistance to virtually any available drugs reflect its extraordinary capacity to adapt 
and survive in a great variety of environments. The pathogenesis of S. aureus infection involves a 
wide range of cell wall-associated adhesins and extracellular toxins that promote host colonization and 
invasion. In addition, S. aureus is extremely well equipped with regulatory systems that sense 
environmental conditions and respond by fine tuning the expression of metabolic and virulence 
determinants. Surface adhesins referred to MSCRAMMs – for Microbial Surface Component 
Recognizing Adherence Matrix Molecules – mediate binding to the host extracellular matrix or serum 
components, including fibrinogen, fibronectin, collagen and elastin, and promote tissue colonization 
and invasion. Major MSCRAMMs include a family of surface-attached proteins covalently bound to the 
cell wall peptidoglycan via a conserved LPXTG motif. Genomic analyses indicate that S. aureus 
contain up to 22 LPXTG surface proteins, which could potentially act individually or in synergy to 
promote infection. 
In the first part of this study we determined the range of adherence phenotypes to fibrinogen 
and fibronectin among 30 carriage isolates of S. aureus and compared it to the adherence phenotypes 
of 30 infective endocarditis and 30 blood culture isolates. Overall there were great variations in in vitro 
adherence, but no differences were observed between carriage and infection strains. We further 
determined the relation between in vitro adherence and in vivo infectivity in a rat model of 
experimental endocarditis, using 4 isolates that displayed either extremely low or high adherence 
phenotypes. Unexpectedly, no differences were observed between the in vivo infectivity of isolates 
that were poorly and highly adherent in vitro. We concluded that the natural variability of in vitro 
adherence to fibrinogen and fibronectin did not correlate with in vivo infectivity, and thus that 
pathogenic differences between various strains might only be expressed in in vivo conditions, but not 
in vitro. Therefore, considering the importance of adhesins expression for infection, direct 
measurement of those adhesins present on the bacterial surface were made by proteomic approach. 
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In the second series of experiments we assessed the physical presence of the LPXTG species 
at the staphylococcal surface, as measured at various time points during growth in different culture 
media. S. aureus Newman was grown in either tryptic soy broth (TSB) or in Roswell Park Memorial 
Institute (RPMI) culture medium, and samples were removed from early exponential growth phase to 
late stationary phase. Experiments were performed with mutants in the global accessory-gene 
regulator (agr), surface protein A (Spa) and clumping factor A (ClfA). Peptides of surface proteins were 
recovered by “trypsin-shaving” of live bacteria, and semi-quantitative proteomic analysis was 
performed by tandem liquid-chromatography and mass-spectrometry (LC-MS). We also determined in 
parallel the mRNA expression by microarrays analysis, as well as the phenotypic adherence of the 
bacteria to fibrinogen in vitro. The surface proteome was highly complex and contained numerous 
proteins theoretically not belonging to the bacterial envelope, including ribosomal proteins and 
metabolic enzymes. Sixteen of the 21 known LPXTG species were detected, but were differentially 
expressed. As expected, 9 known agr-regulated proteins (e.g. including Spa, FnBPA, ClfA, IsdA, IsdB, 
SasH, SasD, SasG and FmtB) increased up to the late exponential growth phase, and were abrogated 
in agr-negative mutants. However, only Spa and SasH modified their proteomic and mRNA profiles in 
parallel in the parent and its agr negative mutant, while all other LPXTG proteins modified their 
proteomic profiles independently of their mRNA. Moreover, ClfA became highly transcribed and active 
in in vitro fibrinogen adherence tests during late growth (24h), whereas it remained poorly detected by 
proteomics. Differential expression was also detected in iron-rich TSB versus iron-poor RPMI. Proteins 
from the iron-regulated surface determinant (isd) system, including IsdA, IsdB and IsdH were barely 
expressed in iron-rich  TSB, whereas they increased their expression by >10 time in iron-poor RPMI. 
We conclude that semi-quantitative proteomic analysis of specific protein species is feasible in S. 
aureus and that proteomic, transcriptomic and adherence phenotypes demonstrated differential 
profiles in S. aureus. Furthermore, peptide signatures released by trypsin shaving suggested 
differential protein domain exposures in various environments, which might be relevant for anti-
adhesins vaccines. A comprehensive understanding of the S. aureus physiology should integrate all 
these approaches. 
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Abbreviations 
AdsA Adenosine synthase A 
agr Accessory gene regulator 
AIP Auto-Inducing Peptide 
Aur Aureolysin 
Bbp Bone sialoprotein-binding protein 
BI Bullous Impetigo 
CA-MRSA Community-Associated MRSA 
CAPs Cationic Antimicrobial Peptides 
CFU Colony Forming Units 
Clf Clumping factor 
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Coa Coagulase 
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DTT  Dithiotreitol 
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Ebps Elastin-binding protein 
Efb Extracellular fibrinogen-binding protein 
EF-Ts Elongation factor TS 
ET Exfoliatin 
FmtB Formyl transferase B 
FnBP Fibronectin-binding protein  
Fur Ferric uptake repressor 
GM17 Glucose M17 medium 
Hla α-hemolysin 
Hlb β-hemolysin 
Hld δ-hemolysin 
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IgG Immunoglobulin G 
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kDA kilo-Dalton 
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MGEs Mobile Genetic Elements 
MgrA Multiple gene regulator A 
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MRSA Methicillin Resistant Staphylococcus aureus 
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NAG N-acetylglucosamine 
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NEAT NEAr Transporter 
OD Optical Density 
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PBP Penicillin Binding Protein 
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PVL Panton and Valentine Leucocidine 
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RT Room Temperature 
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Sas Staphylococcus aureus surface protein 
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Sdr Serine-aspartate repeat protein 
SDS Sodium Dodecyl Sulfate 
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SERAMs Secretable Expanded Repertoire Adhesive Molecules 
SP Signal Peptide 
Spa  Protein A 
Spj Sureface protein in Japanese ST8 CA-MRSA 
SrtA Sortase A 
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sRNA Small non-codant RNA 
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TA Techoic Acids 
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I. General Microbiology of Staphylococcus aureus 
S. aureus is a Gram-positive, non-motile, non-spore forming and facultative anaerobe spherical 
(coccus) bacterium, often found in grape-like clusters of 0.5 to 1.5 µm in diameter. Its genome consists 
of a circular chromosome of approximately 2800 Mb, which contains numerous mobile genetic 
elements (MGEs) such as prophages, transposons, pathogenicity islands and genomic islands (for 
review [1]). This MGEs are responsible for its great adaptability to various environmental conditions, 
including its capacity to colonize and infect mammal hosts. Comparative sequence analysis indicates 
that the core genome of S. aureus shares 50% homology with notoriously non-pathogenic Bacillus 
subtilis, suggesting that the two organisms originated from a common ancestor and diverged 
thereafter [2,3]. However, compared to B. subtilis and other non-pathogenic Gram-positive cocci, the 
genome of S. aureus harbors numerous surface-bound adhesins, secreted virulence factors, and 
antibiotic-resistance determinants that are primarily located on MGEs, and thus have been acquired by 
horizontal gene transfer [3-7]. Since gene exchange is a key player of bacterial evolution, this atypical 
genetic plasticity is a likely explanation for the capacity of S. aureus to behave both as a colonizer and 
disease-inducing microbe. 
S. aureus is known to be a human commensal bacterium, but can become an opportunistic 
pathogen in certain circumstances. It is a permanent colonizer of the anterior nostrils and some other 
anatomical sites in 15-30% of the healthy human adult population, and can be recovered intermittently 
from up to 60% of other healthy individuals [8]. In addition, it can produce a wide array of infections, 
which are summarized in Figure 1. These extend from relatively benign skin infections (folliculitis and 
furunculosis) to life threatening conditions such as osteomyelitis, pneumonia, sepsis, and endocarditis 
[9]. While S. aureus is a leading cause of community-acquired infections, it has also become the first 
cause of nosocomial diseases, often due to multi-resistant strains [10,11]. Moreover, in addition to 
infections where the bacterium can be cultured from the infected site, S. aureus is also responsible for 
“distant” diseases that are mediated via toxin secretion, including well-known staphylococcal toxic 
shock syndrome and food poisoning [12,13]. Thus, the heterogeneity of these diseases and the 
unique ability of S. aureus to develop antibiotic-resistance reflect the extraordinary capacity of this 
organism to adapt and survive in a great variety of environments.  
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12
 
 
Figure 1: Large diversity in S. aureus 
infections [14]. 
 
Recently, technologies encompassing whole genome sequencing and high-throughput 
transcriptomics and proteomics have been widely used to better understand microbial evolution and 
cell physiology. The first sequenced genome of staphylococcus was published in 2001 [3]. Today, 31 
S. aureus full sequenced genomes are available (http://www.ncbi.nlm.nih.gov/genomes/154) and there 
are many more ongoing projects. Over the last decade, molecular and genetic dissection of S. aureus 
has revealed a great number of surface adhesins and secreted enzymes and toxins. Cell-wall-
associated surface adhesins, in particular proteins, play important roles in virulence. Indeed, the ability 
to bind to host extracellular matrix and plasma components allows staphylococci to attach to host 
tissues, invade epithelial and endothelial cell linings, and escape for host defense mechanisms [15-
  GENERAL INTRODUCTION 
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17]. More recently, surface proteins have also been shown to play a role in biofilm formation [18]. 
However, while many of these features (described later in this chapter) were shown to play a role in 
specific in vitro or in vivo experimental models, there is, as yet, not much understanding of their 
integrated interplay during infection, either via protein-protein interactions (e.g., it was shown that 
domains of surface adhesins binding fibrinogen or fibronectin could synergize to produce diseases) 
[19], or via regulation of gene expression during time-course experiments. Given the number of 
determinants involved, and their differential regulation as a function of environmental stimuli, such 
approach appears crucial to better understand pathogenicity. To address this purpose, gene 
regulation of virulence factors is addressed in the next section. 
II. Regulation and virulence determinants 
S. aureus is extremely well equipped in surface factors and secreted proteins that mediate host 
colonization and pathogenicity. For instance, its cell envelope, which represents up to 50-60% of the 
dry weight of the bacterium, plays a major role in the interaction between the bacterium an its direct 
environment. This enveloppe consists of a sturdy peptidoglycan scaffold that is decorated with a 
variety of polyols such as teichoic acids (TA) and lipoteichoic acids (LTA), polysaccharides 
(extracellular capsule), and polypeptides that confer diverse properties such as resistance to 
phagocytosis (capsule), environmental sensing (proteins), and adherence to and invasion of host cell 
tissues (TA, LTA and protein adhesins). The adhesins are collectively referred to Microbial Surface 
Component Recognizing Matrix Molecules or MSCRAMMs [20]. Besides, S. aureus also produces a 
large number of virulence factors such as toxins, exo-enzymes and cell surface proteins implicated in 
pathogenesis, which will be detailed below. The expression of all these features is under the control of 
a serie of integrated gene regulatory systems that sense environmental conditions to respond by fine-
tuning the expression of metabolic and virulence determinants [4]. These are shortly reviewed below. 
II.1. Regulatory systems of virulence-determinant expression 
There are at least three families of regulatory systems controlling gene expression in S. aureus: 
the two component regulatory systems (TCRS), the small regulatory RNAs, and the DNA-binding 
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proteins [4,21-23]. These regulatory systems are interdependent and the major part of virulence genes 
is directly or indirectly regulated by them. 
II.1.1. The two component regulatory systems (TCRS) and the 
example of agr (accessory gene regulator) 
TCRS serve as a basic stimulus-response coupling mechanism to allow organisms to sense 
and respond to changes in many different environmental conditions. They typically consist of a 
membrane-bound histidine kinase that senses a specific environmental stimulus and a corresponding 
response regulator that mediates the cellular response, mostly through differential expression of target 
genes. TCRS are widely present in prokaryotes, and often share homology [24], whereas only a few 
have been identified in eukaryotic organisms. TCRS appear to be major players in gene regulation and 
Table 1 shows the functions and implications of the most important found in S. aureus.  
Table 1: Principal TCRS and functions in S. aureus. 
TCRS Function References 
Agr Regulates many extracellular and cytoplasmic protein accessory genes [4,21] 
SaeRS Repressor of extracellular proteases – Activator of biofilm  formation [25,26] 
ArlSR Regulator of virulence gene expression [27,28] 
SrrAB Regulator of virulence factors under low-oxygen conditions (TSST-1, Spa) [29,30] 
VraSR Regulator of cell-wall biosynthesis pathway – Activator of Pbp2 [31-33] 
LytSR Regulator of biofilm formation [34] 
YycFB Regulator of cell permeability [35,36] 
GraSR Regulator of CAMP resistance, stress response and cell wall metabolism signal transduction pathways [37] 
 
Among these, agr has been particularly well described (Figure 2). It is activated in a population 
density-dependent manner and controls the expression of more than 20 virulence factors, including 
adhesins, exo-enzymes and toxins [21,38]. It is basically composed of an auto-inducing peptide (AIP, 
encoded by AgrD), a transport protein (AgrB) that allows the export of AIP, a transmembrane receptor 
(AgrC) that recognized AIP, a response regulator (AgrA) that dephosphorylates when AIP contacts 
AgrC, and an RNA effector RNAIII. At low cell density (exponential growth phase) the P2 promoter, 
which activates the transcription of agrB-D-C-A (see Figure 2), is OFF and the operon is transcribed at 
a low basic level. As cell growth progresses, the concentrations of both bacteria and extracellular auto-
inducing peptide (AIP) increase in the milieu, thereby augmenting the chance of AIP to make contact 
with its cognate AgrC receptor. Upon contact between AIP and AgrC, AgrC activates the response 
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regulator AgrA, a process that may involve AgrA dephosphorylation [4]. Activated AgrA is a DNA-
binding protein that turns ON the transcription from both promoter P2 – generating a positive feed-
back on the system – and also turn ON P3, which drives the transcription of δ-hemolysin and of an 
atypical effector called RNAIII. RNAIII has a reciprocal effect, activating the expression of most 
secreted proteins while downregulating the expression of surface-bound factors. RNAIII has a complex 
three-dimensional structure and a long half-life (up to 45 min) [39,40]. It is believed to regulate gene 
expression in several ways, including at the translational level by blocking the mRNA ribosome-binding 
site of the target genes [37,40-44]. 
 
Figure 2: Organization of agr locus in S.aureus and functional model. The agr locus contains two divergent 
promoters, P2 and P3, which modulate transcription of two transcripts, RNAII and RNAIII, respectively. The 
promoter P2 drives the transcription of a series of components comprising a transmembrane protein AgrB, an 
auto-inducing peptide (AIP) precursor AgrD, which is processed and exported by membrane-spanning AgrB; a 
transmembrane sensor AgrC, which is the cognate receptor of the AgrD-derived AIP, and a transcription regulator 
AgrA that can be activated by AgrC. See text for functioning details. Adapted from [4,45]. 
 
Importantly, it has been largely accepted that arg-regulation was responsible for turning on the 
expression of surface protein genes (including MSCRAMMs) during the exponential phase of growth, 
while repressing them and turning on genes for secreted enzyme and toxins in the stationary phase of 
growth [4]. This has played an important conceptual role in understanding the sequential contribution 
of cell-surface and secreted determinants pathogenesis, i.e. first colonization via adherence and then 
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invasion via enzymes [4]. However, the expression of agr is itself modulated by a multiplicity of 
additional regulators [22,30,46,47], which are not all described in this introduction, but substantially 
complexify the study of pathogenesis in “mere” agr mutants. Therefore, experiments to understand 
pathogenesis using only arg mutants tend to simplify (maybe oversimplify) reality by first 
compartmentalizing of cell constituents or molecules, and then trying to reconstitute physiopathological 
processes.  Trying to solve this issue is the purpose of one of the experimental approach described in 
the thesis dissertation. 
There are at least seven other TCRS that have been described in S. aureus (Table 1). For 
instance: 
- SaeRS is a regulatory system that activates the production of several exoproteins that would 
otherwise limit accumulation of critical proteins that contribute to biofilm formation [25,26].  
- ArlS-ArlR is a parallel system that controls bacterial attachment to polymer surfaces by affecting 
secreted peptidoglycan hydrolase activity and modifying extracellular proteolytic activity [28]. In 
addition, the arl operon decreases the production of numerous virulence factor, such as α-hemolysin 
(Hla), β-hemolysin, lipase, coagulase, serine protease and especially protein A (Spa) by down 
regulating the transcription of their genes [27].  
- SrrAB acts in the global regulation of virulence factors. This system down-regulates production 
of agr RNAIII, protein A, and toxic shock syndrome toxin 1 (TSST-1) and particularly under low-oxygen 
conditions [29].  SrrAB decreases virulence in the rabbit endocarditis model [30].  
- VraSR was shown to be responsible for resistance to cell wall-damaging compounds, including 
β-lactam antibiotics and some cationic antimicrobial peptides (CAPs) [31-33].  
- LytSR plays an important role in S. aureus biofilm development [34].  
- Yyc plays a role in cell permeability [35]. 
- GraSR controls stress response and cell wall metabolism signal transduction pathways [37].  
Thus, also arg came as an early paradigm in the regulation of genes encoding surface attached 
and secreted molecules, it is part of a broader network that may either directly interact with it (e.g. 
see SrrAB above), or act independently of it. As a result, conclusions drawn from studying mutants in 
only one of these systems are obligatory restrictive, and may provide only a limited view on the more 
complex reality. 
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II.1.2. Small regulatory RNAs: the example of RNAIII 
Small non-coding RNA (sRNA) regulators in prokaryotes are a heterogeneous group of small 
molecules able to act by various mechanisms to rapidly regulate physiological or stress responses 
(e.g. temperature, pH, nutrients, etc). Moreover, in pathogenic bacteria, sRNA are often strategic 
elements for the regulation of virulence genes expression [48,49]. 
sRNAs typically act by modulating transcription, translation, mRNA stability or by gene silencing. 
It generally involves changes in RNA conformation, which eventually affect protein binding, DNA 
binding or antisense base pairing with mRNA targets [50]. In the latter case, positive regulation 
typically activates translation of proteins by making ribosome binding (RB) sites of mRNAs available, 
as in gene attenuation. In contrast, negative regulation involves sRNA-mRNA base-pairing interactions 
in order to sequester mRNA sequences and inhibits RB.  
Over the last few years a great effort has been invested to understand regulation by non-coding 
sRNAs regulators in bacteria. Recently, Beaume et al reported up to 160 sRNA in intergenic regions of 
the S. aureus chromosome, of which 35 had cDNA antisense properties in reference strain S. aureus 
N315 [51]. They were principally localized in key metabolic regions or close to virulence genes or 
MGEs, as for instance in the Staphylococcal Cassette Chromosome mec (SCCmec) island, which is 
responsible for methicillin resistance. Moreover, the expression of these sRNA appeared to be 
modulated along growth and in response to stress conditions [51]. 
All these elements suggest that sRNAs are precious for bacteria to adapt to variable 
environments. One potential advantage for the cells over other regulatory systems is the rapid 
response because of the small size and the absence of translation phase. Moreover, the action is 
reversible by the intervention of RNAse in the case of degradation. Thus, regulation by sRNAs 
provides an additional level of sophistication, which may intervene both upstream of more general 
regulatory systems, in order to modulate global responses, or downstream of them to better tune the 
expression of discrete subsets of specific genes. In any case, however, the best known and most 
thoroughly studied sRNA in S. aureus is RNAIII of agr, which was described almost two decades ago 
[4]. It is implicated in the control of exoproteins and virulence factors expression, such as cell wall-
associated proteins, during growth [21]. RNAIII contains 517 nucleotides covering hld gene, which 
encodes the 26 amino-acids δ-hemolysin. Its 2D structure shows 14 hairpin arrangements (Figure 3). 
After transcription, RNAIII has a long half-life of up to 45 min [40].   
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Figure 3: Secondary 
structure of 
RNAIII. RNAIII contains 
514 nucleotides that 
form 14 hairpin motifs 
linked by unpaired 
nucleotides, which are 
numbered in the figure. 
The encoding region 
of δ-hemolysin is 
represented in green 
and the hld start and 
stop codons are framed. 
Nucleotides 
demonstrated to inhibit 
translation of target 
mRNAs are red. 
Adapted from [39,45]. 
In S. aureus, the agr system up-regulates the expression of some secretory proteins, whereas 
certain surface proteins are down-regulated [21]. RNAIII is the key effector of the agr system and can 
up-regulate the expression of certain target genes (e.g. hla and map), or down-regulate other genes 
(e.g. spa, coa and rot) at the level of translation by mechanisms of antisense base pairing (figure 4) 
[40-45,52]. In the first case, the sRNA transcript interacts with the target mRNA and leads to a 
conformational modification that opens a mRNA loop which hides the Shine-Dalgarno (SD) sequence, 
thus making it available for ribosomal access. In the second way, ribosomal access is prevented by 
double strand RNA forming at the SD domain and promoting RNaseIII cleavages (figure 4).  
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Figure 4: RNAIII mechanisms of post-transcriptional regulation on hla, spa, rot, and coa [45]. RNAIII activates hla 
translation by disrupting the stem-loop and allowing ribosomes to access the SD sequence. RNAIII inhibits the 
translation of genes (spa, rot, and coa) by basepairing with the mRNA, blocking recognition of the SD sequence, 
and promoting RNaseIII cleavage. Targeted mRNAs are shown in black while RNAIII sections are identified in 
red. Numbers reflect nucleotide positions from 5’ to end of transcripts. Blue arrows indicate sites of cleavage by 
RNaseIII. From  [45]. 
II.1.3 DNA-binding proteins and transcription factors 
The virulence of S. aureus is essentially determined by cell wall associated proteins and 
secreted toxins that are regulated and expressed variously as a function of growth and environmental 
stresses. Gene expression is regulated by specific and sensitive mechanisms, which may act both at 
the transcriptional or post-transcriptional levels. Regulatory factors constitute numerous complex 
networks, driving specific interactions with target gene promoters. These factors are largely regulated 
by TCRS (previously described). 
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II.1.3.1. Sar family 
The DNA-binding proteins or transcription factors are largely represented by the Sar family of proteins 
(Staphylococcal accessory regulator) and also regulate virulence factor expression (Table 2). The 
multiple pathways generated by these factors allow the staphylococci to adapt to environmental 
conditions rapidly and specifically, and to develop infection. Figure 5 summarizes the regulatory 
networks between Sar family proteins and agr.  
 
Figure 5: Regulatory network between Sar family DNA-binding proteins and agr. Each Sar type proteins identified 
can have an effect on one or more of these controlled systems, thus creating a network of very complex control 
on target genes. Green and red arrows represent activation and repression respectively. Gene promoters are 
represented by black boxes and denominated P1, P2 or P3. Adapted from [53]. 
 
The sarA operon was initially described in 1992 by Cheung et al. Random insertion of the Tn917 
LTV1 transposon into the chromosome of S. aureus resulted in a pleiotropic effect on the expression 
of a number of extracellular and cell wall-associated virulence proteins [54]. The sarA operon consists 
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of three overlapping transcripts, with common 3’ ends, and a transcriptional termination occurring 
upstream of a typical prokaryotic poly(T) termination signal. The three transcripts are controlled by 
three distinct promoters in a growth phase-dependent manner [55]. Manna et al reported that the P3 
promoter of the sar locus was σB dependent and the three promoters were positively autoregulated by 
SarA [56]. SarA has been shown to be down-regulated by its homologue SarR [57], but the sar locus 
remains complex and may involve the sar gene product(s) and other regulatory protein(s) as well. 
Furthermore, due to the fact that σB activity peaks in the late exponential growth phase and diminishes 
in the stationary growth phase, the expression of sarA peaks during the late exponential phase [58]. 
However, western blot analyses made by Blevins et al [59], indicated that SarA was produced in 
indistinguishable amounts during both exponential and post-exponential growth phases, suggesting 
the SarA protein might be regulated at the post-translational level as well.  
Table 2: Principal DNA binding proteins and functions in S. aureus 
Gene Function References 
sarA 
Activation of agr. Transcription repressor of sarS, sarT, sarV.  
Activation of fnbpA, fnbpB, hemolysins, leucotoxins, enterotoxins, TSST-1 and fmtA. Repressor 
of spa, cna and sspA.  
[39,54,55,59-68] 
sarR Repressor of sarA and agr. Activation of aur and sspA.  [57,69,70] 
sarS Activation of spa and repression of hla, hld and ssp.  [71,72] 
sarT Repressor of rnaIII and sarU. Activator of sarS. [22,73] 
sarU Activation of agr.  [74,75] 
Rot Activation of spa, sspB, sspC and clfB. Repression of hla and hlg genes (hlgB – hlgC) [76-78] 
sarX Repressor of agr [79] 
mgrA Activator of sarX and agr. Repressor of sarS and sarV. Upregulation of exoproteins (hla) and down regulation of surface proteins (spa).  [22,80,81] 
sarV Control of autolysis [22] 
sarZ Activator of agr [22] 
sigB Repressor of agr and sarX and activator of sarA. Activation of stress resistance genes.  [56,58,82-89] 
 
A homodimer of SarA was able to bind to a conserved A/T-rich recognition motif in the promoter 
regions of its target genes [61,90].  SarA was described as an activator of agr, where it directly binds 
to the P2 and P3 promoter regions and increases the levels of both RNAII and RNAIII, thus indirectly 
modifying the expression of agr-dependent virulence factors [60,62]. However, SarA can also 
modulate other target genes via agr-independent pathways. Indeed, an alignment of sequences from 
the promoter regions of hla, spa, fnBPA, fnBPB, and sec revealed an apparent conserved regions, 
termed Sar boxes, that shared homology with the SarA-binding site on the agr promoter [61].  
Interestingly, it is well established now that SarA could promote the transcriptional expression of 
numerous targeted genes, as fnBPA and fnBPB, agr, hemolysins,  leucotoxins (LukED, LukSF), 
enterotoxins, superantigen TSST-1 [58,60,63-67], and more recently fmtA (formyl transferase), 
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which encodes a low-affinity penicillin binding protein in S. aureus [68]. Conversely, SarA also acts as 
a repressor of other target genes, such as spa, cna and sspA (staphylococcal serine protease)  
[64,66,91]. 
Several sarA homologs have been identified in the S. aureus genome by sequence alignment, 
including sarR, sarS, sarT, sarV, sarU, sarY, and rot (repressor of toxins) [22,30]. The staphylococcal-
specific SarA family of transcription regulators controls large numbers of target genes involved in 
virulence, autolysis, biofilm formation, stress responses and metabolic processes, and are recognized 
as potential therapeutic targets. One of them is sarR, which presented around 51% homology with 
sarA. The three sarA promoters are down-regulated by direct binding of the homolog SarR, which 
represses the expression of the SarA protein, especially in the late exponential and stationary phases 
[57]. Furthermore, SarR also binds to the P2 promoter of agr, in order to represse it [70], and activates 
aur (metalloprotease; aureolysin) and sspA [69]. 
Another homolog is SarS, a 29-kDa protein which has been first isolated by Tegmark et al as 
SarH1 (Sar Homolog 1). The expression of sarS is strongly repressed by sarA and agr [71]. SarS has 
the ability to bind to the promoter regions of various genes, like hld, ssp, and hla (repression) or spa 
(activation). The same protein was identified by Cheung et al. [72] at the same time, and was named 
SarS. The sarS gene is located upstream of spa in the S. aureus chromosome. Moreover, they 
conclude that the agr locus probably mediates spa repression by suppressing the transcription of sarS, 
an activator of spa expression whereas sarA repression acts by an independent sarS mechanism [72]. 
The SarS gene is transcribed from two distinct promoters controlled by an σA dependent promoter and 
the σB dependent stress response promoter [72]. 
Yet additional members of the Sar family is the 16,1 kDa SarT protein, which shares 35% of 
homology with the SarA sequence and 20% of homology with SarR. In addition, complex interactions 
exist between sarA, sarT and agr. The sarT gene is down-regulated either by SarA or agr but can also 
repress the transcription of rnaIII [73]. These interactions allow controlling the expression of hla by two 
distinct mechanisms. First, hla transcription could be activated directly by binding of sarA and indirectly 
by the repression of sarT via SarA. In contrast, SarT should repress the hla transcription by 
inactivating the rnaIII expression [73]. Moreover, the activation of sarT results in up-regulation of sarS 
[22], thus leading to hla repression and spa activation [71]. 
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Adjacent but divergently transcribed from sarT is sarU, which is repressed by SarT. However, it 
is an activator of agr that promotes the expression of agr-targeted genes (hla) and decreases the 
expression of genes encoding cell wall-associated proteins like coa [91]. This mechanism may be an 
alternative pathway for the regulation of RNAIII and virulence factors independently of the quorum 
sensing regulation mediated by the auto inducible peptide AIP [75]. 
McNamara et al described Rot (repressor of toxins) as a homolog of the global regulators AgrA 
and SarA that represses toxins [78].  They also demonstrated that Rot could interact with targeted 
gene promoters during the logarithmic phase of growth. In 2003, GeneChips analyses revealed that 
Rot was not only a toxin repressor, but a global regulator with both positive and negative effects on the 
expression of 146 S. aureus genes. Rot and agr showed opposite effects on selected target genes: 
i.e. spa, sspB and sspC were up-regulated by Rot but down-regulated by agr, whereas hla and the γ-
hemolysin genes (hlgB and hlgC) were down-regulated by Rot and upregulated by agr [76]. In 2006, 
Geisinger et al [44] suggested that the agr RNAIII molecule might interact with rot mRNA to inhibit Rot 
translation through a mechanism of base-pairing. More recently, Xue et al [77] demonstrated that Rot 
was an activator of clfB by directly binding to the clfB promoter during the early exponential growth 
phase, and that RNAIII could regulate clfB expression during the exponential phase via Rot. 
SarX regulation has been investigated by Manna et al [79], who found that sarX transcription 
was growth phase-dependent and was expressed maximally during the stationary phase of growth. 
SarX acted also as a repressor of the agr locus and consequently on target genes regulated by the 
agr system [79].  
MgrA (Multiple gene regulator A), another SarA homolog, regulates autolysis by a mechanism 
independent of other global regulators and inducts agr and sarX transcription but represses sarS and  
sarV  [80]. The transcriptome of S. aureus Newman has been analyzed by microarrays and revealed 
that MgrA regulates 355 genes in all function categories. Accordingly, exoproteins are up-regulated 
and surface proteins are down-regulated by MgrA, suggesting that it acts in parallel with agr [80,81].  
Others SarA homolog are SarV and SarZ [22]. The sarV gene seems to be repressed by MgrA 
and SarA in normal in vitro growth conditions, due to is significant enhancement in mgrA and sarA 
mutants. In contrary to mgrA and sarA mutants, the sarV mutants appeared more resistant to 
detergents or cell wall antibiotic-mediated lysis compared to the parent, while overexpression of sarV 
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rendered the parental strain more susceptible to lysis. Hence, sarV may be part of the common 
pathway by which mgrA and sarA control autolysis in S. aureus [22]. 
II.1.3.2. The sigma factor B, σB 
RNA polymerase could involve σ factors to recognize specific promoter elements, leading to the 
initiation of transcription. One group of σ factors is required for the expression of housekeeping genes, 
and a second contains factors, like σB, that are involved in the regulation of the gene expression upon 
various stress conditions.  
The σB factor is located within a chromosomal gene cluster with three other determinants: i.e. 
rsbU, rsbV and rsbW [82]. The regulation of σB is differentially modulated by the rsb (regulator of σB) 
factors, which are self-controlled between them.  Gertz et al [83] have shown that numerous genes, 
most of which are involved in stress responses, are controlled by σB. Moreover, σB influences the 
expression of virulence factors such as enterotoxins B, aur, hla, clfA, fnbA, and numerous other 
surface-associated components, both in vitro and in vivo [84-89]. More generally, σB is responsible for 
the transcription of genes that can confer stress resistance to the vegetative cell.  
In conclusion, S. aureus possesses a very complex network of regulatory systems and elements 
that interact together to allow the bacteria to express specific factors during adaptation to specific 
milieus or including the processes of active infection and persistence. Virulence factors involved in S. 
aureus infection are detailed in the next section. 
II.2. Virulence factors 
The bacterial components and secreted products that affect the pathogenesis of S. aureus 
infections are numerous and include surface-associated MSCRAMMs, antiphagoxytic 
polysaccharides, and exoenzymes or exotoxins. These allow staphylococci to adhere to eukaryotic 
membranes, lyse eukaryotic cells, resist opsonophagocytosis, and trigger the production of a cascade 
of host immunomodulating molecules. Because of the multifactorial nature of staphylococcal infections 
and the functional redundancy of S. aureus virulence factors, it has been difficult to sort out the role 
that individual virulence determinants play in the pathogenic process. The major S. aureus virulence 
factors are overviewed below. 
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II.2.1. Extracellular toxins and enzymes 
S. aureus produces large numbers of secreted virulence factors including two major families of 
exoproteins, namely cytolysins and superantigens, which interfere with the immune system locally or 
systemically, respectively. Moreover, S. aureus secreted factors encompass various extracellular 
enzymes, including proteases and lipases that contribute to tissue invasion.  
II.2.1.1. Cytotoxins or “pore forming toxins” 
S. aureus cytotoxins, such as hemolysins and leukocidins are active on eukaryotic plasma 
membranes. By lysing target cells, they pave the way to polymer degrading proteases and lipases, 
which provide nutrients for the invading bacterium. They act either via channel forming proteins that 
punch holes in the target membranes, or through membrane degrading enzymes. 
a) Hemolysins 
Four types of hemolysins have been described and referred to as α-hemolysin (Hla), β-
hemolysin (a sphyngomyelinase), γ-hemolysin, and δ-hemolysin [92]. They are present in most S. 
aureus isolates, are encoded on the chromosome and contain high-affinity structures that interact with 
the membranes of a variety of eukaryotic cells, including human platelets, monocytes and endothelia. 
Hemolysins are subject to agr regulation and hla is directly regulated by the RNAIII [41]. 
b) The Panton and Valentine leucocidin, PVL 
The PVL is a homologue of γ-hemolysin and was first reported in 1932 by Panton and Valentine. 
The toxin is encoded by the lukS and lukF genes that are carried by the prophage φSLT. The 
prophage can be mobilized and transfer PVL to other strains [93]. PVL, is apparently regulated by agr 
[4], like other hemolysins, and is associated with community-associated methicillin resistant S. aureus 
(CA-MRSA) strains [94]. However, the genuine contribution of PVL to CA-MRSA pathogenesis 
remains controversial. 
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II.2.1.2. Superantigens 
S. aureus can colonize mucosal surfaces, including the anterior nares and vagina. Moreover, 
due to their abilities to secrete a variety of virulence factors, S. aureus that are confined to mucosa, 
can cause distant illnesses by the production of exotoxins factors that cross the mucosal barrier and 
spread throughout the body. Such exotoxins are referred to as superantigens because they induce 
non-specific activation of the immune system [95]. Superantigens interact with antigen-presenting cells 
and T cells, by direct binding of the major histocompatibility complex (MHC) class II proteins and T-cell 
receptors, to induce T lymphocytes proliferation and massive cytokine production, thereby bypassing 
the normal antigen processing and presenting mechanism. To date, 19 different superantigens and 
related toxins have been described in S. aureus with some differences in structure and biological 
activity [96]. Corresponding genes are generally located on MGEs, such as pathogenicity islands, 
plasmids, and phages. The well-known toxic shock syndrome toxin (TSST-1) and enterotoxins belong 
to this class.  
a) Staphylococcal enterotoxins, SEs 
SEs function both as direct gastrointestinal toxins and as superantigens, two activities that are 
mediated by different domains on the protein [97]. SEs have compact structures that allow to be highly 
resistant to proteases, including trypsin, chymotrypsin, and papain, which are all found in the intestinal 
lumen. All enterotoxins seem to be regulated by agr, except SEA [21]. 
Several SEs have been described. For instance, SEA (encoded by the entA gene carried by a 
temperate bacteriophage [98,99]), is one of the major toxins implicated in staphylococcal food 
poisoning [13]. Its expression is not affected by the agr system [100]. SEA, like the majority of SEs, 
involves a Zn2+ coordination site to bind to the MHC receptor. Besides, SEB is the toxin most 
commonly associated with classical food poisoning. It has also been demonstrated to cause a non-
menstrual toxic shock syndrome (TSS). The entB gene needs a functional agr for maximal expression 
[101]. Is it situated on the bacterial chromosome in most clinical isolates responsible for food 
poisoning, but may be carried on plasmids in other strains [102]. Ingestion of SEB produces profound 
gastrointestinal symptoms, including anorexia, nausea, vomiting, and diarrhea.  
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b) The toxic shock syndrome toxin, TSST-1 
TSS leads to fever, rash, capillary leak and subsequent hypotension, the major symptoms of 
toxic shock syndrome. In the early 1980s a dramatic increase in the number of staphylococcal TSS 
cases occurred in young women who used high-absorbency tampons during menses [12]. This 
appeared to be due to colonization with TSST-1 positive S. aureus. TSST-1 is able to cross the 
mucosal membrane and disseminate throughout the body. TSST-1 activates directly epithelial cells 
and the innate immune system [103].  The toxin is also regulated by agr [21,92]. 
Non-menstrual TSS clinical forms do exist, especially following surgical wound dressing with 
hyper absorbent bandages. These cases, referred to surgical TSS, seems be association with SEB 
and SEC.  
II.2.1.3. Enzymes and exotoxins 
Numerous additional enzymes are implicated in S. aureus virulence and diseases. Diverse 
proteases, elastases, and hyaluronidases are able to degrade conjunctive tissues [104,105]. Some of 
these are described in some details below. 
a) Coagulase 
Coagulation is an innate defense mechanism against microbial pathogens that traps and 
immobilizes invading bacteria in a clot. However, coagulation is also the target of bacterial immune 
evasive strategies. For instance, inoculation of anticoagulated plasma or blood (with calcium 
chelators) with S. aureus results in rapid clotting in spite of anticoagulation [106]. This phenomenon is 
due to coagulase (Coa), a S. aureus protein of approximately 670 amino acids that triggers 
coagulation by direct activation of prothrombin [107]. The N-terminal part of Coa encompasses D1-D2 
domains [108], which bind to the prothrombin [109]. The C-terminal domain is composed of 2–8 
tandem repeats of a 27-residue peptide corresponding to the same fibrinogen-binding domain found at 
the C-terminal end of another staphylococcal fibrinogen-binding protein [108,110]. Thus, by interacting 
directly with both fibrinogen and prothrombin, Coa mediates clotting of plasma or blood [111]. 
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b) Staphylococcal serine protease, Ssp 
SspA (or V8 protease) was one of the first secreted enzymes of S. aureus to be purified and 
characterized in detail [112]. Using sequence analysis of the S. aureus strain RN6390 genome, Rice 
et al [113] found that sspA was closely followed by an open reading frame encoding an extracellular 
cysteine protease, sspB. They described an operon, which also includes a third open reading frame 
sspC, of unknown function. Moreover, they also described a cascade pathway of proteolytic activity, 
where metalloproteases were required for maturation of SspA, which then processes SspB and 
controls cell wall autolytic activity. Ssp can degrade the bacterial cell surface FnBPs and affect the 
overall surface protein composition that confers a controlling role in microbial adhesion [113,114]. 
Moreover, Karlsson et al [115] demonstrated that SspA was also able to degrade Spa and FnBPs at 
the cell surface. Thus, although serine proteases (e.g. V8 protease) may intuitively be associated to 
pathogenicity and invasion, these enzymes may primarily carry housekeeping functions, including 
regulation of the functional expression of surface proteins. 
At the level of regulation, agr was shown to positively regulate the ssp operon [113,116], 
whereas SarA acted as a repressor of protease activity [66]. 
c) The aureolysin, a metalloprotease family member 
Aureolysin is encoded by the aur gene that is up-regulated by agr at the end of exponential 
phase and repressed by SarA [49,66]. Different studies suggested that not only coagulase, but also 
other extracellular proteolytic enzymes could stimulate plasma clotting [117]. Aureolysin, in addition to 
V8 protease, was shown to modify cell surface proteins of S. aureus, for instance by inactivating ClfB 
dependent of fibrinogen binding activity of the bacteria when they enter into the stationary phase. It 
was suggested that this mechanism could facilitate the detachment of bacterial cells in certain 
conditions, in order to promote their dissemination to other colonization sites within the host [118]. 
d) Exfoliatins, ETs 
ETs promote superficial skin disorder that varies from local blistering (bullous impetigo or BI) to 
impressive generalized scalding (staphylococcal scalded-skin syndrome or SSSS). It was first 
described in young children in 1878. SSSS generally occurs in newborns and infants less than one 
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year old and rarely in adults, but BI can occur at any age [119]. It is typically the result of mucosal or 
skin colonization (e.g., umbilical cord) with a toxigenic S. aureus that produces either exfoliatin toxin A 
(ETA) or ETB, encoded by the eta and etb genes, which are located on a phage inserted in the 
bacterial chromosome and a plasmid, respectively. ETA is generally associated with BI whereas ETB 
is associated with generalized SSSS [120]. Two additional isoforms of SSSS toxins, ETC and ETD, 
were isolated through pathologic observations in animals and with genome screening [121-123]. ETA 
expression was reported to be regulated by agr in exponential growth phase [124].  
II.2.2. Bacterial envelope and surface determinants 
II.2.2.1. Capsule 
The microbial envelope is not an amorphous scaffold that merely ensures bacterial shape. It is a 
sophisticated structure indispensable to mediate adherence, sensing and growth in complex 
environments. From the outermost layer of the bacterium, one first finds the polysaccharidic capsule. 
The majority of clinic isolates causing invasive diseases produce a polysaccharidic capsule (Figure 6). 
This extracellular structure mostly prevents the access of phagocytes to phagocytosis-triggering 
molecules such as pathogen associated molecular patterns (PAMPs) that trigger innate immunity, or 
antibody or complement-mediated phagocytosis. The production of capsule by S. aureus was first 
described in 1931 by Gilbert [125]. Since 1985, eleven polysaccharide serotypes have been 
characterized in S. aureus [126].  
 
Figure 6: Transmission electron micrographs of S. aureus cells cultured on agar plates. Prior to fixation, both 
strains were incubated with rabbit CP5-specific antibodies to stabilize and visualize the capsule. On the left, CP5-
producing strain Reynolds; on the right, an acapsular S. aureus mutant. From [127]. 
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Most clinical isolates of S. aureus produce either CP5 (Capsular Polysaccharides 5) or CP8 
(75%) and are often referred to as microencapsulated. Colonies of serotype 5 and 8 strains of S. 
aureus are not mucoid (hence, they are distinguishable from mucoid serotype 1 or 2), and their colony 
morphology is usually indistinguishable from that of acapsular isolates. The expression of the CP5 and 
CP8 capsules in vitro is highly sensitive to various environmental signals and is probably influenced by 
the in vivo environment as well [128-132]. Importantly, the expression of capsular polysaccharides 
inhibits S. aureus ClfA-mediated binding to fibrinogen and platelets. This is most likely due the fact that 
the thick capsules masks the access to ClfA, a phenomenon which has unforeseen implications for 
vaccine development [133]. In 1995, Soel et al [134] revealed that CP5 and CP8 were also able to 
bind to human epithelial cells, endothelial cells, and monocytes. They concluded that capsules were 
bacterial adhesins with immunomodulatory effects for human cells.  
Agr positively regulates CP5 and CP8 production (with a minimal similar impact of SarA) in vitro 
[135,136]. Likewise, Van Wamel et al. [137] reported that agr positively regulates cap5 expression 
both in vitro and in vivo in a rabbit model of experimental endocarditis, suggesting that it might be 
important for invasive diseases. Conversely, capsule-negative S. aureus induced more promptly 
chronic experimental mastitis in mice [138], suggesting that the loss of CP5 or CP8 expression might 
favor the persistence of staphylococci in the mammary glands of chronically infected hosts. This is 
consistent with the fact that the number of S. aureus isolates from patients with chronic infections that 
do not express capsular polysaccharides is significantly higher than in isolates from acute infections, 
suggesting again that loss of capsule expression is associated with S. aureus with persistence. Thus, 
is appears that the capsule may promote bacterial colonization and persistence in various conditions. 
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II.2.2.2. Peptidoglycan  
The peptidoglycan is a highly conserved constituent of both the Gram-positive and Gram-
negative envelopes. It is constituted of glycan chains made of N-acetylglucosamine (NAG) and N-
acetylmuramic acid (NAM) disaccharide subunits, in which the N-acetylmuramate moiety is linked to 
highly conserved pentapeptide or tetrapeptide stems (L-alanine – D-isoglutamine – L-lysine – D-
alanine – [D-alanine]) (Figure 7) [2].  
 
 
Figure 7: Schematic representation of 
Gram positive bacteria cell envelope 
(http://202.204.115.67/jpkch/jpkch/200
8/wswx/chapter%203.htm).
In Gram-positive bacteria the thick peptidoglycan (50-100 nm in width) [139] functions as a 
surface organelle that ensures the contact between the external environment and the inside of the cell. 
It also serves to convey a number of functional proteins to the bacterial surface. In order to be targeted 
to bacterial envelope, proteins must carry the specific sequence YSIRK/GS [140,141]. The 
peptidoglycan is the major scaffold for anchoring most MSCRAMMs and other molecules. In that way 
it plays a key, yet indirect role in pathogenesis. Concomitantly, it is recognized by the innate immune 
system and triggers cytokine release and inflammation, through components such as LTA [142]. Thus, 
it is important for the microorganisms to hide these structures from host recognition, an objective that 
can be achieved by producing antiphagocytic components such as a capsule, or protein A.  
Because peptidoglycan is a critical cell structure, its assembly is the target of antibiotics such as 
β-lactams and glycopeptides. Accordingly, modification of peptidoglycan synthesis is a response of 
resistant staphylococci to cell wall-active antibiotics [143]. 
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II.2.2.3. Teichoic acids and lipoteichoic acids 
TA represent up to 50% of the dry weight of purified staphylococcal walls. It is constituted of 
polyribitol-phosphate polymers crosslinked to NAM residues of the peptidoglycan (Figure 7) and 
decorated with D-alanine and NAG residues [144]. TA play an important physiologic role in the cell 
wall metabolism, and are likely to be a site of attachment of cell wall active enzymes and other 
proteins. They have been involved in adherence to nasal epithelia [145], but their role in invasive 
infection and host inflammatory response is unclear [142]. 
LTA are the plasma membrane-bound counterparts of TA. They share a common general 
structure but contain polyglycerol-phosphates and are linked to a diacylglycerol moiety that serves as 
a plasma membrane anchor. LTA have been implicated in inflammation by triggering the release of 
cytokines by macrophages and other players of the innate immune system. In particular, it was shown 
that the stereochemistry of the D-alanine decorations as well as the presence of the diacylglycerol lipid 
anchor were critical for host recognition and subsequent inflammation [144].  
While LTA may facilitate bacterial recognition by host innate immunity, they also protect the 
microbes from killing by cationic antimicrobial peptides (CAPs) that are produced by professional 
phagocytes. Native LTA are polyanionic and may attract CAPs, which may be detrimental for the 
bacterium. To circumvent this problem, LTA become decorated with D-alanyl residues by the dltABC 
gene products, which render the structure more positively charged and thus repulses CAPs. Mutants 
impaired in dltABC are less adherent to endothelial cells and less able than wild type staphylococci to 
produce experimental endocarditis in rabbits [146].  
II.2.2.4. Cell surface loosely and strongly associated proteins 
Colonization is an important factor in the initiation of S. aureus infection. In order to colonize 
host tissues, S. aureus is capable of binding to extracellular host matrix or serum components, 
including fibrinogen, fibronectin, collagen, elastin, laminin, vitronectin, bone sialoprotein and 
thrombospondin, to mention some of them.  
These proteins either remain associated with the surface, like MSCRAMMs, or may be released 
into the culture supernatant, like SERAMs (for Secretable Expanded Repertoire Adhesive Molecules). 
Both types of proteins are involved in colonizing host tissues and in evading the host immune 
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response [20,147]. Table 3 summarizes the main known species of these two groups. Individual 
species of the two groups are also described below.  
Table 3: S. aureus surface proteins and secreted proteins that contribute to adherence to extracellular matrix 
components and serum proteins. 
Full Protein name Gene Binding ligand - Function Ref 
SERAMs    
Extracellular adherence protein eap Fibrinogen (α-chain), fibronectin, prothrombin, endothelial cells [148,149] 
Extracellular fibrinogen binding protein efb Fibrinogen (α-chain), C3b, platelets aggregation [150-154] 
Coagulase coa Fibrinogen, prothrombin [107-109,111] 
MSCRAMMs    
Protein A spa IgG, TNFR1, Von Willerbrand factor, platelets activation, superantigen [155-161] 
Fibronectin binding protein A fnbpA Fibronectin, fibrinogen, elastin [110,162-165] 
Fibronectin binding protein B fnbpB Fibronectin, Elastin [162-166] 
Clumping factor A clfA Fibrinogen (γ-chain), fibrin [167] 
Clumping factor B clfB Fibrinogen (α/β-chain), Cytokeratin I-10 [168,169] 
Iron-regulated surface determinant A isdA Heme [170,171] 
Iron-regulated surface determinant B isdB Hemoglobin, heme [170-172] 
Iron-regulated surface determinant C isdC Heme [170,171] 
Iron-regulated surface determinant isdH Heme [171,172] 
Serine-aspartate repeat protein C sdrC Unknown [173] 
Serine-aspartate repeat protein D sdrD Unknown [173] 
Serine-aspartate repeat protein E sdrE Unknown [173] 
Serine-rich adhesin for platelets srap Platelets  [174] 
Staphylococcus aureus surface proteins C sasC Biofilm formation, cell aggregation [175] 
Staphylococcus aureus surface proteins  D sasD Unknown [176] 
Staphylococcus aureus surface proteins  F sasF Unknown [176] 
Staphylococcus aureus surface proteins  G sasG Biofilm formation, nasal epithelial cells [177-180] 
Staphylococcus aureus surface proteins  H sasH Unknown [181] 
Staphylococcus aureus surface proteins  K sasK Unknown [181] 
Formyl transferase B fmtB Penicillin resistance, cell wall synthesis [182,183] 
Collagen binding protein cna Collagen  [184,185] 
Plasmin sensitive protein pls Preventing adherence [186] 
Surface protein in Japanese ST8 CA-MRSA spj Unknown [187] 
Elastin binding protein ebps Elastin [188,189] 
Bone sialoprotein binding protein bbp Bone sialoprotein, fibrinogen [190,191] 
a) SERAMs 
Extracellular adhesive proteins, Eap 
SERAMs are not structurally related, but share a common functionality. A major studied 
SERAM, Eap, binds to multiple matrix proteins, including fibrinogen, fibronectin, prothrombin, and 
vitronectin. After secretion, it mediates agglutination by acting as a bridge between bacteria and host 
cell, either by Eap–Eap interaction or via other components of the bacterial surface [148]. Recently, 
Edwards et al [149] demonstrated that S. aureus Eap promoted attachment to endothelial cells via 
Protein A and generated more severe infections in a murine bacteremia model, thus demonstrating its 
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role in invasive diseases. Moreover, S. aureus strains that fail to produce Eap, exhibited a significantly 
decreased affinity for eukaryotic tissue binding and lacked the ability to colonize and invade host 
tissues [192-194]. 
Extracellular fibrinogen binding, Efb  
As a prototype of SERAMs, Efb is an innate immune evasion molecule which was reported to 
inhibit complement activation [150] and to block platelet aggregation in vitro and in vivo [151,154]. 
Moreover, Efb was shown to bind to fibrinogen [150,152] with an unusually high affinity [153]. 
Interestingly, it has been show that such a high-affinity binding resulted in an inhibition of neutrophil 
adherence to immobilized fibrinogen, suggesting Efb could be powerful evader of human host 
defenses[153]. 
b) MSCRAMMs 
Protein MSCRAMMs are encoded on the chromosome and have single or multiple binding 
properties for ligands. In Gram-positive bacteria many protein MSCRAMMs are covalently attached to 
the peptidoglycan via conserved mechanism (Figure 8A).  
This mechanisms involves a conserved protein archtecture that starts with a N-terminal 
secretory signal peptide, required for Sec-dependent secretion and ends with a positively-charged C-
terminal extension, which ensures that the protein is not secreted. Just proximal to the positively-
charged C-terminal is a transmembrane-spanning domain, which is itself preceded by a conserved 
LPXTG motif that is indispensable for further anchoring the protein into the peptidoglycan. This 
anchoring involves a transpeptidation mechanism, which is mediated by an enzyme called sortase. 
The principal S. aureus sortase is encoded by the srtA gene [195]. It is a membrane protein which 
cleaves the MSCRAMMs between the threonine and the glycine of its LPXTG motif, and catalyzes the 
formation of an amide bond between the carboxyl-group of threonine and the amino-group of 
peptidoglycan penta-glycine cross-bridges (Figure 8B) [196]. Mutants lacking srtA are defective in 
surface proteins and are attenuated in animal infection models [197].  
At least 22 genes encoding surface proteins belonging to the LPXTG family have been 
identified by in silico analysis of six S. aureus genome sequences [176,187,196]. The domain 
architecture, repeat regions and common signal peptide motif suggest that the evolution of these 
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LPXTG proteins may have arisen in a modular fashion [176]. These adhesins are described in more 
details below. 
 
Figure 8: A, General structure of MSCRAMMs B, Surface protein anchoring in S. aureus. (i) Export. (ii) Retention. 
(iii) Cleavage. (iv) Linkage. (v) Cell wall incorporation. From [196].  
Protein A, Spa 
Protein A is encoded by the spa gene and is a major surface-attached protein of S. aureus. 
Dedent et al demonstrated that Protein A was unevenly distributed over the bacterial surface and that 
this distribution was related to the process of cell wall synthesis [156].  
Protein A carries several important functions in pathogenesis. First, it interferes with 
opsonisation by catching immunoglobulin G (IgG) by their Fc portion, and thus hiding their opsonizing 
domain to professional phagocytes [155,157]. Second, Protein A may trigger pulmonary epithelial cell 
inflammation by attracting polymorphonuclear cells into respiratory tract, via TNFR1 (Tumor Necrosis 
Factor Receptor 1) activation [158]. Thus, it seems to play a role in the pathogenesis of pneumonia. 
Third, Protein A may be implicated in endothelial damages via binding to Von Willebrand factor, which 
is a multimeric glycoprotein involving platelet adhesion [159], and to a platelet complement receptor 
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(gC1qR/p33) [160]. Finally, Protein A can act as a superantigen and trigger non-specific inflammation 
in response to staphylococcal infection [161]. 
As mentioned above, numerous global regulators interact between themself to regulate spa 
expression during the bacterial growth (Figure 5). The first regulator identified was agr, which acts via 
RNAIII as a repressor at the post-transcriptional level during the late exponential and stationary growth 
phases (Figure 4) [21,40]. Spa expression is also controlled by the transcription regulators SarA, SarS, 
SarT and Rot. SarS seems to be the key effector of this regulation. SarS is localized just before spa in 
the S. aureus genome and directly active the spa transcription [71,72]. SarT and Rot activate indirectly 
spa via SarS [76,198].  
Fibronectin binding protein, FnBP 
FnBPs expression and ability to bind fibronectin are found in most clinical isolates of S. aureus 
[162]. fnBPA and fnBPB genes are located in tandem on the chromosome and corresponding proteins 
are crucial for invasion mechanisms in eukaryotic cells [163,164]. Figure 9 exposes the structural 
organization of S. aureus Fnbp. 
 
Figure 9: Structural organization of S. aureus FnbpA and FnbpB. The newly defined segments containing putative 
fibronectin-motifs binding with the F1 modules of fibronectin are represented in dark blue [199]. The N1, N2 and 
N3 domains in light blue represent the fibrinogen and elastin-binding domains. The signal peptide (SP, in green), 
the proline rich repeat domain (PRR, in purple), the cell wall-spanning W region (in grey), the membrane-
spanning M region (in grey), and the LPETG cell wall anchor motif (in yellow) are also indicated. Adapted from 
[166,200]. 
One of the pathogenic properties of S. aureus, that has been difficult to assess in vivo, is the 
role of host-cell invasion during infection. Recent in vitro studies have provided convincing evidences 
that staphylococci can invade non-professional phagocytes, including epithelial and endothelial cells, 
fibroblasts, osteoblasts and keratinocytes [201-204]. The fibronectin-binding proteins were identified 
as major factors in initiating the internalization of S. aureus [19,200]. Furthermore, evidences from 
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several experimental models suggest that interfering with the ability of the bacteria to associate with 
fibronectin attenuates S. aureus virulence [205].  
Additional studies investigating interactions between more than one surface protein help clarify 
the complex interplay between different virulence factors, or even between distinct domains within 
single proteins. They also clearly provided in vivo demonstration that Fnbp expression is sufficient to 
confer an invasive phenotype when heterogeneously expressed in non-pathogenic L. lactis [19]. 
Additional clinical evidence that cell invasion by S. aureus occurs in vivo came from a recent study in 
which intracellular S. aureus were detected in the endonasal mucosa of patients suffering from 
recurrent rhino-sinusitis [206]. Taken together, these studies clearly underline the importance of S. 
aureus host cell invasion for infection in vivo. Moreover, these findings support the concept that an 
“intracellular life-style” protects S. aureus from attacks by the immune system and shelters it from the 
action of antibiotics.  
It has been recently reported that some MRSA strains formed a novel type of biofilm that was 
promoted by FnBPA and FnBPB under mildly acidic growth conditions. MRSA biofilm phenotype 
appeared by a secondary and indirect interaction mechanism of intercellular accumulation. However, 
this seems not to be the case in MSSA (methicillin sensible S. aureus) strains [165]. Although rather 
similar, polymorphism does exist between FnBPA and FnBPB in S. aureus isolates and should be 
considered for the development of vaccines or immunotherapeutics that target FnBP [166].  
Clumping factors, Clf 
ClfA and ClfB are members of the Sdr (Serine-aspartate repeat protein) family characterized by 
the presence of an R region composed largely of repeated SD dipeptides (more details in Sdr 
paragraph below) [173]. They exhibit a comparable structural organization including an N-terminal 
secretory signal sequence followed by a ligand-binding A region, the dipeptide R region, and the 
LPXTG cell wall-anchoring motif (W). However, the Sdr proteins are not closely related in sequence, 
with only 20 to 30% identical amino acid residues in the ligand-binding A domain, suggesting different 
roles in S. aureus pathogenesis [207]. A hydrophobic membrane-spanning domain (M) and a short 
positively charged cytoplasmic domain are located at the C-termimus of the native protein, but these 
regions are cleaved upon LPXTG- attachment on the peptidoglycan.  
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ClfA is the major fibrinogen-binding protein on the surface of cells in stationary phase of growth 
[167,168]. ClfB binds not only to fibrinogen [167], but also to human type I cytokeratin 10 (CK10) 
expressed on squamous epithelial cells, which plays a key role in establishing human nasal 
colonization [168,169]. Likewise, studies have shown that immunization of mice with ClfB reduced 
nasal colonization [208]. Binding to fibrinogen is expected to be significant in platelet activation and 
aggregation and might contribute to the pathogenesis of experimental endocarditis in rats [209,210]. 
The Rot and agr systems have no significant effect on clfA expression [77]. On the other 
hand, Rot and agr exhibited consistent regulatory effects on clfB transcription and bacterial fibrinogen-
binding ability. Thus, the Rot and agr systems might affect bacterial fibrinogen-binding ability mainly 
through the regulation of clfB transcription [77]. 
Iron regulated surface determinants, Isd 
The isd locus of S. aureus encodes four surface proteins, one lipoprotein, one membrane 
transporter, one cytoplasmic protein, and one sortase (srtB) [171]. The figure 10 shows a schematic 
structure representation of the Isd surface proteins, and Table 4 provides additional information on 
them. The isdH gene is not located on the isd locus. All these proteins, except IsdC are covalently 
bound to peptidoglycan by a sortase A system. IsdC is attached by the sortase B.  
 
 
Figure 10: Organisation of the isd locus of S. aureus. Black boxes represent Fur boxes. Genes are represented in 
grey arrows. Black arrows indicate the initiation site of transcriptional units (adapted from [171]). The three 
transcriptional units encompass a ferric uptake repressor (fur) box, which inhibits transcription when iron 
concentration is high. Free iron is low in most environments including blood (approximately 10-18M). S. aureus 
uses the specific Isd system as its primary heme-iron uptake pathway to promote iron acquisition in such 
limitating conditions [26].  
 
IsdA, IsdB, IsdC and IsdH are cell wall associated proteins. Each Isd surface protein contains a 
secretion signal to be export, a sortase anchoring domain for SrtA or SrtB and one to three copies of a 
conserved NEAT (NEAr Transporter) domain [211]. NEAT domains are members of the 
immunoglobulin (Ig) superfamily.  
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Table 4: Localization and function of the Isd system components  [170] 
Protein Localisation Function Ref 
IsdA Cell wall Cell wall LPXTG anchored surface receptors  [170] 
IsdB Cell wall Cell wall LPXTG anchored surface receptors  [170] 
IsdC Cell wall Cell wall NPQTN anchored surface receptors [170] 
IsdD Membrane Unknown [170] 
IsdE Membrane Heme binding lipoprotein [170,212] 
IsdF Membrane Iron/heme permease – ABC transporter [171] 
IsdG Cytoplasmic Heme degrading enzyme [171,213] 
IsdH Cell wall Cell wall attached surface receptors [172] 
IsdI Cytoplasmic Heme degrading enzyme [213] 
SrtB Cell wall Attachment of IsdC NPQTN cell surface receptor  [170] 
 
A schematic representation of the Isd surface receptors is presented of figure 11. 
 
 
Figure 11: Schematic representation of 
the Isd surface proteins. All proteins 
contain a secretion signal represented 
by a black box, a sortase recognition 
sequence (in purple square for sortase 
A processing and in yellow square for 
sortase B), and at least one NEAT 
domain. NEAT domains are identified 
by IsdX-Ny where “x” indicates the 
unique protein and “y” the order of the 
NEAT domain. Blue boxes represent 
the heme-binding NEAT domains.  
Adapted from [172]. 
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Figure 12 summarizes the heme transport from the environment to the bacterial cytoplasm. 
Heme transport starts with the capture of heme after binding to hemoglobin at the surface of the 
bacterial cells by surface proteins IsdB or IsdH [171,172]. First, IsdH transfers its cargo to IsdB, which 
is then transported more deeply inside the peptidoglycan by IsdA or IsdC [171]. After crossing the wall, 
the heme molecule is relayed to the membrane binding protein IsdE that interacts with the membrane 
transporter IsdF. Once in the cytoplasm, IsdG and IsdI degrade the heme to liberate the central iron 
atom and make it available for the bacteria [171,213].  
 
Figure 12: Schematic representation of the Isd heme transport pathway. In blood, hemolysin acts by disrupting 
the red blood cell membrane in order to free its hemoglobin content. IsdA, IsdB, IsdC and IsdH, which are 
covalently bound to the peptidoglycan, are capture iron sources ant transfer it to the membrane receptor IsdE, 
which function is as yet unknown. Then, heme or iron could cross the membrane using the permease IsdF. In the 
cytoplasm, IsdG binds to the heme and IsdI reduces it in free iron. Adapted from [172]. 
Serine-aspartate (SD) repeat proteins, Sdr 
The Sdr proteins are a subset of putative staphylococcal MSCRAMMs, covalently anchored to 
the cell wall and characterized by a R segment composed of repeated serine-aspartate (SD) 
dipeptides. The Sdr proteins are encoded by sdrC, sdrD and sdrE tandemly present in the sdr locus 
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[173]. They have similar structural organizations, where the N-terminal ligand-binding A region can be 
further divided into three subdomains N1, N2, and N3. The N2 and N3 subdomains adopt IgG-like 
folds.  
The ligand-binding A region is similar in size, but is not closely related between the different 
members of the sdr family (with only 20 to 30% of similar amino acid residues), as well as with ClfA 
and ClfB, suggesting that Sdr proteins have different roles in pathogenesis [173]. The B-domains 
binds to Ca2+ and promotes the maintenance of structure to modulate the distance between the 
interactive A region and the bacterial cell surface. The C-terminal domain of Sdr contains the SD 
repeats followed by the cell wall anchoring LPXTG motif. 
Serine-rich adhesin for platelets, Srap 
The N-term of Srap contains an atypical putative signal peptide, followed by a short serine-rich 
region, a non-repeat region, a second serine-rich region and a cell wall anchoring motif LPDTG 
[174]. SraP promotes bacterial aggregation and binding to their own non-repeat domains via the 
serine-rich repeat domain located within its N-terminal region. Moreover, SraP appears to be a direct 
virulence determinant in endovascular infection [174]. 
Staphylococcus aureus surface proteins, Sas 
Analyses of primary sequences of the Sas family of proteins indicated that they present a similar 
structural organization and a common signal sequence with a characterized LPXTG motif of S. aureus 
and other Gram-positive cocci. SasC represents a novel S. aureus protein implicated in cell 
aggregation and biofilm formation, which may play an important role in colonization during infection 
[175]. SasD and SasF harbour a single residue variation in the fourth position of the LPXTG motif: 
LPXAG [176] and not the YSIRK/GS motif, which addresses proteins to the cellular pole [141]. SasK is 
absent from the majority of S. aureus genomes [181].  
SasG is an important mediator of biofilm formation in virulent strains of S. aureus [178,179]. It 
contains an N-terminal A domain and repeated B domains. Geoghegan et al [180] demonstrated that 
biofilm formation due to SasG accumulation is a process that requires a physiological concentration of 
Zn(2+) and is supported by the B domains. The sasG and sasH genes were positively and 
independently associated with disease isolates [177]. 
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Factor affecting methicillin resistance and triton X-100 suseptibility, FmtB (formyl transferase) 
The β-lactam antibiotic resistance of S. aureus is mainly mediated by penicillin-binding protein 
2A (PBP2A), which is active in the presence of methicillin and other β-lactam antibiotics [214]. A 
transposon insertion in fmtB demonstrated its implication in methicillin resistance in MRSA strain COL 
[183]. In the presence of the non-ionic detergent triton X-100, MRSA were shown to be more sensitive 
to methicillin-like antibiotics by a mechanism implicating autolysis [182]. The fmtB gene codes for a 
cell wall anchored protein of 263 kDa that contains 17 tandem repeats of 75 amino acids and a C-
terminal LPDTG cell wall-sorting motif [183]. Moreover, FmtB contained two of the three conserved 
motifs shared by PBPs and β-lactamases, suggesting that FmtB may be involved in cell wall synthesis 
[182].  
Collagen binding protein, Cna 
Cna was described as a specific S. aureus adhesin capable of binding collagen and 
collagenous tissues [184,185]. The structural organization of Cna follows the standard MSCRAMMs 
features. However, Ryding et al. [215] demonstrated that binding to collagen was possible despite the 
absence of cna, but with a lesser affinity.  
Plasmin sensitive protein, Pls 
The structure of Pls revealed three distinct repeated regions, of which one was made of serine-
aspartate dipeptide repeats similar to those found in the Clf and Sdr families [186]. Pls is sensitive to 
proteolysis by plasmin. It is a surface protein only present in MRSA, because it is located in the 
methicillin-resistance genomic island SCCmec. Unless it is cleaved by plasmin, Pls inhibits bacterial 
adhesion to immobilized fibronectin, fibrinogen, laminin, and immunoglobulin G as well as invasion of 
host cells [186]. This suggests that Pls could play a role in preventing adhesion at some stages of the 
infection process. However, the mechanism of the anti-adhesive and anti-invasive effect of Pls is 
unclear. 
Surface protein in Japanese ST8 CA-MRSA, spj 
The spj gene is a 4.8 kb novel open reading frame (ORF), encoding for a large LPXTG protein 
in a major ST8 CA-MRSA. This new MSCRAMMs encompass a typical LPXTG protein [187].  
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Elastin binding proteins, Ebps 
EbpS is a cell surface integral membrane protein that is not covalently attached to the 
peptidoglycan [189]. It mediates binding to the extracellular matrix protein elastin in vitro, but its 
function in virulence in vivo remains unclear [188]. 
Bone sialoprotein-binding protein, Bbp 
Bbp mediate binding to bone sialoprotein, a glycoprotein of bone and belongs to the sdr family 
[190]. The S. aureus Bbp protein may be important in the targeting of bacteria towards bone tissues, 
and thus might be of relevance in the pathogenicity of osteomyelitis. Recently, a study has shown that 
Bbp was also able to bind fibrinogen [191], implying that Bbp may have two independent functions: an 
important factor in the colonization of bone tissue (i.e. sialoprotein binding) and a contributing factor in 
S. aureus hematologic diseases (i.e. fibrinogen binding), such as sepsis [191].  
III Aim of the study 
The description summarized above highlights the multiplicity of S. aureus pathogenic features, 
as well as the complexity of their regulation. Thus, although useful to dissect out the system, any 
simplistic approach to understand the function or regulation of S. aureus virulence factors is bound to 
provide only a limited view of reality, and may lead to conclusions that do not much the natural history 
of infection. This is particularly true for surface proteins, which undergo a complex ride with potentially 
multiple modifications at both the intracellular and extracellular levels (a minimal example is the 
cleavage of the signal peptide).  
This thesis work tried to address these issues by a two-steps logical experimental approach, 
first phenotypic and second transcriptomic and proteomic. In the first part of the thesis we asked a 
seemingly very simple question, i.e. is the in vitro adherence phenotype of S. aureus, for instance to 
fibrinogen or fibronectin, predictive of its ability to infect humans or animals? The premises of this 
question was that, based on studies of specific adhesins [19,77], adherence to fibrinogen or 
fibronectin should promote adherence to endovascular tissues and thus be more pronounced in S. 
aureus isolates recovered from patients with bacteremia or endocarditis than in isolates recovered 
from healthy carriers. The first study presented below addressed this very question (Chapter 2). 
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However, unexpectedly the results contradicted the hypothesis. S. aureus isolates recovered from a 
variety of environments, including nasal cultures from healthy carriers and blood isolates from patients 
with bacteremia or endocarditis, demonstrated a wide array of adherence phenotypes in vitro, which 
did not correlate with any particular colonization of disease status.  Even more, S. aureus isolates that 
were highly adherent to fibrinogen and fibronectin in vitro where not necessarily more prone to induce 
experimental endocarditis in rats than poorly adherent strains [216]. This was in apparent contradiction 
with the paradigm that fibrinogen and fibronectin-binding were necessary and sufficient for 
endovascular infection [19,79].  
However, the interpretation of these results might be subtler than just concluding that adherence 
was not involved in disease. Indeed, it could be that the tested S. aureus isolates did just not express 
their surface adhesins identically when grown in vitro than when exposed to in vivo conditions, and 
that differential gene regulation in these two conditions obscured the interpretation. To try better 
understand these features, we run a second serie of studies, presented in the second paper of this 
thesis dissertation (Chapter 3). Here we specifically enquired about the physical presence of surface 
protein MSCRAMMs in time-course experiments in S. aureus grown in different milieu, and compared 
these results to their transcriptomes and in vitro adherence phenotypes. We found a number of 
differences between the expected protein expression based on previous gene regulation literature [4] 
and the physical presence of these factors on the bacterial surface. Moreover, proteomic analyses 
performed by trypsin shaving of live bacteria also revealed that the same protein, although present, 
could hide certain of their domains in the complex peptidoglycan-polysaccharide meshwork of the 
bacterial envelope, thus making them unavailable for trypsin digestion [217]. This has a potentially 
important consequence in terms of disease mechanisms and also vaccine development. Indeed, 
whether transient or not, steric hindrance of specific proteins domains may make them (temporarily) 
available or unavailable for adherence purposes, in case of disease mechanism, or recognition by 
antibodies in case of host defenses. This type of behavior implicates an additional, sometimes 
underestimated, type of regulation, i.e. conformation plasticity or induced-fitness. 
While this new question arose from the present work, the proteomic experiments also revealed 
other as yet unknown features of the S. aureus proteome, as exemplified by a new post-translational 
modification described in a collaborative study with P. Waridel (Annexe 1) [218]. 
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Taken together, the present work provides a threefold answer to the original question regarding 
the correlation or not between in vitro and in vivo phenotypes in S. aureus isolates: 
1. No, the in vitro adherence phenotypes do not correlate or predict the in vivo disease capacity.  
2. Yes, differential in vitro and in vivo gene and protein regulation may explain these differences. 
3. In addition, alternative regulation mechanisms of protein function, via steric modification or 
induced-fitness, are likely to operate in medium-dependent phenotypic differences.  
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V. Introduction to Chapter 2 
Chapter 2 describes the natural variability of in vitro adherence to fibrinogen and fibronectin of 
carriage isolates and the correlation with in vivo infectivity of S. aureus in an endocarditis model in rat. 
Carriage of S. aureus is a significant risk factor for infection and studies of colonization offer a 
potential way to disease prevention [1]. Although there is some evidence that certain S. aureus 
genotypes are more virulent than others, it is generally accepted that all colonizing strains are 
potentially infectious. 
This study investigates the use of infectivity profiles of different carriage isolates of S. aureus to 
predict and classify the risk of disease development in permanent or intermittent carriers. To do this, 
we compare the ability of adherence to immobilized fibronectin or fibrinogen in vitro of 
carriage strains with strains from endocarditis and blood culture isolates. We demonstrate that no 
matter the source of bacteria, the profile of adhesion to either ligand was very heterogeneous. 
Next, we choose two pairs of carriage strains that have opposing abilities to adhere to 
fibronectin and fibrinogen in vivo in order to compare their infectivities in an endocarditis model in rats. 
The results show that regardless of the profile of adhesion, all strains are able to infect rats despite 
their inability to adhere in vitro.  
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I. Abstract 
Adherence to fibrinogen and fibronectin plays a crucial role in Staphylococcus aureus 
experimental endocarditis. Previous genetic studies have shown that infection and carriage isolates do 
not systematically differ in their virulence-related genes, including genes conferring adherence, such 
as clfA and fnbA. We set out to determine the range of adherence phenotypes in carriage isolates of 
S. aureus, to compare the adherence of these isolates to the adherence of infection isolates, and to 
determine the relationship between adherence and infectivity in a rat model of experimental 
endocarditis. A total of 133 healthy carriage isolates were screened for in vitro adherence to fibrinogen 
and fibronectin, and 30 isolates were randomly chosen for further investigation. These 30 isolates 
were compared to 30 infective endocarditis isolates and 30 blood culture isolates. The infectivities of 
the carriage isolates, which displayed either extremely low or high adherence to fibrinogen and 
fibronectin, were tested using a rat model of experimental endocarditis. The levels of adherence to 
both fibrinogen and fibronectin were very similar for isolates from healthy carriers and members of the 
two groups of infection isolates. All three groups of isolates showed a wide range of adherence to 
fibrinogen and fibronectin. Moreover, the carriage isolates that showed minimal adherence and the 
carriage isolates that showed strong adherence had the same infectivity in experimental endocarditis. 
Adherence was proven to be important for pathogenesis in experimental endocarditis, but even the 
least adherent carriage strains had the ability to induce infection. We discuss the roles of differential 
gene expression, human host factors, and gene redundancy in resolving this apparent paradox. 
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II. Introduction 
Staphylococcus aureus is a human commensal, but at the same time it is one of the most 
important bacterial pathogens that cause community-acquired and nosocomial infections. It can 
produce a wide variety of diseases, from benign skin infections, such as folliculitis or furunculosis, to 
life-threatening conditions, like osteomyelitis, septic arthritis, sepsis, pneumonia, and endocarditis [2]. 
About 20% of humans carry S. aureus permanently in their noses, and another 60% are intermittent 
carriers [3]. The association between S. aureus nasal carriage and staphylococcal disease has been 
reported for several decades [4,5]. More recently, it has been unambiguously shown that carriers have 
a higher risk of infection, at least when they are hospitalized [1,6]. The pathogenicity of S. aureus 
involves a wide range of cell wall-associated adhesins and extracellular toxins. Surface adhesins, 
referred to as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs), 
bind to the host extracellular matrix and thus promote tissue colonization and infection [7]. The major 
MSCRAMMs involved in S. aureus pathogenesis are particular surface proteins that are covalently 
bound to the cell wall peptidoglycan via a conserved LPXTG motif [8]. Genomic analyses indicated 
that the S. aureus genome contains up to 21 such LPXTG surface proteins [9]. In addition to their 
multiplicity, these proteins often have redundant functions, as exemplified by clumping factors A and B 
(ClfA and ClfB), which bind fibrinogen [10,11], and fibronectin-binding proteins A and B (FnBPA and 
FnBPB), which bind fibronectin [12], fibrinogen [13], and elastin [14]. It has been unambiguously 
demonstrated that in S. aureus ClfA and FnBPA are key pathogenicity factors, at least in infective 
endocarditis. This has been achieved by expressing these adhesins in bacteria lacking the rest of the 
S. aureus surface features [15]. Using a variety of truncated and chimera constructs of these proteins, 
Que et al. observed that fibrinogen-binding domains were necessary and sufficient for colonization of 
damaged valves in experimental endocarditis, but not for persistence and invasion, whereas 
fibronectin-binding domains of FnBPA were unable to initiate infection but mediated aortic cell invasion 
and microbial persistence. Thus, the two adherence functions were necessary for progressive infection 
[16]. Despite the great effort to establish whether there are specific genetic determinants that 
distinguish carriage and invasive infection strains, the answer was largely negative [17,18]. Genetic 
studies revealed that many S. aureus wild-type strains lack some of the genes coding for LPXTG motif 
proteins, but there is no overall difference between carriage and infection isolates [19]. However, fnbA 
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and clfA are nearly always present in carriage and clinical isolates, confirming their pivotal role. 
Moreover, sequence analysis of functional regions of the two proteins has shown that there is a high 
degree of conservation in sporadic and epidemic isolates of S. aureus [20]. On the other hand, the 
presence of the genes does not imply that there is efficient expression of a protein on the cell surface. 
It is entirely possible that either the carriage isolates express FnBPA and ClfA at a lower level or the 
adherence to the host matrix is less efficient. To our knowledge, a comparison of the adherence 
phenotypes of infection and carriage isolates has never been conducted. Here we determined the 
levels of adherence to fibrinogen and fibronectin of 133 carriage isolates. We compared these isolates 
to 30 infective endocarditis and 30 blood culture isolates. In addition, we compared the infectivities of 
isolates displaying extreme adherence phenotypes in a rat model of experimental endocarditis. 
III. Material and methods  
III.1. Bacterial strains and growth conditions 
The carriage isolates used in this study were described in detail elsewhere [21]. Briefly, 133 S. 
aureus isolates were collected from 406 healthy adults in western Switzerland in 2005 and 2006. The 
blood culture isolates originated from patients at a tertiary care hospital in western Switzerland, and 
they came from the same catchment area as the carriage isolates and were collected over the same 
time period. These isolates were consecutive isolates received by the clinical microbiology laboratory 
of the university hospital and thus represented both community and acquired episodes of bacteremia 
that were associated or not associated with intravenous catheter colonization. Infective endocarditis 
isolates were collected between January and December 1999 during a population-based study 
conducted prospectively in six regions of France [22]. S. aureus was grown at 37°C without agitation 
in tryptic soy broth (Difco Laboratories, Detroit, MI). S. aureus NCTC 8325-4 was used as a control 
strain to monitor the overall quality of the assays. Strains DU5883 (fnBPA-, fnBPB-), a mutant of 
NCTC8325-4 [23], and DU5852 (clfA-) [24], were used as negative controls for adherence to 
fibronectin and fibrinogen, respectively. 
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III.2 Bacterial adherence to solid-phase fibrinogen and fibronectin 
We modified a previously described staphylococcal adherence assay [25] to measure the ability 
of S. aureus to adhere to low levels of surface-adsorbed fibrinogen and fibronectin. Serial 2-fold 
dilutions of fibrinogen (Sigma) or fibronectin (Sigma) in phosphate-buffered saline (PBS) were placed 
in 96-well plates (Nunc-Immuno plates; MaxiSorp surface; Nalge Nunc International). PBS without a 
ligand was placed in the last well as a negative control. The plates were incubated at 4°C for 16 h. 
Then they were washed three times with PBS, and 200 μl of 2% bovine serum albumin (Fluka) in PBS 
was added to each well to block nonspecific sites. The plates were incubated for 1.5 h and then 
washed three times with PBS. Bacterial cultures were harvested in the mid-logarithmic phase of 
growth (optical density at 600 nm [OD600], 0.6). After centrifugation for 10 min at 3,000 rpm, cells were 
frozen. Shortly before the test, the cells were resuspended in PBS, and the concentration was 
adjusted to 5 x109 CFU/ml. Portions (50 μl) of the cell suspension were applied to individual wells (2.5 
x 108 CFU per well) and incubated for 2 h at 37°C. Then the wells were washed with PBS and fixed at 
55°C for 30 to 45 min. Bound bacteria were detected by staining with crystal violet, and the OD570 
was determined with an enzyme-linked immunosorbent assay plate reader. For the initial screen of 
133 carriage isolates, the assay was carried out once with 11 ligand concentrations starting with same 
initial concentration. For all subsequent tests the measurements were repeated twice with five 
concentrations using independently grown bacterial cultures. The adherence score was calculated by 
subtracting the control value (no ligand) from the area under the curve. The optical densities for five 
substrate concentrations were added, and from the resulting value we subtracted the value for the well 
containing no ligand multiplied by 6 (Figure 1). 
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Figure 1: Relationship between ligand concentration and adherence measured using optical density. The 
adherence value was calculated as an approximation of the area under the curve as follows. The optical density 
values for all concentrations were added, and the control value (which represented the optical density when no 
ligand was present) was multiplied by six and subtracted from the sum. 
III.3. Rat model of infective endocarditis 
All animal experiments were carried out according to Swiss federal and cantonal regulations 
(authorization 879-6). Sterile aortic vegetations were produced in female Wistar rats as described 
previously [26]. Groups of animals were inoculated with 103 or 104 CFU from cultures in the 
exponential growth phase. These inoculum sizes were used because clinical isolates have been 
shown to induce 50% and 90% experimental endocarditis in this model [27-29]. Rats were sacrificed 
24 h after inoculation, quantitative vegetation and spleen culture analyses were performed, and 
bacterial densities were expressed in log10 CFU/g. Median bacterial titers in the vegetations were 
compared by using the nonparametric Kruskal-Wallis test with Dunn’s correction for multiple 
comparisons. The chi-square test with Yates correction was used to detect differences among 
infection rates. Differences were considered significant if the P value was < 0.05, using two-tailed 
significance levels. 
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IV. Results  
The initial screen of 133 carriage isolates originating from healthy carriers showed that there 
was great variation in adherence to fibrinogen and fibronectin (Figure 2). The two adherence scores 
were significantly correlated (Spearman’s rank correlation, 0.52; P < 0.0001).  
Twenty-eight carriage isolates were randomly chosen further investigation. Similar to carriage 
isolates, both types of infection isolates displayed variability in adherence to fibronectin and fibrinogen 
(Figure 3). The adherence to both ligands was the same for the three groups of isolates. However, 
individual strains differed significantly in adherence to fibrinogen (Kruskal-Wallis chi-square test, 123; 
df, 87; P = 0.006). The differences in adherence to fibronectin were not significant (Kruskal-Wallis 
chisquare test, 105; df, 87; P = 0.08). Strain NCTC 8325-4 exhibited relatively strong adherence to 
both substrates. 
 
Figure 2: Adherence to fibrinogen and fibronectin of 133 carriage isolates. Each circle represents an isolate (one 
assay). The axes indicate adherence scores as described in Material and Methods. The isolates indicated by filled 
circles were subsequently used for comparison with infection isolates. 
We chose four carriage isolates which exhibited very low (two isolates) and very high (two 
isolates) levels of adherence to fibrinogen and fibronectin to test infectivity in the rat model of 
experimental endocarditis. The abilities of all isolates to induce endocarditis were similar for both 
inoculum sizes tested (Figure 4).  
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Figure 3: Adherence of S. aureus carriage and infection isolates to fibronectin (A) and fibrinogen (B). The bars 
and error bars indicate the average and standard deviation for each isolate (two assays per isolate). The average 
for each category is indicated by a horizontal line. Isolates which were used for testing in the experimental 
endocarditis model are indicated by filled bars (high adherence) and striped bars (low adherence) and numbers.  
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Figure 4: Incidence of endocarditis in rats challenged with 103 (A) or 104 (B) CFU of S. aureus carriage isolates 
exhibiting a low (strains 1 and 2) or high (strains 3 and 4) level of adherence to fibrinogen and fibronectin. 
In addition, all animals had 80 to 100% infected spleens and similar densities of bacteria in 
vegetations and spleens irrespective of the challenge strain (Table 1). There were no differences 
among the strains in any of the variables measured. 
Table 1: Bacterial counts in infected spleens and vegetations 
   Inoculum countaning 103 CFU  Inoculum countaning 104 CFU 
    Bacterial counts (log10 CFU/g)   
Bacterial counts 
(log10 CFU/g) 
Location Adhesion Strain n Median Range  n Median Range 
Spleens Weak 1 9 2.21 1.56–4.71  9 4.73 3.79–5.71 
  2 7 2.57 1.60–4.67  9 4.70 3.28–5.80 
 Strong 3 8 2.18 2.02–4.65  10 4.71 3.48–6.67 
  4 9 3.65 2.91–4.53  10 5.73 4.72–6.78 
Vegetations Weak 1 3 6.32 4.59–7.76  10 9.05 4.64–9.66 
  2 3 7.90 7.68–7.98  8 8.59 7.96–9.29 
 Strong 3 1 6.28   8 7.58 5.25–9.39 
  4 4 8.47 4.41–8.84  9 8.50 4.23–9.63 
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V. Discussion  
V.1. No difference in adherence between infection and carriage 
isolates 
The present study showed that a prominent aspect of the S. aureus phenotype, adherence to 
fibrinogen and fibronectin, does not correlate with the source of isolates. The levels of adherence to 
fibrinogen and fibronectin, as measured in in vitro assay, were very similar for isolates obtained from 
healthy carriers and members of two different groups of infection isolates. Given the prominent role of 
adherence to fibrinogen and fibronectin conferred by ClfA and FnBPA, which was demonstrated in an 
experimental endocarditis study [16], stronger adherence could have been expected for infective 
endocarditis isolates than for carriage isolates. Our phenotypic observations complement the results of 
previous studies, which did not identify factors associated with increased virulence in S. aureus at the 
genetic level. It was demonstrated previously that all lineages (clonal complexes) of S. aureus were 
equally likely to cause an infection [17]. Likewise, Lindsay et al. [19] were unable to identify any genes 
overrepresented in infection isolates, further confirming the lack of simple genetic determinants of 
staphylococcal infection. This suggested that most, if not all, natural isolates of S. aureus are capable 
of infection. We have not tested whether the clfA and fnbA genes are present in the isolates used in 
this study, because previous studies demonstrated that these genes were nearly universally present in 
human infection and carriage isolates [20,30]. However, a recent study reported a tendency toward 
specific features for methicillin-resistant S. aureus strains responsible for persistent bacteremia 
compared with the strains responsible for transient bacteremia [31]. Persistent bacteremia isolates 
were phenotypically more adherent to fibrinogen, fibronectin, and endothelial cells in vitro. 
Nevertheless, although persistence was associated with a phenotypic and molecular signature, the 
two types of strains were equally able to induce endocarditis in rabbits, which suggests that a disease-
inducing capacity is universal in S. aureus strains. Similarly, it has been shown that certain genotypes 
(clonal complexes) might be associated with more severe disease [32]. However, these findings 
appear to be due, at least in part, to the association of certain genotypes, predominantly ST36, with 
methicillin resistance. While no specific genetic makeup correlated with invasive infection, specific 
genes are indeed related to specific disease syndromes, such as the genes encoding superantigens 
  NO RELATIONSHIP BETWEEN ADHERENCE AND INFECTIVITY 
69 
(e.g., toxic shock syndrome toxin and enterotoxins) or exfoliative toxins. Human host factors are 
crucial for S. aureus infection. The most important risk factor is illness, as shown by the nearly 100- 
fold increase in the risk of invasive staphylococcal infection in humans who are ill, from 0.03% in the 
general population (or approximately 30 cases/100,000 people [33]) to 5.7% during hospitalization (80 
cases/14,000 people [6]). Various medical conditions and interventions, such as diabetes, dialysis, 
surgery, and drug and alcohol abuse, have been identified as important risk factors [33]. Nasal 
carriage was shown to increase the risk of staphylococcal bacteremia 3-fold but not the risk of death 
inhospitalized nonsurgical patients [6]. Specific genetic predispositions do not seem to play a major 
role, with the exception of male gender and a few very rare inherited immune deficiencies. 
Nevertheless, whether host predisposition is a unique factor promoting S. aureus infection remains to 
be determined. 
V.2. Wide range of adherence phenotypes but no correlation with 
infectivity 
A wide range of adherence phenotypes was observed for all types of isolates, including infective 
endocarditis isolates displaying very low adherence. In particular, the carriage isolates displaying very 
low adherence might be expected to show lower infectivity in experimental endocarditis. However, 
even these isolates were capable of inducing experimental valve infection. Human endocarditis 
isolates were tested previously on multiple occasions using this model, and they exhibited infectivities 
very similar to those reported here [27-29,34,35]. 
This was clearly shown by the minimum inoculum size necessary to infect 90% of the animals, 
which was 104 CFU for both the isolates used in the present study and endocarditis isolates tested in 
previous experiments. 
V.3. Proven role of adherence in infection but no difference in 
infectivity between strongly and weakly adherent isolates 
Although adherence to fibrinogen and fibronectin has been proven to be important for 
pathogenesis in experimental endocarditis, even the least adherent carriage strains were able to 
induce infection in this model. Several explanations can be offered for this apparent paradox. The first 
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explanation is the possible inability of the in vivo endocarditis model to detect relevant differences. It is 
always questionable to use specific models, in this case experimental endocarditis, to examine 
general characteristics, such as infectivity. Moreover, induction of valve infection proceeds via at least 
two steps; it starts with tissue colonization, which may be reversible if the bacterium is susceptible 
(and accessible) to host defense mechanisms, and this is followed by invasion and persistence, when 
the microbes settle further, invade local tissues, and spread to distant sites. 
These two steps may involve different virulence factors that might be regulated  differently to 
achieve optimal infectivity (see below). The present study addressed primarily induction of infection 
(with relatively early sacrifice 24 h after inoculation), because this is the unavoidable primum movens 
for further invasion. Moreover, it attempted to correlate adherence to fibrinogen and fibronectin with 
the capacity to promote experimental endocarditis, because the adhesins mediating these phenotypes 
were specifically associated with valve infection in previous studies [16,29,36], whereas other 
adhesins were not [37]. Therefore, the system model is pertinent to the questions asked. The second 
putative explanation is adhesin redundancy. Indeed, our observations are reminiscent of the situation 
where knockout mutations of major adherence-promoting genes had very modest effects on infectivity 
in experimental endocarditis, despite marked decreases in adherence to the specific ligands [29,38]. 
S. aureus possesses a wide array of virulence factors, including up to 21 LPXTG cell wall-anchored 
adhesins [9]. Moreover, many isolates contain only some of these factors but are still infectious [19], 
suggesting that there is great functional overlap among the factors. This issue was recently studied by 
expressing 18 of the 21 S. aureus LPXTG proteins in surrogate lactococci and testing the recombinant 
organisms to determine their capacities to induce experimental endocarditis [37]. ClfA and FnBPA 
significantly increased the ability of the recombinants to produce experimental valve infection, but 
other proteins (including Cna, SdrC, SdrD, SdrE, and Pls) had a marginal effect, suggesting that they 
might cooperate to cause infection as well. Hence, it is likely that an isolate of S. aureus needs only 
some of these proteins to display the full functionality necessary for an infection. 
The third hypothesis concerns differential gene expression in various milieus. The difference 
between infection isolates and carriage isolates might be manifested only during actual infection and 
not under standard in vitro conditions. A seminal example is microbial crowding and quorum sensing 
via agr (accessory gene regulator), which promotes expression of surface adhesins during the 
exponential phase of growth and production of exoproteins in the stationary phase [39,40]. Apart from 
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cell density, agr is highly dependent on environmental factors [41]. For example, standard adherence 
experiments, including our experiments, are conducted under static conditions, whereas flow 
conditions were shown to have a notable effect on adherence phenotypes [42]. There has been 
increasing interest in how the regulation via agr works in vivo [43], and remarkable differences in 
regulation, and consequently in the expression of virulence factors, between experimental and human 
infection and in vitro conditions have been found [44-47]. In particular, a recent study showed that the 
differences between in vitro and in vivo conditions involve the regulation of FnBPA by both the global 
regulon genes saeRS and the sigB gene [48]. Moreover, many other regulators, which often interact 
with agr, have been described (e.g., sarA, sarR, sarS, sarT, sarV, sarU, sarY, rot, and alternative 
sigma factors) (for reviews, see references [44] and [43]). Because of the complexity of gene 
regulation in S. aureus, which is not fully understood yet, the differences in regulation, and 
consequently the differences in expression of virulence factors, undoubtedly present among natural 
isolates of S. aureus cannot be captured at the genetic level. Although in vitro profiles of adherence (in 
this case adherence to fibrinogen and fibronectin) did not correlate with in vivo infection in humans 
and experimental endocarditis in rats, the laboratory tests that have been performed cannot capture 
differential gene expression at the infection site. Hence, appraising the importance of adhesins 
expression for infection requires direct measurement of the adhesins present in infected tissues 
compared to the adhesins present under in vitro conditions. Such measurement requires more specific 
molecular approaches, such as in situ hybridization or proteomic techniques (29).  
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 VIII. Introduction to chapter 3 
The virulence of S. aureus is essentially determined by cell wall associated proteins and 
secreted toxins that are regulated and expressed according to growth phases and/or growth 
conditions. 
Chapter 3 describes the results of correlations between three different approaches to study the 
presence and function of LPXTG-proteins in S. aureus Newman, using variants carrying different 
regulatory mutations and grown in variable conditions. We determined the protein and mRNA 
expression of the 18 LPXTG-proteins presents in S. aureus Newman in time-course experiments and 
their relation to fibrinogen binding in vitro. We used an isogenic mutant of S. aureus Newman deleted 
for agr in order to examine the impact of this global regulator on adhésines profiles. Moreover, we 
made parallel cultures in two different media, one rich in iron and the other poor in iron, to explore the 
influence of iron on adhésines regulation.  
The results indicate first that proteomic, transcriptomic and adherence phenotypes 
demonstrated different profiles in S. aureus Newman. Moreover, peptide released by trypsin treatment 
for proteomic profiling indicated that exposure of protein domains on the bacterial surface may change 
in various environments as well as between different strains. This differential surface display may be 
critical for antibody recognition, and thus might be important to take into account for further vaccine 
strategies.  
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Proteomic and transcriptomic profiling 
of Staphylococcus aureus surface 
LPXTG-proteins: correlation with agr 
genotypes and adherence phenotypes 
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I. Abstract 
Staphylococcus aureus infections involve numerous adhesins and toxins, which expression 
depends on complex regulatory networks. Adhesins include a family of surface proteins covalently 
attached to the peptidoglycan via a conserved LPXTG motif. Here we determined the protein and 
mRNA expression of LPXTG-proteins of S. aureus Newman in time-course experiments, and their 
relation to fibrinogen adherence in vitro. Experiments were performed with mutants in the global 
accessory-gene regulator (agr), surface protein A (Spa) and fibrinogen-binding protein A (ClfA), as 
well as during growth in iron-rich or iron-poor media. Surface proteins were recovered by trypsin-
shaving of live bacteria. Released peptides were analyzed by Liquid-Chromatography coupled to 
Tandem Mass-Spectrometry (LC-MS/MS). To unambiguously identify peptides unique to LPXTG-
proteins, the analytical conditions were refined using a reference library of S. aureus LPXTG-proteins 
heterogeneously expressed in surrogate Lactococcus lactis. Transcriptomes were determined by 
microarrays. Sixteen of the 18 LPXTG-proteins present in S. aureus Newman were detected by 
proteomics. Nine LPXTG-proteins showed a bell-shape agr-like expression that was abrogated in agr-
negative mutants – including Spa, fibronectin-binding protein A (FnBPA), ClfA, iron-binding IsdA and 
IsdB, immunomodulator SasH, functionally uncharacterized SasD, biofilm-related SasG and methicillin 
resistance-related FmtB. However, only Spa and SasH modified their proteomic and mRNA profiles in 
parallel in the parent and its agr- mutant, while all other LPXTG-proteins modified their proteomic 
profiles independently of their mRNA. Moreover, ClfA became highly transcribed and active in 
fibrinogen-adherence tests during late growth (24h), whereas it remained poorly detected by 
proteomics. On the other hand, iron-regulated IsdA-B-C increased their protein expression by >10-
time in iron-poor conditions. Thus, proteomic, transcriptomic and adherence-phenotype demonstrated 
differential profiles in S. aureus. Moreover, trypsin peptide signatures suggested differential protein 
domain exposures in various environments, which might be relevant for anti-adhesin vaccines. A 
comprehensive understanding of the S. aureus physiology should integrate all three approaches. 
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II. Introduction 
S. aureus is a highly successful opportunistic pathogen that can produce a wide variety of 
diseases [1]. Moreover, it has a unique ability to develop antibiotic resistance, which reflects its 
extraordinary capacity to adapt and survive in a great variety of environments. Over the last decades 
molecular and genetic dissections of S. aureus have revealed a great number of surface adhesins, 
secreted enzymes, and toxins that might be implicated in pathogenesis [2-5]. In particular, cell-wall-
associated surface adhesins – referred to as Microbial Surface Components Recognizing Adherence 
Matrix Molecules or MSCRAMMs [5] – mediate binding to extracellular matrix and plasma 
components, enabling staphylococci to colonize and invade host tissues and cells, as well as to 
escape immune defenses [6-8]. Surface proteins are also implicated in biofilm formation [9], which 
promotes chronic infections and helps bacteria to escape antibiotic-induced killing. 
MSCRAMMs encompass several surface components including proteins, teichoic acids, 
lipoteichoic acids, and maybe polysaccharidic capsules, which have been implicated in tissue 
colonization and disease to various extents [5,10,11]. Important surface proteins include polypeptides 
covalently attached to the peptidoglycan via a conserved anchoring mechanism. After membrane 
translocation, a transpeptidase called “sortase” cleaves the exported protein at a specific LPXTG motif 
present at its C-terminus, and attaches its penultimate threonine to a side-chain of the peptidoglycan 
stem peptides, i.e. a pentaglycine in the case of S. aureus [12]. Twenty-one genes encoding LPXTG-
proteins have been identified by in silico analysis of S. aureus genomes [13]. Experimental deletion or 
heterologous expression of these proteins helped identify their physiological functions and infer their 
roles in diseases [14,15]. However, while highlighting the multiple facets of S. aureus pathogenesis, 
none of these experiments provided a comprehensive view of the infection process. For instance, 
none of the gene inactivation experiments could entirely abrogate the S. aureus disease capacity, 
suggesting that infection is a multi-factorial process. Moreover, experimental results may be difficult to 
interpret, due to the complex regulatory gene network operating in S. aureus (e.g. agr, sae, srrAB, 
arlS, sarA sarR, sarS, sarT, sarV, sarU, sarY, and rot) [3,16-22]. As an example, the TSST-1 toxin is 
positively regulated by the “global accessory gene regulator” agr when bacteria are grown in vitro. 
However, the agr-regulation pathway may become over-ruled by other regulators in vivo, as TSST-1 
can be expressed in animals even in the absence of agr [23].  
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Several approaches have been used to understand the pathogenic behavior of S. aureus. 
These include genomics, transcriptomics, and more recently proteomics [15,24-29]. In particular, 
proteomics might provide the most realistic picture of the infective process, since it detects the very 
end-products of gene biosynthetic pathways, which may eventually determine a biological phenotype. 
Moreover, post-translational protein regulation (or modification) may affect the stability and function of 
proteins independently of their upstream transcriptional or translational regulation – e.g. proteins may 
persist longer than their encoding mRNAs. Therefore, in addition to transcriptional and translational 
regulation, understanding the behavior of an organism requires both qualitative and quantitative 
assessment of its protein equipment over time. 
Here we describe a semi-quantitative proteomic approach based on trypsin digestion (i.e. 
trypsin shaving) of surface-exposed proteins and spectral counting of resulting peptides. This 
technique was applied to time course analysis in order to determine the level of LPXTG-proteins 
expressed in a variety of conditions known to affect the expression of their corresponding mRNAs. 
Transcriptomic controls were performed in similar conditions using microarrays. Experimental 
conditions included mutants inactivated in the global regulator agr, which promotes expression of 
adhesin mRNAs in post-exponential growth phase, and shuts it off in the stationary phase [16,30,31], 
as well as growth of bacteria in iron-poor or iron-rich media, promoting or repressing the expression of 
mRNAs of LPXTG siderophore proteins, respectively [32,33]. Eventually, the adherence phenotype to 
host matrix proteins was determined. The results show that the time course profiles of LPXTG-proteins 
detected on the bacterial surface do not systematically follow the time course profile of their encoding 
mRNAs [16,30,31], and that some of these proteins can be functionally very active, e.g. in case of 
adherence to fibrinogen, in spite of the fact that they are poorly detected in vitro. The results also 
suggest that surface proteins may adopt different conformations and expose different portions on the 
surface of different bacteria. Indeed, trypsin digestion released different sets of peptides when LPXTG-
proteins were expressed in parent S. aureus or surrogate L. lactis, as exemplified by protein A (Spa), 
clumping factor A (ClfA), clumping factor B (ClfB) and fibronectin-binding protein A (FnBPA). Our work 
extends previous proteomic studies in S. aureus [27,34,35] and adds a level of subtlety in the 
continuum of transcriptional to post-translational protein regulation. Notably, the differences in domain 
exposure in various bacterial backgrounds might have unforeseen implications in vaccine 
development. 
PROTEOMIC AND TRANSCRIPTOMIC PROFILING OF S. AUREUS LPXTG- PROTEINS 
81
III. Material and methods  
III.1. Bacterial strains and growth conditions 
Bacterial strains used in this study are listed in Table1. Staphylococcal strains included the well-
described S. aureus Newman, one isogenic mutant (S. aureus ALC355) deleted in the global regulator 
agr [36], one isogenic mutant (S. aureus DU5873) deleted in the protein A gene (spa) [37] and one 
isogenic mutant (S. aureus DU5852) deleted in the clumping factor A gene (clfA) [38]. Lactococcal 
recombinants were used for method validation and included the18 previously described L. lactis 
constructs, each expressing a different staphylococcal LPXTG-protein [39-41] (see below).  
Table 1 : strains used in this study 
Strains Relevant genotype or phenotype References 
Lactococcus lactis   
Pil 253 L. lactis subsp. cremoris 1363 with pIL253 vector  [42] 
pOri23-spa L. lactis strain expressing staphylococcal proteinA [41] 
pOri23-clfA L. lactis strain expressing staphylococcal ClfA [39] 
pOri23-clfB L. lactis strain expressing staphylococcal ClfB [41] 
pOri23-fnbpA L. lactis strain expressing staphylococcal FnBPA [43] 
pOri23-fnbpB L. lactis strain expressing staphylococcal FnBPB [41] 
pOri23-isdA (sasE) L. lactis strain expressing staphylococcal IsdA [41] 
pOri23-isdB (sasJ) L. lactis strain expressing staphylococcal IsdB [41] 
pOri23-isdH (sasI) L. lactis strain expressing staphylococcal IsdH [41] 
pOri23-sdrC L. lactis strain expressing staphylococcal SdrC [41] 
pOri23-sdrD L. lactis strain expressing staphylococcal SdrD [41] 
pOri23-sdrE L. lactis strain expressing staphylococcal SdrE [41] 
pOri23-sasD L. lactis strain expressing staphylococcal SasD [41] 
pOri23-sasF L. lactis strain expressing staphylococcal SasF [41] 
pOri23-sasG L. lactis strain expressing staphylococcal SasG [41] 
pOri23-sasH L. lactis strain expressing staphylococcal SasH [35] 
pOri23-sasK L. lactis strain expressing staphylococcal SasK [41] 
pOri23-cna L. lactis strain expressing staphylococcal Cna [41] 
pOri23-pls L. lactis strain expressing staphylococcal Pls [41] 
Staphylococcus aureus   
Newman ClfA-producing S. aureus strain [44] 
DU5873 S. aureus Newman defective in proteinA  [37] 
ALC355 S. aureus Newman defective in agr [36] 
DU5852 S. aureus Newman defective in ClfA [38] 
 
Staphylococci were grown at 37°C either in tryptic soy broth (TSB, Becton Dickinson, NJ, USA) 
or agar, or in Roswell Park Memorial Institute culture medium 1640 (RPMI, Life Technology, NY, 
USA), without agitation. Lactococci were grown at 30°C in GM17 broth (M17 medium containing 0,5% 
CHAPTER 3 
82 
glucose, Becton Dickinson) supplemented with 5 μg/ml of erythromycin (Sigma-Aldrich, MO, USA) 
without agitation, or on GM17 agar.  
Growth was followed by colony counting on plates and OD600nm measurements of the different 
cultures using a spectrophotometer (Ultrospec 500 pro, GE Healthcare, NJ, USA). Bacterial stocks 
were kept frozen at -80oC in 20% (v/v) glycerol.  
III.2. Bacterial cell preparation for proteolysis of surface proteins 
Three different protocols were tested including (i) bacterial cell wall purification [35] prior to 
proteolysis, (ii) bacterial cell wall purification followed by teichoic acid removal with hydrofluoric acid for 
48h [45] prior to proteolysis, and (iii) trypsin surface shaving of live bacteria according to a slightly 
modified described methods [34]. Protocols (i) and (ii) (described in supplemental experimental 
procedures) appeared too stringent and resulted in the loss of up to 2/3 of the released peptides. 
Therefore, trypsin-shaving was used and is described here. In brief, bacteria were grown in 300 ml 
liquid cultures in the different media described above. At various times of the logarithmic or stationary 
growth phases, samples (between 10 and 100 ml depending on the cell density) were removed, 
immediately chilled at 4°C, and harvested by centrifugation. Pellets were washed 3-times with ice-cold 
PBS and finally resuspended in 1ml of the same buffer. To allow semi-quantitative comparisons 
between the proteomes of different samples, cell concentrations were adjusted to 1x109 bacteria/ml in 
all samples. Cell counts were validated by optical microscopy (Neubauer cell) and viable colony 
counts on nutrient agar. There were<0.5 log10 differences between the Neubauer cell and viable 
counts, indicating that the large majority of cells were alive. Samples were then shaved for 1 h with 1 
μg/ml (final concentration) of trypsin (Promega, Madison, USA) at 37°C, after which they were chilled 
at 4°C and bacterial cells removed by centrifugation for 10 min at 4,000 rpm and 4°C. Supernatants 
containing trypsin-shaved peptides were filtered (0,22 μm) and freeze-dried until further use. 
III.3. Peptide preparation for LC-MS/MS analysis  
The freeze-dried shaved peptides were re-diluted in 100 μl of 100 mM ammonium bicarbonate, 
reduced with 10 μl of 45 mM DTT (Sigma-Aldrich) for 30 min at 60°C, and alkylated with 10 μl of 100 
mM IAA (Sigma-Aldrich) for 30 min at RT in the dark. The resultant mixtures were digested a second 
time at 37°C with 1 μg of trypsin (Promega) for 4h. The digested peptides were desalted through Sep-
Pak tC18 cartridges (Waters, MA, USA) following the manufacturer’s recommendations and eluted 
PROTEOMIC AND TRANSCRIPTOMIC PROFILING OF S. AUREUS LPXTG- PROTEINS 
83
with 1 ml of 60% (v/v) and 1 ml of 30% (v/V) acetonitrile (Merck, NJ, USA). Solutions of purified 
peptides were pooled, dried under vacuum, and kept at -20°C.  
III.4. Liquid Chromatography-MS/MS analysis and protein identification 
Samples were analyzed on a hybrid linear trap LTQ-Orbitrap mass spectrometer (Thermo 
Fisher Scientific, Bremen, Germany) interfaced via a TriVersa Nanomate (Advion Biosciences, 
Norwich, UK) to an Agilent 1100 nano HPLC system (Agilent Technologies, Waldbronn, Germany). 
Solvents used for the mobile phase were 95:5 H2O:acetonitrile (v/v) with 0.1 % formic acid (solvent A) 
and 5:95 H2O:acetonitrile (v/v) with 0.1 % formic acid (solvent B).  
Solutions of purified peptides were loaded onto a trapping microcolumn ZORBAX 300SB C18 (5 
mm x 300 μm ID, 5 μm, Agilent) in H2O:acetonitrile 97:3 (v/v) + 0.1 % formic acid at a flow rate of 10 
μl/min. After 5 min, they were back-flush eluted and separated on a reversed-phase nanocolumn 
ZORBAX 300SB C18 column (75 μm ID x 15 cm, 3.5 μm, Agilent) at a flow rate of 300 nl/min with a 7-
step gradient from 5 to 85 % acetonitrile in 0.1% formic acid as following: 1) 5 min at 0 % of solvent B, 
2) from 0 to 25 % of B in 35 min, 3) from 25 to 50 % B in 15 min, 4) from 50 to 90 % in 5 min, 5) 90 % 
B during 10 min, 6) from 90 to 0 % in 5 min and finally 7) 15 min at 0 % (total time: 90 min). 
For spraying, a 400 nozzle ESI Chip (Advion Biosciences) was used with a voltage of 1.65 kV, 
and the mass spectrometer capillary transfer temperature was set at 200°C. In data-dependent 
acquisition controlled by Xcalibur 2.0 software (Thermo Scientific), the four most intense precursor 
ions detected in the full MS survey performed in the Orbitrap (range 350-1500 m/z, resolution 60000 at 
m/z 400) were selected and fragmented. MS/MS was triggered by a minimum signal threshold of 
10’000 counts, carried out at relative collision energy of 35 %, and with isolation width of 4.0 amu. 
Only precursors with a charge >1 were selected for CID fragmentation and fragment ions were 
analyzed in the LTQ linear trap. The m/z of fragmented precursors was then dynamically excluded, 
with a tolerance of 0.01 amu-from any selection during 120 s. From raw files, MS/MS spectra were 
exported as mgf files (Mascot Generic File, text format) using the extract_msn.exe script from Thermo 
Scientific. 
MS/MS spectra were analyzed using Mascot 2.2 (Matrix Science, London, UK). Mascot was set 
up to search the UNIPROT database (SWISSPROT + TrEMBL, www.expasy.org) restricted to Other 
Firmicutes taxonomy (database release used was 13.2 of April 8th 2008, 527’426 sequences after 
taxonomy filter). For time course experiments, a sub-set database of UniProt was used (2’594 
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sequences), which contained only proteins of S. aureus strain Newman, as well as sequences of S. 
aureus LPXTG-proteins expressed in L. lactis clones. Trypsin (cleavage at K,R, not before P) was 
used as the enzyme definition. Mascot searches were done with a fragment ion mass tolerance of 
0.50 Da and a parent ion tolerance of 10 ppm. Iodoacetamide derivative of cysteine was specified in 
Mascot as a fixed modification. Deamidation of asparagine and glutamine, and oxidation of methionine 
were specified as variable modifications. 
Scaffold (version Scaffold_2_06_02, Proteome Software Inc., Portland, OR, USA) was used to 
validate MS/MS based peptide and protein identifications, and to perform dataset alignment. Peptide 
identifications were accepted if they could be established at a probability >90.0% as specified by the 
Peptide Prophet algorithm [46]. Protein identifications were accepted if they could be established at a 
probability >95.0% and contained at least 1 identified peptide. Protein probabilities were assigned by 
the Protein Prophet algorithm [47]. Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. 
Relative quantification of proteins between samples was based on spectral counting [48]. Spectral 
counts were normalized by Scaffold (semi-quantitative values) to take into account variations of 
protein amounts between samples. 
III.5. Microarrays 
Total RNAs from 2 independent triplicates of 100 ml bacterial cultures of S. aureus Newman 
and its isogenic agr- mutant were harvested at OD600nm of 0.2, 0.6, 1.8, and 2.2 by centrifugation at 
4000 rpm at 4°C for 10 min and processed as follows. Resuspended bacterial cells were first lysed in 
100μl TE containing 800 μg/ml lysostaphin (Sigma-Aldrich, Saint Louis, USA) for 1h at room 
temperature. Total RNA were further purified and stabilized using the RNeasy Protect Bacteria mini kit 
(Qiagen) following the manufacturer’s recommendations. All RNA quantities were assessed by 
NanoDrop®ND-1000 spectrophotometer and the RNA quality was assessed using RNA 6000 
NanoChips with the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, USA). Triplicates were equitably 
pooled to obtain at least 10 μg of RNA. For each sample, 10μg of total RNA were reverse transcribed 
using dUTP for enzymatic fragmentation; 2μg of the resulting sense cDNA was fragmented by UDG 
(uracil DNA glycosylase) and APE 1 (apurinic/apyrimidic endonuclease 1) and biotin-labelled with TdT 
(terminal deoxynucleotidyl transferase) using the GeneChip® WT Terminal labelling kit (Affymetrix 
Cat.no. 900671, Santa Clara, USA). Affymetrix GeneChip S. aureus Genome Array (Affymetrix, Cat. 
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No. 900514) were hybridized with 1.8 µg of biotinylated target, at  45°C for 16 hours washed and 
stained according to the protocol described in Affymetrix GeneChip® Expression Analysis Manual 
(Fluidics protocol FS450_0007).  
The arrays were scanned using the GeneChip® Scanner 3000 7G (Affymetrix) and raw data was 
extracted from the scanned images and analyzed with the Affymetrix Power Tools software package 
(Affymetrix). 
All statistical analyses were performed using the free high-level interpreted statistical language 
R and various Bioconductor packages (http://www.Bioconductor.org). Hybridization quality was 
assessed using the Expression Console software (Affymetrix). Normalized expression signals were 
calculated from Affymetrix CEL files using RMA normalization methods. Differential hybridized features 
were identified using Bioconductor package “limma” that implements linear models for microarray data 
[49]. The p values were adjusted for multiple testing with Benjamini and Hochberg’s method to control 
the false discovery rate (FDR). Probe sets showing a FDR < 0.05 were considered significant. 
III.6. Bacterial adherence to solid-phase extracellular matrix 
compounds 
We used a previously described in vitro adherence assay to measure the ability of S. aureus to 
adhere to increasing concentrations of surface-adsorbed fibrinogen, fibronectin, and collagen [50]. 
Briefly, 96-well plates (Nunc-Immuno plates; MaxiSorp surface; Thermo Fisher Scientific) were filled 
with 100 µl of 2-fold serial dilutions of fibrinogen (1 mg/ml initial concentration; Sigma-Aldrich), 
fibronectin (250 μg/ml initial concentration; Sigma-Aldrich) and collagen I and VI (20 μg/ml initial 
concentrations; Sigma-Aldrich). The last well served as a negative control and was filled with 100 µl of 
PBS without ligand. After washing, bovine serum albumin (Sigma-Aldrich) was added to each well to 
block non-specific binding sites. Bacterial cultures were harvested at different times during growth by 
centrifugation (4000 g at 4°C for 20 min). Cells were re-suspended in PBS and bacterial cell 
concentrations were adjusted to 5.109 CFU/ml. Fifty microliters (i.e. 2,5.108 cells) were added to each 
well. Plates were incubated for 1.5 h at 37°C, after which wells were washed with PBS and fixed at 
55°C. Adherent bacteria were detected by staining with crystal violet, and the OD570nm was determined 
with an enzyme-linked immunosorbent assay plate reader [50]. 
CHAPTER 3 
86 
IV. Results  
IV.1. Trypsin-shaving of live cells 
As mentioned in Experimental procedures, initial attempts to recover LPXTG-proteins from 
purified staphylococcal cell walls resulted in too much contamination with non-wall proteins, and/or 
poor recovery of LPXTG-proteins (described in supplemental Experimental procedures). In contrast, 
trypsin-shaving decreased contamination with non-wall proteins by >5 times and reproducibly released 
similar sets of peptides from individual LPXTG-proteins. Figure 1 indicates that the recovery of 
peptides during trypsin treatment of live staphylococci was time-dependent, and that 1 h of treatment 
appeared optimal. This duration was experimentally amenable for serial extractions during time course 
experiments and thus was used in all subsequent experiments. The decrease in peptide recovery after 
longer incubation periods is not explained, but could be due to concomitant proteolysis by intrinsic S. 
aureus proteases (see Discussion section).  
 
 
Figure 1: Kinetics of unique peptides released during trypsin-shaving of S. aureus Newman. Liquid cultures of S. 
aureus Newman were grown to the early stationary growth phase, harvested by centrifugation, and bacteria were 
shaved with 1 μg/ml of trypsin for various periods of time (1h, 4h and 8h). Released peptides were processed as 
described in Experimental procedures and identified by LC-MS. Studied LPXTG-proteins are indicated at the 
bottom of the graph. Columns indicate the numbers of unique peptides (nonredundant) recovered. Since a 
maximum of unique peptides were detected after 1h, this incubation time was further used in all experiments of 
trypsin-shaving. 
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IV.2. Construction of a reference peptide library of S. aureus LPXTG-
proteins expressed in lactococci 
An important prerequisite to this study was to unambiguously identify the trypsin peptide 
signatures of S. aureus LPXTG-proteins using the LC-MS/MS system described herein. This was 
achieved thank to a preliminary analysis of each of these proteins expressed in L. lactis, which does 
not carry S. aureus proteins [35]. This permitted to alleviate certain ambiguities regarding to different 
adhesin denominations in UniProt, due to redundancies or isoforms. It also allowed verifying if an 
observed set of peptides could be attributed to a unique parent protein, or whether peptides were 
found in different proteins showing sequences similarities.  
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Table 2: Number of unique peptides released after trypsin-shaving of the surface of L. lactis strains expressing S. 
aureus recombinant LPXTG-proteins. 
  Lactococci recombinant expressing staphylococcal LPXTG-proteins 
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The presence of two numbers for certain lactococci expressing a single LPXTG-species (i.e. SdrC, SdrD, and SdrE) indicates 
the existence of redundant peptides that are shared with other LPXTG-species.  
 
 
To address these questions, we reinvestigated the 18 lactococcal clones successfully 
expressing unique S. aureus MSCRAMMs (Table 1) [35] using the shaving technique, and assigned  
the obtained peptides to the corresponding proteins. Table 2 shows that the shaving procedure 
generated sets of peptides (between 3 and 59 peptides) for 16 out of the 18 LPXTG-proteins studied. 
The great majority of the detected peptides was specifically assignable to a unique parent LPXTG-
protein (Table 2). Only few peptides were redundant between more than one protein species, for 
instance between IsdB and IsdH, Spa and Pls, and between SdrD, SdrE, and SdrC. No peptides were 
detected for IsdB and SasH when expressed in lactococci (Table 2). Possible explanations could be 
either poor expression in this particular organism, or poor detectability of these peptides by LC-
MS/MS.  
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This allowed constructing a concordance table between UniProt protein nomenclatures (shown 
in Table 3) as well as a dedicated sequence database specific for S. aureus Newman (supplementary 
Table 1). Specifically, Table 3 also presents the number of unique peptides and the percentage of 
peptide coverage of each of the LPXTG-proteins detected in recombinant L. lactis. Coverage varied 
from 6% to 60% (median 31%).  
Table 3 : UniProt nomenclature, numbers of unique peptides, and sequence coverage of LPXTG wall-associated 
protein obtained in lactococcal recombinants shaving experiments 
Protein 
Name 
Accession 
Number UniProt Protein Name 
Number of 
uniques 
peptides 
Sequence 
Coverage 
(%) 
ClfA A3F6G7_STAAU 
A3F6G8_STAAU  
Clumping factor A 
Clumping factor A 
9 31 
ClfB CLFB_STAAE 
A5IW57_STAA9 
A6U514_STAA2 
A7X714_STAA1 
CLFB_STAA8 
CLFB_STAAC 
CLFB_STAAM 
CLFB_STAAN  
Clumping factor B precursor - Newman  
LPXTG-motif cell wall anchor domain precursor  - JH9 
LPXTG-motif cell wall anchor domain precursor  - JH1 
Clumping factor B - Mu3 / ATCC 700698 
Clumping factor B precursor - NCTC 8325 
Clumping factor B precursor – COL 
Clumping factor B precursor - Mu50 / ATCC 700699 
Clumping factor B precursor - N315 
20 41 
FnBPA FNBA_STAA8  Fibronectin-binding protein A precursor - NCTC 8325 10 19 
FnBPB A8YYQ2_STAAT 
Q2FE04_STAA3 
Q2G1T5_STAA8 
Q53682_STAAU 
Q5HD53_STAAC  
Fibronectin-binding protein B - USA300 / TCH1516 
Fibronectin binding protein B - USA300 
Fibronectin binding protein B, putative - NCTC 8325 
Fibronectin binding protein B 
Fibronectin binding protein B - COL 
5 15 
Cna A2PZA0_STAAU 
Q6GDB2_STAAR  
Collagen adhesion 
Collagen adhesin - MRSA252 
3 6 
Pls PLS_STAAC 
PLS_STAAU 
Q9LC00_STAAU  
Putative surface protein SACOL0050 precursor – COL 
Surface protein precursor  
Putative uncharacterized protein  
8 8 
SasD A6QDB8_STAAE 
A8YZ60_STAAT 
Q2FKC5_STAA3 
Q2G260_STAA8 
Q2YUU8_STAAB 
Q5HJN4_STAAC  
Putative uncharacterized protein – Newman 
Cell wall surface anchor protein - USA300 
Cell wall surface anchor family protein - USA300 
Putative uncharacterized protein - NCTC 8325 
Surface protein - bovine RF122 
Cell wall surface anchor family protein - COL 
5 39 
IsdA ISDA_STAAE  
A5IS16_STAA9 
A6U0U7_STAA2 
A7X148_STAA1 
A8Z1R0_STAAT 
ISDA_STAA3 
ISDA_STAA8 
ISDA_STAAC 
ISDA_STAAM 
ISDA_STAAN 
ISDA_STAAS 
ISDA_STAAW  
Iron-regulated surface determinant protein A precursor – Newman 
LPXTG-motif cell wall anchor domain precursor - JH9 
LPXTG-motif cell wall anchor domain precursor - JH1 
Cell surface protein - Mu3 / ATCC 700698 
Iron - USA300 / TCH1516 
Iron-regulated surface determinant protein A precursor - USA300 
Iron-regulated surface determinant protein A precursor - NCTC 8325 
Iron-regulated surface determinant protein A precursor – COL 
Iron-regulated surface determinant protein A precursor - Mu50 / ATCC 700699 
Iron-regulated surface determinant protein A precursor - N315 
Iron-regulated surface determinant protein A precursor - MSSA476 
Iron-regulated surface determinant protein A precursor - MW2  
4 12 
SasF A6QKD5_STAAE  
Q6G628_STAAS 
Q8NUK1_STAAW  
Q6T1N1_STAAU  
Putative uncharacterized protein – Newman 
Putative surface anchored protein - MSSA476 
Putative uncharacterized protein MW2567 - MW2 
Surface protein SasF  
13 26 
SasG A6QJY2_STAAE 
Q5HD57_STAAC 
SASG_STAA8  
Putative uncharacterized protein - strain Newman 
Cell wall surface anchor family protein - strain COL 
Surface protein G precursor - strain NCTC 8325 
20 16 
IsdH A6QHR4_STAAE 
A8Z2P9_STAAT 
ISDH_STAA3 
ISDH_STAAC  
Haptoglobin-binding surface anchored protein – Newman 
Cell wall surface anchored protein - USA300 / TCH1516 
Iron-regulated surface determinant protein H precursor - USA300 
Iron-regulated surface determinant protein H precursor - COL 
28 47 
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Protein 
Name 
Accession 
Number UniProt Protein Name 
Number of 
uniques 
peptides 
Sequence 
Coverage 
(%) 
IsdB  ISDB_STAAE  Iron-regulated surface determinant protein - Newman 0 0 
SasK A7X6X3_STAA1 
Q7A3B0_STAAN 
Q99R43_STAAM  
Putative uncharacterized protein - Mu3 / ATCC 700698 
Putative uncharacterized protein SA2381 - N315 
Putative uncharacterized protein - Mu50 / ATCC 700699 
5 31 
SdrC SDRC_STAAE  
SDRC_STAA3 
SDRC_STAA8 
SDRC_STAAC 
A8YZQ9_STAAT 
Serine-aspartate repeat-containing protein C precursor - Newman  
Serine-aspartate repeat-containing protein C precursor - USA300 
Serine-aspartate repeat-containing protein C precursor - NCTC 8325 
Serine-aspartate repeat-containing protein C precursor - COL 
Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrC - USA300 / TCH1516 
20 31 
SdrD SDRD_STAAE 
A8YZR0_STAAT 
SDRD_STAA3 
SDRD_STAA8 
SDRD_STAAC 
Serine-aspartate repeat-containing protein D precursor - strain Newman 
Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrD - USA300 / TCH1516 
Serine-aspartate repeat-containing protein D precursor - strain USA300 
Serine-aspartate repeat-containing protein D precursor - NCTC 8325 
Serine-aspartate repeat-containing protein D precursor - COL 
49 53 
SdrE A8YZR1_STAAT 
SDRE_STAA3  
Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrE - USA300 / TCH1516 
Serine-aspartate repeat-containing protein E precursor - USA300 
59 60 
Spa A6QD95_STAAE 
A1KDX8_STAAU 
A1KDY8_STAAU 
A1KE04_STAAU 
A1KE29_STAAU 
A1KE57_STAAU 
A1KE58_STAAU 
A1KE61_STAAU 
A1KE85_STAAU 
A1KEA2_STAAU 
A4L7T5_STAAU 
A5INY2_STAA9 
A6TXP6_STAA2 
A7XW80_STAAU 
A8YZ36_STAAT 
Q2FKE8_STAA3 
Q2UW16_STAAU 
Q2UW21_STAAU 
Q2UW30_STAAU 
Q2UW31_STAAU 
Q2UW33_STAAU 
Q2UW54_STAAU 
Q2UW59_STAAU 
Q5HJQ8_STAAC 
Q6GD14_STAAS 
Q8NYT0_STAAW 
SPA1_STAA8  
Immunoglobulin G binding protein A – Newman 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A precursor 
LPXTG-motif cell wall anchor domain precursor - JH9 
LPXTG-motif cell wall anchor domain precursor - JH1 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A - USA300 / TCH1516 
Immunoglobulin G binding protein A - USA300 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A 
Immunoglobulin G binding protein A – COL 
Immunoglobulin G binding protein A - MSSA476 
Immunoglobulin G binding protein A - MW2 
Immunoglobulin G-binding protein A precursor - NCTC 8325 
17 42 
 
 
IV.3. Profiling of LPXTG-proteins in S. aureus Newman and its agr- 
mutant in various growth conditions 
Time course profiling of the surface proteome of S. aureus was performed during growth from 
early logarithmic (OD600nm = 0.2) to late stationary (OD600nm = 2.2) phases (Figure 2). At each time 
point, the proteomic analysis assessed the relative quantity of proteins in 1x109 bacterial cells. This 
semi-quantification was based on spectral counting [48] normalized to take into account the variations 
of protein amounts between samples (n = 3 to 4). Spectral counting measures the number of times 
that a peptide is selected for fragmentation during a LC-MS/MS analysis, and is correlated to 
abundance of specific peptides and proteins [48]. As dynamic exclusion has a direct impact on 
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spectral counting, a value of 120 s was chosen as a compromise between redundant peptide 
fragmentations requested for better quantitation accuracy and the need of selecting low abundant 
peptides for a higher proteome coverage. 
 
Figure 2: Growth curves or S. aureus Newman in iron-rich (TSB) or iron-poor (RPMI) liquid media. Bacteria were 
grown at 37°C without agitation in in either TSB (closed circles) of RPMI (open circles).and optical densities at a 
wavelength of 600nm (OD600nm) were followed. Samples were removed at OD600nm values of 0.2; 0.6; 1.8; 
and 2.2 in TSB and 0.2; 0.5; 0.8 and 1.2 in RPMI, and then processed for proteomic and transcriptomics analysis, 
as shown in Figure 3 and 4 and for adherence phenotype in Figure 5.  
IV.3.1. Overall protein profiling:  
Figure 3 depicts the results obtained for the wild-type S. aureus Newman and its agr- mutant 
grown either in iron-rich TSB (Figure 3A and 3C, respectively) or iron-poor RPMI (Figure 3B and 3D, 
respectively). Overall, 16 of the 21 putative LPXTG-proteins described in S. aureus [13] were 
successfully identified in our tests. Three (i.e. Cna, Pls and SasK) of the 5 undetected species had no 
gene counterparts in the genome of S. aureus Newman (GenBank Accession Number AP009351) [51] 
and thus were not expected to be found, and 2 (Srap and SasC) remained undetected, maybe 
because of poor detectability of their corresponding peptides by LC-MS/MS. As a negative control, no 
Spa was detected at the surface of the spa-negative mutant DU5873, while the profile of the other 
LPXTG-proteins remained unaffected in this mutant (data not shown). 
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Figure 3: Semi-quantitative assessment of S. aureus Newman LPXTG proteins in time course experiments. The 
parent S. aureus Newman and its agr-negative mutant were grown in TSB (A and C) or RPMI (B and D) liquid 
medium. Samples were collected at four different time points during the exponential and stationary growth 
phases, adjusted to 1x109 bacterial cell/ml, shaved for 1h with trypsin, and peptides released from LPXTG-
proteins were quantified by LC-MS as described in Experimental procedures. Columns and error bars indicate the 
mean + SD of normalized spectral counts of 3 to 4 independent experiments for each detected protein. Statistical 
analysis was performed by pairwise comparisons with Student’s t test and asterisks above columns indicate 
significant differences with the sample collected at the previous time point (*, p<0.05 ; **, p<0.001). 
IV.3.2. Effect of agr:  
Figure 3 indicates that the amounts of several LPXTG-proteins depended on agr integrity and 
growth conditions. When wild type S. aureus Newman was grown in TSB, 9 of the 16 LPXTG-proteins 
(i.e. Spa, FnBPA, ClfA IsdA, IsdB, SasD, SasG, SasH and FmtB) showed a time-dependent agr-like 
bell-shape expression, with an increase in abundance during late logarithmic growth followed by a 
decrease up to the late stationary phase (Figure 3A). Although there were some variations between 
individual adhesins, as well as few relatively unexpected findings (e.g. poor detection of ClfA, see 
below), such a time-dependent expression pattern is in general agreement with proteins regulated by 
agr [16,30,31]. On the other hand, ClfB was present quite early during growth, and was rather stable 
until it disappeared in late stationary phase, and SdrD and SdrE reproducibly presented a biphasic 
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expression pattern. Iron-regulated IsdH was not detected in TSB grown staphylococci, most probably 
because this rich medium provides ample iron for growth (see below). 
Strikingly, this agr-like pattern was abrogated when the isogenic agr-negative mutant of S. 
aureus Newman was tested in similar conditions (Figure 3C). In this case, the bell-shape pattern was 
replaced by a continuing increase of protein quantities into the late stationary phase for all nine 
proteins mentioned above. Moreover, several proteins became either detectable or became more 
expressed in the agr mutant, including FnBPB, ClfA, SdrC, SdrE, SasF, and SasG. This is compatible 
with the loss of agr-mediated down-regulation of surface protein synthesis during stationary growth 
phase [16]. Besides, some protein decreased (e.g. FmtB), while the atypical patterns of ClfB, SdrD 
and SdrE persisted. 
IV.3.3. Effect of iron:  
The experiments were repeated in the iron-poor medium RPMI. Of note, the growth rate of 
strains was substantially slower than in TSB (Figure 2). Nevertheless, when wild type S. aureus 
Newman was tested in this condition (figure 3B), the global expression profile was very similar to that 
in TSB, except for the sharp increase in iron-regulated surface determinants IsdA, IsdB and IsdH 
[32,33]. The IsdC determinant of the iron-capturing system was not analyzed herein. IsdC is 
processed by Sortase B and associated to the peptidoglycan via a NPQTN module, and its expression 
should increase as well [32,33]. Aside from these major changes, minor differences were also 
observed, notably increase in the presence of iron of SasD and SasH, and decrease of SdrE (Figure 
3A and 3B). 
When the isogenic agr-negative mutant was examined in RPMI (figure 3D), the loss of the agr 
bell-shape pattern was much less striking than in TSB. Nevertheless, some obvious modifications 
occurred such as a significant (p < 0.05) increase of the detection of SasF and a decrease for SasH.  
IV.4. Transcriptome analysis 
In order to assess the relationships between the profiles of time course expression of LPXTG-
proteins and their mRNAs, we determined the parallel time course transcriptomes of the parent S. 
aureus Newman and its agr- mutant grown in TSB. Transcriptomic results indicated that the two 
organisms segregated very well at the level of their global transcriptomes. In addition, all duplicated 
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microarray experiments clustered together, using all 7668 Probe sets, indicating high reproducibility 
and consistency of the data (supplemental Figure 1). Figure 4 presents the dynamics of the relative 
changes in mRNA amounts for specific transcripts in the parent S. aureus Newman and its agr- 
mutant. Note that these are relative changes – not absolute mRNA quantities – with regard to a basal 
value arbitrarily fixed at 1 for the first time point of the growth curve, i.e. at OD600nm = 0.2. Therefore, 
the relative dynamics of proteomic and transcriptomic profiles (Figure 3 and 4, respectively) can be 
compared.  
Considering agr-related genes, the agr+ parent demonstrated a linear increase (by 1.6 fold) of 
the RNAIII transcript over the whole growth duration. Conversely, the agr- mutant did not show any 
hybridization to the structural genes of the arg locus (i.e. argA, agrB, argC and argD), as well as a 
>300 fold decrease in hybridization to RNAIII and hemolysin δ as compared to the parent strain 
(supplemental Table 2). Thus, the transcription of agr was genuinely silenced in the mutant 
(supplemental Table 2). As an additional control, the mRNA of the gene of protein A (spa), which is 
typically regulated by agr, followed an agr-like bell-shape profile in the parent strains whereas this 
profile was flattened in the mutant (figure 4), as previously described [30]. One additional LPXTG-
protein genes sasH adopted an agr-like bell-shape pattern in the parent, which was modified in the 
arg- mutant. Moreover, the transcription of sasD and fmtb showed statistically significant modifications 
(p<0.001) in the late growth phase, i.e. at OD600nm of 2.2, in the agr- mutant. Of note, the transcript of 
clfA showed a sharp increase in the late growth phase, i.e at OD600nm of 1.8 (p<0.001) and 2.2 
(p<0.05), in both the parent and the agr- mutant (Figure 4), an observation that comes in support to 
recent observations of clfA regulation using the RNAseq technology [52]. Thus, at least four of the 
LPXTG-protein mRNAs (spA, sasD, sasH and fmtB) showed clear modifications between the agr+ and 
agr- strains, and two of them (spA and sasH) had a clear agr-like profile. On the other hand, most of 
the other LPXTG-protein genes adopted various mRNA profiles that were essentially not affected by 
inactivation of agr. 
When comparing mRNA and proteomic profiles, the expression of Spa clearly followed an arg-
like profile at both the transcriptional and translational levels, which was abrogated in the agr- mutant. 
SasH followed a relatively similar pattern. On the other hand, FnBPA and to a lesser extend FnBPB, 
ClfA, ClfB, IdsB, SdrC SdrE, and SasF modified their protein expression patterns between the two 
mutants, but not their mRNA profiles. Only SasG did not modify its proteins and mRNA profiles in both 
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parent strains. Therefore, while the transcriptome profile was remarkably predictive of the LPXTG-
protein profile in some cases, it appears that additional factors were interfering with the physical 
presence – or access to trypsin – of several adhesins at the bacterial surface. Of note, Srap was 
detected at the transcriptional but not at the protein level.  
 
Figure 4: Expression profiles of mRNA from LPXTG-proteins in time course experiments. The parent S. aureus 
Newman and its agr- mutant were grown in TSB, and harvested at four different time-points (i.e. at OD600nm of 
0.2, 0.6, 1.8 and 2.2,) before being processed for RNA extraction. The transcriptomes were analyzed by 
microarray as described in Experimental procedures. The amounts of mRNA at the different time points are 
represented as fold changes compared to a value arbitrarily fixed at 1 for the first time point (i.e. at OD600nm = 
0.2). Thus, all measures are reported as relative values. The results represent the mean of > 2 determinations on 
2 separate chips, with relative variations between individual values of < 15%. Asterisks above the columns 
indicate that the values are statistically significantly different (*p<0.05; ** p<0.01 and *** p<0.001) from the 
previous time point. P values were adjusted for multiple testing with Benjamini and Hochberg’s method to control 
the false discovery rate (FDR). 
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IV.5. Correlation between proteomic expression profiles and in vitro 
adherence phenotypes  
Figure 3A shows that 9/16 LPXTG proteins detected in S. aureus Newman (i.e. Spa, FnBPA, 
ClfA, IsdA, IsdB, SasD, SasG, SasH and FmtB) followed an agr-like expression pattern. Therefore, we 
tested whether the in vitro adherence profile of this organism followed a similar pattern when grown in 
the same conditions. Figure 5 indicates that adherence to fibrinogen adopted differential profiles 
depending on both the growth medium and the presence or not of an intact agr.  
 
 
Figure 5: Adherence of parent S. aureus Newman and its agr-negative mutant to immobilized fibrinogen. The 
parent S. aureus Newman, its agr-negative mutant and a clfA-negative (but agr+) mutant were grown in TSB (A) 
or RPMI (B). Samples were removed at various times during the exponential and stationary growth phases 
(OD600nm values are indicated on the graph; last sampling time was 24h), titrated to identical concentrations of cell 
bodies, and tested for their ability to stick to immobilized fibrinogen. Negative and positive controls included L. 
lactis carrying the empty expression vector Pil253 and L. lactis carrying the same vector expressing ClfA, 
respectively (C). Columns and error bars indicate the mean + and SD of 3 independent determinations for each 
isolate. Statistical analysis was performed by pairwise comparisons with Student’s t test: asterisks above columns 
indicate significant differences with the previous sample (*, p<0.05; **, p<0.001). 
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In TSB (Figure 5A), binding of the parent S. aureus Newman to fibrinogen was more 
pronounced during exponential growth and decreased in the early stationary phase, thus obeying an 
agr-like pattern. As a control, the clfA- mutant was virtually unable to bind to immobilized fibrinogen, 
indicating that ClfA was largely responsible of the phenotype. The early stationary phase drop was 
even more pronounced in the arg- mutant, in spite of the fact that adhesins are supposed to be more 
expressed during late growth in the agr- mutant [16,30,31]. Finally, adherence increased again after 
24 h in both strains, a phenotype that did not correlate with the proteomic detection of ClfA (Figure 3), 
but correlated well with the clfA gene transcription profile (Figure 4).  In consequence, ClfA-mediated 
binding to fibrinogen did not strictly follow an agr pattern in these experimental conditions, and 
senescent bacteria were still able to bind fibrinogen to a substantial extent.  
Conversely, binding to fibrinogen adopted an agr-like bell-curve in RPMI (Figure 5B) and this 
bell-curve was abrogated in the agr-inactivated mutant. Besides, binding to fibronectin and collagens 
was quasi null (data not presented), which is coherent with the fact that in S. aureus Newman, the 
genes encoding for fibronectin binding and collagen binding are either truncated (for fnA and fnB) or 
absent (for cna).  
IV.6. Trypsin releases different sets of peptides from LPXTG-proteins 
expressed on the surface of S. aureus or L. lactis  
S. aureus had a much lower adherence score to fibrinogen than ClfA-positive L. lactis in in vitro 
adherence tests (Figure 5). This difference could result from a lower expression of ClfA on the surface 
of S. aureus than on the surface of L. lactis, or from differences in the accessibility to ClfA-binding 
domains when the protein is exposed on the surface of S. aureus versus L. lactis, or from both 
reasons. 
Figure 6 compares the ClfA, ClfB, Spa and FnBPA-specific sets of peptides released by trypsin 
shaving of the surface of recombinant lactococci or S. aureus Newman. In case of ClfA, 9 peptides 
were released from lactococci expressing ClfA and 8 from the surface of S. aureus. Thus, the peptides 
numbers were quite similar. However, among these, three peptides were specific of lactococci and 2 
were specific of S. aureus. Therefore, while the majority of the released peptides were similar (i.e. 6/9 
in lactococci and 6/8 in S. aureus), some were specific of the host bacteria, suggesting that different 
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portions of the protein were accessible to trypsin digestion on the surface of the two microorganisms. 
Details on these peptides are presented in supplemental Table 1.  
This small difference in peptide numbers was also true for ClfB and Spa (Figure 6). Regarding 
to ClfB, amongst 20 and 21 released peptides 3 and 4 were specific for L. lactis and S. aureus, 
respectively. For Spa, amongst 23 and 29 released peptides, 0 and 5 were specific for L. lactis and S. 
aureus, respectively. Moreover, in these cases, some peptides, which were recovered in the same LC-
MS runs, displayed redundancies between partial and complete hydrolysis (see overlapping black 
boxes in Figure 6). Partial hydrolysis could result from a too short duration of trypsin digestion. 
However, extending the length of digestion to more than 1h did not yield more peptides (Figure 1). 
Therefore, partial trypsin hydrolysis of LPXTG-proteins might depend on other factors, possibly 
including protein conformation and trypsin accessibility.  
 
Figure 6: Comparison of the sets of peptides released by trypsin digestion of several LPXTG-proteins expressed 
on the surface of recombinant L. lactis or S. aureus Newman. Sets of unique peptides of ClfA, ClfB, Spa, or 
FnBPA released by trypsin shaving of recombinant L. lactis or S. aureus Newman are shown. Data were 
extracted from the experiments presented in Table 2 and Figure 3. Major protein domains and gross amino acid 
numbering are indicated. Precise amino acid numbering of the peptides is presented in supplemental Table 1. 
Trypsin-released peptides are represented by the inserted black boxes. Note that some peptides displayed both 
completely and partially digested species simultaneously (indicated by overlapping boxes). LPXTG motifs are 
indicated by thin yellow bars and the peptide removed by sortase in grey. SP stands for signal peptides, which are 
indicated as green boxes. The ligand binding domains are highlighted in blue and SD repeat regions in purple. 
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Finally, an unexpected observation was that twice as many peptides were released from FnBPA 
expressed in S. aureus than from FnBPA-positive L. lactis (18 versus 9 peptides, respectively). This 
observation is interesting since the fnbpA gene of S. aureus Newman carries a stop codon, which 
leads to a premature arrest of the transcription and the translation of a protein devoid of the C-terminal 
LPXTG anchoring domain. Hence, this truncated protein could be free-floating in the cell envelope of 
S. aureus Newman and thus more accessible to trypsin digestion. Such a possibility would support the 
differential trypsin accessibility of other surface proteins expressed in either of the two tested bacteria, 
as suggested above. 
V. Discussion  
S. aureus produces a plethora of virulence determinants [53], which are regulated by a complex 
network of two-component regulatory systems, DNA-binding proteins, and small RNAs 
[3,16,21,30,54,55]. This explains why there is no simple approach to assess the presence or absence 
of each individual pathogenic feature along the successive steps of infection. Previous experiments in 
which specific genes were inactivated were sometimes difficult to interpret, particularly when bacteria 
were equipped with multiple genes encoding redundant or complementary functions [13,40,43]. 
Moreover, gene regulation may vary between in vitro and in vivo conditions [23].  
To integrate this multilevel information, experimental systems should allow appraising 
quantitative snapshots of global macromolecule expression in both in vitro and in vivo conditions. 
While this is possible at the level of mRNA [11,29,31], its equivalent at the protein level is as yet less 
developed [27-29]. Individual proteins can be quantitatively evaluated by western-blotting or in situ 
hybridization. However, these methods are not amenable to evaluate multiple proteins simultaneously, 
due to the need of numerous different antibodies and the limited number of dyes that can be used 
together in a single experiment. Here, we attempted to bypass this limitation by using a proteomic 
approach. Since we previously contributed to the understanding of the role of S. aureus surface 
adhesins using heterologous gene expression [13,39-41,43,56], we intentionally concentrated our 
efforts on the analysis of the time course detection of the 21 known S. aureus LPXTG surface 
proteins.  
Initial analyses indicated that the whole proteome of purified cell walls was much more complex 
than expected, revealing numerous proteins that were not anticipated to be found in the peptidoglycan 
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and its appendages. The unexpected presence of these species was considered as contamination, at 
least in the setting of crude bacterial walls purified after mechanical cell breakage. However, this kind 
of contamination persisted both after harsher purification (e.g. removal of teichoic acids), and in the 
trypsin-shaving protocol, which was performed on >99,9 % integral cells as assessed by microscopy 
and colony counts. Therefore, the question as to whether some cytoplasmic proteins might be 
constitutive parts of the normal wall environment, as also suggested by others [27,34], remains open. 
We previously showed that LPXTG-proteins from S. aureus could be heterogeneously 
expressed in L. lactis and individually detected by LC-MS/MS in the recombinant lactococci [35,41]. 
On this basis we constructed a peptide library specific to each of these LPXTG-proteins. This library 
was indispensable to further quantify LPXTG-proteins in the more complex S. aureus environment. 
With some exceptions, the amounts of LPXTG-proteins in S. aureus increased up to the early 
stationary growth phase, and decreased thereafter. This bell-shape behavior is reminiscent of agr-
regulated surface proteins such as protein A, which is expressed during logarithmic growth and 
repressed in stationary phase [3,30]. In the present experiments, comparisons between proteomic and 
transcriptomic profiles confirmed this parallelism for protein A, which is in accordance with previous 
studies [29,31,57]. Moreover, we identified at least one additional LPXTG-protein,SasH, that 
demonstrated similar profile modifications between protein and mRNA detection in the parent strain 
and its agr- mutant, suggesting that it was also under tight control by agr. Conversely, however, 
several LPXTG-proteins modified their proteomic profiles between the parent and the mutant in spite 
of the fact that transcriptomic profiles remained unchanged. This suggests that, in addition to mRNA, 
protein expression was further affected by additional factors at the post-transcriptional level, e.g. via 
interference with mRNA, or post-translational level via protein modification [58] or protease 
degradation [29,31,57]. 
This was particularly relevant when comparing proteomic profiles with adherence phenotypes. 
Taking fibrinogen binding as a model, the present results show that adherence was indeed affected by 
both agr integrity and growth conditions, but did not follow an absolute agr paradigm. For instance, in 
TSB, adherence decreased in the early stationary phase of growth and re-increased later on (at 24h) 
without a clear correlate with measured amounts of surface ClfA, but with a clear correlate with 
increasing clfA mRNA. Likewise, in RPMI adherence tended to decrease over time, without a good 
proteomic correlate either (mRNA was not measured in this condition). This seeming incoherence 
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most likely reflects our lack of understanding of the subtlety of the wall environment, which implicates 
additional factors that may affect the phenotype. Indeed, the Gram-positive envelope is not a static 
peptidoglycan scaffold merely decorated with protein, polyols (teichoic and lipoteichoic acids) and 
polysaccharide appendages. It rather acts as a dynamic interface between the environment and the 
intracellular milieu. For instance, the S. aureus envelope is constantly traversed by secreted molecules 
including > 10 different proteases [59], among which some were shown to regulate LPXTG-proteins by 
protein degradation (e.g. ClfB) [29,31,57]. These could be responsible for the progressive decreases 
in recovery of unique peptides over time, as observed in Figure 1.  
Alternatively, mutual interactions between various wall polymers may influence the exposure of 
protein binding domains to the extracellular milieu. This was recently exemplified with recombinant 
ClfA, where artificial lengthening or shortening of the spacer region (R-repeats) between the proximal 
wall anchor and the outermost binding domains increased or decreased adherence to fibrinogen, 
respectively, because they modified the exposure of distal binding domains to their ligand fibrinogen 
[60]. These authors reported similar variations in the presence of absence of an expo-polysaccharide 
capsule.  Therefore, the bacterial surrounding may influence the access of exogenous ligands or 
proteases to LPXTG-protein domains, a phenomenon that observed with trypsin herein.  
Apart from these differences, some other proteins also demonstrated differential regulation 
between TSB and RPMI, including genes of the iron-capturing isd locus, as well as sizable increases 
in SasD and SasH in iron starvation. The increase in isd genes is expected in low iron medium [32,33]. 
On the other hand, the reason for the increase in SasD and SasH is more difficult to interpret. While 
the physiological role of SasD is as yet unclear, SasH (recently renamed AdsA [61]) is a cell wall 
associated adenosine synthase that converts adenosine-monophosphate into adenosine, a strong 
immunomodulator helping staphylococci to escape phagocyte-induced killing. Hence, SasH (or AdsA) 
could well be co-regulated with the siderophore locus isd, which expression is induced in experimental 
S. aureus nasal colonization [11]. In this setting, expression of isd could be required for survival in the 
low-iron mucosal environment, while SasH could be required to damper host defenses and promote 
bacterial persistence. Eventually, the mRNA of Srap was detected but its encoded protein was not, 
suggesting the possible lack of access to trypsin shaving. 
The present study yielded other interesting observations. First, FnBPA was detected in both 
purified walls and trypsin-shaving experiments, in spite of the fact that it lacks the LPXTG-anchoring 
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module and the entire cell wall proximal D-W regions in S. aureus Newman, due to the presence of a 
stop codon [62]. This is also true for its FnBPB counterpart, which in contrast was barely detected at 
all our experiments. One possibility for this difference is that the 741 (out of 1018) amino acids of 
truncated FnBPA is enough for non-specific wall attachment, whereas the 678 (out of 940) residues of 
truncated FnBPB is too short. Alternatively, the two proteins could have been differentially expressed 
in the present experimental conditions, a possibility which has yet to be demonstrated. Another 
noteworthy observation was the fact that trypsin released different sets of peptides from LPXTG 
proteins expressed in S. aureus or in recombinant L. lactis. Thus, some kind of differential domain 
hindrance or exposure must have taken place in the two bacterial backgrounds, as suggested by 
others [27,34]. In the same line, a few LPXTG-proteins were not detected at all (i.e. Srap and SasC) in 
S. aureus Newman, although they were detected by LC-MS/MS in recombinant lactococci [35,41]. 
This raises the question of their conditional expression, as observed in the present experiments and 
by others for isd genes [32,33], or of differential access of trypsin digestion. 
Taken together, two sets of conclusions can be drawn from these results. First, from the 
biological point of view, they indicate that some LPXTG-proteins followed an agr-like regulation, which 
was abrogated in agr-negative mutants and correlated with the mRNA transcription profile in the 
parent strain and its agr- mutant. On the other and, several LPXTG-proteins varied their expression 
without a good mRNA correlate, and remained functionally active for prolonged periods of time, such 
as, for instance, for fibrinogen-binding. This study revises somewhat the dogma that surface adhesins 
are essentially active during the exponential growth phase, in order to colonize new sites, and shut off 
after colonization, to facilitate bacterial detachment and colonization of other sites. Moreover, it also 
reveals that the bacterial wall environments are different in S. aureus and L. lactis, potentially resulting 
in different exposure of LPXTG-proteins at the bacterial surface, which in turns might lead to a 
differential accessibility for trypsin digestion. Whether this altered access has functional consequences 
for bacterial adherence remains to be determined. Likewise, whether this could influence the 
protective efficacy of blocking antibodies might be relevant for vaccine development. 
Second, from the technical point of view, the results open the way to semi-quantitative and time 
course proteome analysis of multiple S. aureus pathogenic polypeptides simultaneously. Hence, they 
add to other recently published proteomic analyses [27,29,34]. One theoretical limitation of trypsin-
shaving is that it peptide-release is limited to the trypsin-accessible proteins. Thus, it may 
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underestimate proteins buried deeper in the multi-polymeric wall. However, preliminary purification of 
cell walls or removal of teichoic acids further decreased the recovery of LPXTG-protein peptides, 
suggesting that trypsin-shaving was a good compromise in this complex surrounding. Another 
limitation is strain-dependency, which may require re-characterization of each singular organism. 
However, the same remark is valid for any physiologic or phylogenic characterization of any isolates. 
Finally, the method could help determining the real-time behavior of numerous bacterial adhesins not 
only in vitro, but possibly also in vivo. For the latter case, targeted mass spectrometry techniques 
based on selected reaction monitoring [63,64] could be easily developed to specifically detect and 
quantify bacterial surface molecules in complex matrices such as those obtained from animal models 
or clinical samples. 
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VI. Supplemental Experimental procedures 
VI.1. Preparation of bacterial cells walls  
Bacterial cell walls were purified as previously described [35], in order to remove all possible 
contaminants from the cytoplasm as well as proteins non-covalently attached to the peptidoglycan. In 
brief, bacteria were grown in 300 ml batch cultures to the late exponential phase, chilled on ice, and 
centrifuged for 10 min at 6,000 rpm at 4°C. Bacterial pellets were suspended and washed in 
phosphate buffer saline (PBS) before being boiled for 10 min in 8% (final concentration) of sodium 
dodecyl sulfate (SDS, Sigma) to denature proteolytic enzymes and remove soluble materials. SDS-
treated cells were washed by suspension-centrifugation 2 times with 1 M NaCl and several times with 
MiliQ water, until no more foaming was observed. Washed pellets were resuspended in 1 ml of water. 
Bacterial sacculi were broken by shaking with ceramic beads (FastPrep apparatus, Qbiogene, Morgan 
Irvine, CA, USA; 3 cycles for 45 seconds at 6,5m/s). The extent of cell breakage (>99.9%) was 
assessed by phase-contrast microscopy. Unbroken cells were removed by low speed centrifugation. 
Broken cells were recovered by centrifugation for 20 min at 16,000 rpm at 4°C, resuspended in water 
and stored at -20oC before processing for trypsin digestion.  
VI.2. Bacterial cell wall purification followed by teichoic acid removal 
with hydrofluoric acid for 48h 
In certain experiments purified walls were further treated with hydrofluoric acid (48 %) for 48h at 
4°C to remove the covalently bound teichoic acids [45]. Indeed, considering the high complexity of the 
proteome recovered from purified walls (see Results section), it was reasoned that physico-chemical 
treatment such as removal of the charged teichoic acids could decrease contamination by proteins 
attached to the walls via non-specific (e.g. ionic) binding. Teichoic acid removal was assessed by loss 
of >80% of the phosphate content of the samples as described [65]. 
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VII Suplemental Tables and Figure 
Supplemental Table 1 : Protein sequences and position of peptides detected by MS/MS in S. aureus and L. lactis protein sequences  
Protein Sequence 
Position 
(aa) 
Peptides detected in S. aureus Peptides detected in L. lactis 
ClfA 
MNMKKKEKHAIRKKSIGVASVLVGTLIGFGLLSSKEADASENSVTQSDSASNESKSNDSSSVSAA
PKTDDTNVSDTKTSSNTNNGETSVAQNPAQQETTQSSSTNATTEETPVTGEATTTTTNQANTP
ATTQSSNTNAEELVNQTSNETTFNDTNTVSSVNSPQNSTNAENVSTTQDTSTEATPSNNESAP
QSTDASNKDVVNQAVNTSAPRMRAFSLAAVAADAPAAGTDITNQLTNVTVGIDSGTTVYPHQ
AGYVKLNYGFSVPNSAVKGDTFKITVPKELNLNGVTSTAKVPPIMAGDQVLANGVIDSDGNVIY
TFTDYVNTKDDVKATLTMPAYIDPENVKKTGNVTLATGIGSTTANKTVLVDYEKYGKFYNLSIKG
TIDQIDKTNNTYRQTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSIKVYKVDNAADLSES
YFVNPENFEDVTNSVNITFPNPNQYKVEFNTPDDQITTPYIVVVNGHIDPNSKGDLALRSTLYGY
NSNIIWRSMSWDNEVAFNNGSGSGDGIDKPVVPEQPDEPGEIEPIPEDSDSDPGSDSGSDSNS
DSGSDSGSDSTSDSGSDSASDSDSASDSDSASDSDSASDSDSASDSDSDNDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSD
SDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSASDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSESDSDSDSDSDSDSDS
DSDSDSDSASDSDSGSDSDSSSDSDSESDSNSDSESGSNNNVVPPNSPKNGTNASNKNEAKDS
KEPLPDTGSEDEANTSLIWGLLASIGSLLLFRRKKENKDKK 
40-55  SENSVTQSDSASNESK 
56-67  SNDSSSVSAAPK 
200-212 DVVNQAVNTSAPR DVVNQAVNTSAPR 
259-271 LNYGFSVPNSAVK LNYGFSVPNSAVK 
282-293 ELNLNGVTSTAK  
331-345 ATLTMPAYIDPENVK ATLTMPAYIDPENVK 
347-363 TGNVTLATGIGSTTANK TGNVTLATGIGSTTANK 
375-381  FYNLSIK 
396-434 
QTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSI
K 
QTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSI
K 
438-473 VDNAADLSESYFVNPENFEDVTNSVNITFPNPNQYK  
474-500 VEFNTPDDQITTPYIVVVNGHIDPNSK VEFNTPDDQITTPYIVVVNGHIDPNSK 
   
ClfB MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSE 57-125  NNASADSEKNNMIETPQLNTTANDTSDISANTNSAN
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KNNMIETPQLNTTANDTSDISANTNSANVDSTTKPMSTQTSNTTTTEPASTNETPQPTAIKNQ
ATAAKMQDQTVPQEANSQVDNKTTNDANSIATNSELKNSQTLDLPQSSPQTISNAQGTSKPS
VRTRAVRSLAVAEPVVNAADAKGTNVNDKVTASNFKLEKTTFDPNQSGNTFMAANFTVTDKV
KSGDYFTAKLPDSLTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNN
KENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFNNKITYNYSSPIAGIDKPNGANISSQIIGV
DTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDS
YYADPNDSNLKEVTDQFKNRIYYEHPNVASIKFGDITKTYVVLVEGHYDNTGKNLKTQVIQENV
DPVTNRDYSIFGWNNENVVRYGGGSADGDSAVNPKDPTPGPPVDPEPSPDPEPEPTPDPEPS
PDPEPEPSPDPDPDSDSDSDSGSDSDSGSDSDSESDSDSDSDSDSDSDSDSESDSDSESDSDSD
SDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSESDSESDSDSDSDSDSDSDSDSDSDSDSD
SDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSD
SDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKVSKQHKTDALPETGDKSENTNATL
FGAMMALLGSLLLFRKRKQDHKEKA 
VDSTTKPMSTQTSNTTTTEPASTNETPQPTAIK 
66-125  
NNMIETPQLNTTANDTSDISANTNSANVDSTTKPMS
TQTSNTTTTEPASTNETPQPTAIK 
133-149 MQDQTVPQEANSQVDNK MQDQTVPQEANSQVDNK 
150-164 TTNDANSIATNSELK  
165-191 NSQTLDLPQSSPQTISNAQGTSKPSVR NSQTLDLPQSSPQTISNAQGTSKPSVR 
197-211 SLAVAEPVVNAADAK SLAVAEPVVNAADAK 
212-225 GTNVNDKVTASNFK GTNVNDKVTASNFK 
229-250 TTFDPNQSGNTFMAANFTVTDK TTFDPNQSGNTFMAANFTVTDK 
261-286 LPDSLTGNGDVDYSNSNNTMPIADIK LPDSLTGNGDVDYSNSNNTMPIADIK 
296-303 ATYDILTK ATYDILTK 
304-316 TYTFVFTDYVNNK TYTFVFTDYVNNK 
317-331 ENINGQFSLPLFTDR ENINGQFSLPLFTDR 
337-354 SGTYDANINIADEMFNNK SGTYDANINIADEMFNNK 
355-391 ITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYK ITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYK 
392-399 QTVFVNPK  
402-411 VLGNTWVYIK  
412-423  GYQDKIEESSGK 
442-456 LSDSYYADPNDSNLK LSDSYYADPNDSNLK 
442-463 LSDSYYADPNDSNLKEVTDQFK LSDSYYADPNDSNLKEVTDQFK 
PROTEOMIC AND TRANSCRIPTOMIC PROFILING OF S. AUREUS LPXTG- PROTEINS 
107
433-441 IFEVNDTSK  
466-477 IYYEHPNVASIK IYYEHPNVASIK 
484-498 TYVVLVEGHYDNTGK TYVVLVEGHYDNTGK 
502-515 TQVIQENVDPVTNR TQVIQENVDPVTNR 
516-529 DYSIFGWNNENVVR DYSIFGWNNENVVR 
Protein A 
MMTLQIHTGGINLKKKNIYSIRKLGVGIASVTLGTLLISGGVTPAANAAQHDEAQQNAFYQVLN
MPNLNADQRNGFIQSLKDDPSQSANVLGEAQKLNDSQAPKADAQQNNFNKDQQSAFYEILN
MPNLNEAQRNGFIQSLKDDPSQSTNVLGEAKKLNESQAPKADNNFNKEQQNAFYEILNMPNL
NEEQRNGFIQSLKDDPSQSANLLSEAKKLNESQAPKADNKFNKEQQNAFYEILHLPNLNEEQR
NGFIQSLKDDPSQSANLLAEAKKLNDAQAPKADNKFNKEQQNAFYEILHLPNLTEEQRNGFIQS
LKDDPSVSKEILAEAKKLNDAQAPKEEDNNKPGKEDNNKPGKEDNNKPGKEDNNKPGKEDGN
KPGKEDNKKPGKEDGNKPGKEDNKKPGKEDGNKPGKEDGNKPGKEDGNGVHVVKPGDTVN
DIAKANGTTADKIAADNKLADKNMIKPGQELVVDKKQPANHADANKAQALPETGEENPFIGT
TVFGGLSLALGAALLAGRRREL 
74-81 NGFIQSLK NGFIQSLK 
74-96 NGFIQSLKDDPSQSANVLGEAQK NGFIQSLKDDPSQSANVLGEAQK 
82-96 DDPSQSANVLGEAQK DDPSQSANVLGEAQK 
105-134 ADAQQNNFNKDQQSAFYEILNMPNLNEAQR ADAQQNNFNKDQQSAFYEILNMPNLNEAQR 
115-134 DQQSAFYEILNMPNLNEAQR DQQSAFYEILNMPNLNEAQR 
135-142 NGFIQSLK NGFIQSLK 
135-156 NGFIQSLKDDPSQSTNVLGEAK NGFIQSLKDDPSQSTNVLGEAK 
143-156 DDPSQSTNVLGEAK DDPSQSTNVLGEAK 
157-165 KLNESQAPK KLNESQAPK 
166-192 ADNNFNKEQQNAFYEILNMPNLNEEQR  
173-192 EQQNAFYEILNMPNLNEEQR EQQNAFYEILNMPNLNEEQR 
193-200 NGFIQSLK NGFIQSLK 
193-214 NGFIQSLKDDPSQSANLLSEAK NGFIQSLKDDPSQSANLLSEAK 
201-214 DDPSQSANLLSEAK DDPSQSANLLSEAK 
201-215 DDPSQSANLLSEAKK  
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215-223 KLNESQAPK KLNESQAPK 
228-250 FNKEQQNAFYEILHLPNLNEEQR  
231-250 EQQNAFYEILHLPNLNEEQR EQQNAFYEILHLPNLNEEQR 
251-258 NGFIQSLK NGFIQSLK 
251-272 NGFIQSLKDDPSQSANLLAEAK NGFIQSLKDDPSQSANLLAEAK 
259-272 DDPSQSANLLAEAK DDPSQSANLLAEAK 
273-281 KLNDAQAPK KLNDAQAPK 
286-308 FNKEQQNAFYEILHLPNLTEEQR  
289-308 EQQNAFYEILHLPNLTEEQR  
309-316 NGFIQSLK NGFIQSLK 
309-323 NGFIQSLKDDPSVSK NGFIQSLKDDPSVSK 
413-440 EDGNKPGKEDGNGVHVVKPGDTVNDIAK  
421-440 EDGNGVHVVKPGDTVNDIAK  
459-471 NMIKPGQELVVDK NMIKPGQELVVDK 
459-472 NMIKPGQELVVDKK NMIKPGQELVVDKK 
FnBPA 
MKNNLRYGIRKHKLGAASVFLGTMIVVGMGQDKEAAASEQKTTTVEENGNSATDNKTSETQT
TATNVNHIEETQSYNATVTEQPSNATQVTTEEAPKAVQAPQTAQPANIETVKEEVVKEEAKPQ
VKETTQSQDNSGDQRQVDLTPKKATQNQVAETQVEVAQPRTASESKPRVTRSADVAEAKEAS
NAKVETGTDVTSKVTVEIGSIEGHNNTNKVEPHAGQRAVLKYKLKFENGLHQGDYFDFTLSNN
VNTHGVSTARKVPEIKNGSVVMATGEVLEGGKIRYTFTNDIEDKVDVTAELEINLFIDPKTVQTN
57-97 
TSETQTTATNVNHIEETQSYNATVTEQPSNATQVTTE
EAPK 
TSETQTTATNVNHIEETQSYNATVTEQPSNATQVTTE
EAPK 
98-114 AVQAPQTAQPANIETVK AVQAPQTAQPANIETVK 
98-119 AVQAPQTAQPANIETVKEEVVK  
115-127 EEVVKEEAKPQVK  
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GNQTITSTLNEEQTSKELDVKYKDGIGNYYANLNGSIETFNKANNRFSHVAFIKPNNGKTTSVTV
TGTLMKGSNQNGNQPKVRIFEYLGNNEDIAKSVYANTTDTSKFKEVTSNMSGNLNLQNNGSY
SLNIENLDKTYVVHYDGEYLNGTDEVDFRTQMVGHPEQLYKYYYDRGYTLTWDNGLVLYSNKA
NGNGKNGPIIQNNKFEYKEDTIKETLTGQYDKNLVTTVEEEYDSSTLDIDYHTAIDGGGGYVDG
YIETIEETDSSAIDIDYHTAVDSEAGHVGGYTESSEESNPIDFEESTHENSKHHADVVEYEEDTNP
GGGQVTTESNLVEFDEDSTKGIVTGAVSDHTTIEDTKEYTTESNLIELVDELPEEHGQAQGPIEEI
TENNHHISHSGLGTENGHGNYGVIEEIEENSHVDIKSELG 
148-165 KATQNQVAETQVEVAQPR KATQNQVAETQVEVAQPR 
149-165 ATQNQVAETQVEVAQPR ATQNQVAETQVEVAQPR 
201-216 VTVEIGSIEGHNNTNK VTVEIGSIEGHNNTNK 
233-260 FENGLHQGDYFDFTLSNNVNTHGVSTAR  
267-282 NGSVVMATGEVLEGGK  
285-294 YTFTNDIEDK  
311-331 TVQTNGNQTITSTLNEEQTSK TVQTNGNQTITSTLNEEQTSK 
337-357 YKDGIGNYYANLNGSIETFNK  
339-357 DGIGNYYANLNGSIETFNK  
362-374 FSHVAFIKPNNGK  
375-386 TTSVTVTGTLMK  
399-411 IFEYLGNNEDIAK IFEYLGNNEDIAK 
423-451 FKEVTSNMSGNLNLQNNGSYSLNIENLDK  
452-471 TYVVHYDGEYLNGTDEVDFR  
472-483 TQMVGHPEQLYK  
524-537 EDTIKETLTGQYDK  
622-655 HHADVVEYEEDTNPGGGQVTTESNLVEFDEDSTK  
656-672 GIVTGAVSDHTTIEDTK GIVTGAVSDHTTVEDTK 
673-702  EYTTESNLIELVDELPEEHGQAQGPVEEITK 
764-786  YEQGGNIVDIDFDSVPQIHGQNK 
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Supplemental Table 2 : Fold change of agr locus RNA expression in S. aureus agr- mutant versus its parent Newman in TSB. 
Locus tag Gene IDa 
Gene 
name 
Function OD 0.2b OD 0.8 b OD 1.8 b OD 2.2 b 
NWMN_1946 5331721 agrA Transcription regulator -360.4 *** -367.6 *** -484.5 *** -422.3 *** 
NWMN_1943 5331201 agrB Transmembrane protein -575.8 *** -664.9 *** -762.1 *** -969.8 *** 
NWMN_1945 5331722 agrC Transmembrane sensor -331.6 *** -422.8 *** -479.5 *** -661.2 *** 
NWMN_1944 5331720 agrD Auto-inducing peptide precusor -711.1 *** -772.9 *** -730.2 *** -828.4 *** 
  rnaIII Small RNA regulator -562.5 *** -696.6 *** -883.1 *** -875.5 *** 
            
a GeneID in S. aureus Newman 
b the asterix indicate significant changes of expression between S. aureus Newman agr mutant and S. aureus Newman grown in TSB at various OD during growth, as determined by false discovery 
rate control, FDR; *, p<0.05; **, p<0.01; ***p<0.001. 
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Supplemental Figure 1: Hierarchical clustering analysis using all 7668 Probe sets of the different microarray runs. 
The left panel depicts the clustering according to the variations in all 7688 probes, and the right panel according 
to variation in 100 randomly probes. The figure shows the high reproducibility between replicates as biological 
repeats always cluster together. cAGR stands for the agr- mutant and cNEeman for the parent. A and B stands 
for the first and the second chip testes in parallel. The additional values of 02, 08, 18 and 22 stand for the different 
optical densities of the sampling.  
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The series of experiments presented above shed new light on the subtlety with which S. aureus 
fine tunes the expression of its gene end products, i.e. its proteins, and on our lack of ability to predict 
it. Until recently, molecular microbiologists have concentrated on understanding specific structures 
and mechanisms of molecules, alone or in combination, including specific regulatory of systems (e.g. 
transcriptional units, operons and regulons), interactions between specific systems, and 
consequences of alterations of systems (via mutations) on the bacterial phenotype in various 
environments. These were indispensable and powerful tools that helped unravel the myriads of 
intertwined functional elements allowing a bacterium to grow and divide, to put in the most global 
sense of life sciences.  
Moreover, in the more specific context of S. aureus colonization and invasion of the mammal 
host, experiments aimed at dissecting the individual function of each of the 21 (recently 22) 
MSCRAMM LPXTG-proteins and their role in experimental infection. For instance, they demonstrated 
the critical implication of protein-protein and protein domains cooperation (e.g. between fibrinogen-
binding and fibronectin-binding) in colonization and invasion of endovascular tissues.  
With such premises, it was tempting to try setting up a new clinical microbiology tool that would 
screen S. aureus strains on the basis of their in vitro adherence phenotype, and tag them as more or 
less prone to produce severe infection or innocuous nasal colonization. However, this maybe too 
naïve hope was turned down by the first series of experiments presented above (Chapter 2, [1]), which 
demonstrated a total lack of correlation between in vitro adherence phenotypes, e.g. to fibrinogen and 
to fibronectin, and the ability of clinical isolates of S. aureus to induce severe endovascular infection 
rather than mere colonization. Even more, some isolates that were very adherent in vitro were less 
infectious in vivo than isolates that were very poorly adherent, thus contradicting the working 
hypothesis.  
These paradoxical phenotypes raised the critical issue of contextualizing the experimental 
settings when trying to draw general conclusions. Indeed, before concluding that molecular 
mechanisms revealed by functional dissection of protein domains were wrong, it was important to first 
know whether the paradoxical results described above were due to differential regulation of genes or 
gene products in different environments. The Introduction chapter (Chapter 1) of the present thesis 
dissertation offers a glimpse at what might be expected from gene regulation, including the knowns 
and (certainly underestimating) the unknowns. Among the knowns is the seminal discovery of the agr 
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global regulatory system in the early 90s, which has rapidly set the widely accepted paradigm that S. 
aureus produce adhesins during the logarithmic phase of growth, and switch to the production of 
toxins in the stationary growth phase. However, additional work progressively showed that while agr 
was indeed a kind of a regulatory hub, its activity was largely positively and negatively modulated by 
up to 10 parallel systems that were also interconnected by stimulatory or inhibitory interactions, and 
responded to different signals. 
Just considering these individual systems, it is relevant that the effect of each of them on the 
others were mostly tested in deleted mutants, and the effect of their loss of activity was monitored on 
other systems individually or globally by microarray. However, although instructive, none of these 
approaches provides integrative information on the functioning of the whole system, which should 
include the sum of all the regulatory elements together. Moreover, comparing ON / OFF responses 
between parent cells and deleted mutants does not provide information on the effect of intermediate 
stages of gene modulation (rather than radical ON / OFF responses), which is much more likely to 
occur in nature. Therefore, already at the level of gene expression there is an urgent need to 
understand regulatory circuitries at a more systemic level, which is emerging thank to the approach of 
systems biology. 
Moreover, aside from transcriptional and post-transcriptional regulation, there is even more 
unknowns on post-translational protein regulation, because several of these aspects were less 
systematically studies, at least in S. aureus. For instance, while we know how proteins are exported, 
how they may be retained in the plasma membrane, covalently attached to the peptidoglycan, or 
loosely attached to extra-membrane structures of the cell envelope, not much is known on the 
dynamics of their functional regulation, for instance by protease degradation (except for ClfB), 
including what could affect such regulation during growth or when facing peculiar environmental 
conditions. Likewise, little is known on the functional consequences of protein-protein interaction, 
including steric hindrance, domain exposure, or interactions with other structures of the cell envelope 
or ligands in the environment.  Yet, salient examples of such phenomena do exist, for instance when 
the production of capsular polysaccharides manage to obscure fibrinogen-binding proteins, resulting in 
phenotypically fibrinogen-binding-negative staphylococci. Likewise, capsule production can also 
obscure Protein A, which is one of the most important immune-escape features of S. aureus. Hence, 
the functional expression of important fibrinogen-binding proteins and Protein A can be modulated by 
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capsule expression, which is strain-dependent and regulated by agr. Moreover, another example is 
the capping of fibrinogen- and fibronectin-binding proteins by plasmin-sensitive LPXTG-protein Pls, 
which is found only in certain MRSAs, because it is encoded on certain types of SCCmec cassettes. 
Pls is cleaved when it encounters activated plasmin, i.e. in the vicinity of blood clots, and this 
cleavages restores fibrinogen- and fibronectin-binding. Therefore, here the functional expression of 
bacterial adhesins depends on the host. 
These (at least) two aspects of protein regulation, i.e. proteins half-life and functional “aptitude” 
could well explain the paradoxical observation described in the first published article presented in this 
thesis. Therefore, this question was further addressed in a second series of experiments investigating 
the correlation between proteomic and transcriptomic profiles, and adherence phenotypes, in time 
course experiments during growth in various conditions. The experiments concentrated on LPXTG-
proteins and revealed a few noticeable points that are very briefly summarized here. First, while the 
physical presence of proteins on the bacterial surface followed, in several cases, an agr-like regulatory 
pattern, this was by far not the case for all of them. Second, this relatively poor correlation with agr 
was also true for a number of LPXTG-protein mRNAs, indicating that they were not under strict control 
of agr; this information was new for most of the studies proteins and mRNAs. Third, some proteins 
(e.g. Protein A) could persist on the surface of the bacteria for very prolonged periods of time, 
indicating that they did not undergo protease degradation. Fourth, some LPXTG-proteins (e.g. ClfA) 
were poorly detected by trypsin shaving, but yet very active in phenotypic adherence tests to 
fibrinogen in vitro.  Finally, this paradox was likely explained by the fact that some LPXTG-proteins 
could adopt conformations that allowed them to hide some of their domains to trypsin shaving, most 
probably by interactions with other molecules on the polysaccharidic meshwork of the outermost 
microbial envelope.  
These experiments confirmed that the regulation of the S. aureus surface proteome was de 
facto complex, multilevel, medium and environment dependent, and that phenotypes of live bacterial 
were difficult to predict form knowledge on individual determinants tested separately. While this more 
global appraisal did not help understand the individual role of each of the factors within the system, it 
allowed setting a new paradigm for future work, i.e. next generation studies will need to integrate both 
traditional approaches and systems biology. Indeed, cross-fertilization between these zoom-in / zoom-
out views will be the only way to progress.  
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Just take the example of anti- S. aureus vaccination, which has failed in human so far. While 
antibodies can be raised against a number of S. aureus surface determinants, and while virtually every 
human individuals carry many such antibodies due to previous exposure to S. aureus, these 
antibodies do not confer protective immunity. The second article presented in this dissertation 
(Chapter 3, [2]) proposes at least two further thoughts regarding this issue. First concerning protein 
domain availability. If we do carry antibodies targeted against a given S. aureus surface determinant 
that can be detected in in vitro tests, it does not necessarily mean that the same determinant will be 
available for recognition in vivo as well. It could be that these antibodies were raised by the host 
against dead rather than against live bacteria, but that live bacteria hide these specific determinants 
because they are sensible. As suggested above, S. aureus do have a number of ways to hide surface 
determinants, for instance fibrinogen-binding proteins and Protein A via capsule production. 
Second, we may not target the right proteins domain(s) when choosing bacterial determinants 
that are expressed during growth in in vitro conditions, because these may become hidden in vivo.  
Then, how would the bacterium use a specific adhesin in vivo if it keeps it hidden to the immune 
system? The issue is speculative, but one could imagine some solutions. One would be that hidden 
surface components reveal themselves only transiently when making physical contact with their target 
protein or target membrane. The physical contact, for instance with endothelial cells, would trigger a 
conformational change of the staphylococcal protein that would engage with the ligand and lock with it 
in a transient structure conformation that is different from its native domains. This “deadly kiss” type of 
mechanism would imply induced-fitness, and be elusive enough to remain undetected by the host. 
Therefore, future vaccine strategies should take into account not only protein domains, but protein 
interacting with other molecules, and variations in macro- and micro-environments. 
Taken together, the experiments presented herein have conducted us from paradoxical 
phenotypes to new insights in the global staphylococcal life style. From this very point of view, we 
envision future work progressing toward both (i) proteomic and transcriptomic analyses of surface 
proteins in infected tissues, (ii) analyses of specific peptide availability in such conditions, and (iii) 
generating and testing preventive antibodies directed against hidden domains revealed by 
experiments (i) and (ii). 
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Accepted 8 December 2011Staphylococcus aureus is an opportunistic pathogen whose infectious capacity depends on
surface proteins, which enable bacteria to colonize and invade host tissues and cells. We
analyzed “trypsin-shaved” surface proteins of S. aureus cultures by high resolution LC-MS/
MS at different growth stages and culture conditions. Some modified peptides were identi-
fied, with a mass shift corresponding to the addition of a CH2O group (+30.0106 u). We pre-
sent evidence that this shift corresponds to a hyxdroxymethylation of asparagine and
glutamine residues. This known but poorly documented post-translational modification
was only found in a few proteins of S. aureus grown under specific conditions. This specific-
ity seemed to exclude the hypothesis of an artifact due to sample preparation. Altogether
hydroxymethylation was observed in 35 peptides from 15 proteins in our dataset, which
corresponded to 41 modified sites, 35 of them being univocally localized. While no function
can currently be assigned to this post-translational modification, we hypothesize that it
could be linked to modulation of virulence factors, since it was mostly found on some sur-
face proteins of S. aureus.
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The Gram-positive bacterium Staphylococcus aureus is a highly
successful opportunistic pathogen that can induce a wide vari-
ety of diseases [1]. Over the last decades molecular and genetic
dissection of S. aureus has revealed numerous virulence factors
that might be implicated in pathogenesis [2]. Among these are
proteins involved in adhesion, invasion and spreading in host
cells, others enabling bacteria to avoid host immune response,
as well as proteins allowing the bacteria to utilize nutrients
from the host cells [3]. The majority of virulence factors are se-lity, Genopode, University of
P. Waridel).
, University of Liège, 503
r B.V. All rights reserved.
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glutamine, J Prot (2012),creted in the extracellular medium or attached to the cell sur-
face [4]. Proteins exposed on the surface — the “surfaceome”
— include membrane, cell wall bound and secreted proteins,
and can be specifically studied by various proteomics methods
[5,6]. In one of them— named surface shaving— cells are incu-
bated with a protease and the peptides cleaved from surface
proteins are analyzed by LC-MS for protein identification [7,8].
Several groups used variants of this method — with soluble or
immobilized trypsin, alone or in combination with proteinase
K — to study the surfaceome of different S. aureus strains
[9,10,11]. This technique was also used in combination with aLausanne, 1015 Lausanne, Switzerland. Tel.: +41 21 692 39 47; fax: +41
0 Gembloux, Belgium.
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2 J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 2 ) X X X – X X Xbiotinylation approach and supernatant precipitation for a
more general profiling of the outer sub-proteome fraction [12]
of bacteria. In a quantitative comparison of S. aureus proteome
between growing (exponential phase) and non-growing cells
(stationary phase), Becher et al. also used surface shaving as a
part of a sub-proteomic fractionation strategy to characterize
an extensive fraction of the bacterial proteome, covering about
80% of all expressed genes [13].
As stressed by Dreisbach et al. in their recent review [5],
post-translational modifications of surface proteins have
been scarcely studied so far, although they could be important
for cell wall binding, surface exposure, modulation of viru-
lence factors and evasion of immune response. Ravipaty and
Reilly observed several modifications, such as oxidation, acet-
ylation, formylation, loss of methionine and various proces-
sing events — removal of signal peptide, proteolytic
processing — in S. aureus surface and secreted proteins [14].
Data reported from S. aureus and other bacteria suggest also
that glycosylation of surface proteins may play a role in path-
ogenesis and antigenicity, for example through its contribu-
tion to antigen diversity or modulation of adhesion
[15,16,17]. Recent studies also showed that phosphorylation
is important in the central metabolic processes of S. aureus,
but it does not seem to play a direct role in bacterial virulence
through modulation of adhesion and invasion of host cells
[18]. Nevertheless, the function of protein phosphorylation in
staphylococcal pathogenesis still needs further investigation
to be clarified.
In this paperwe report the LC-MS/MSanalysis of surfacepro-
teins by “trypsin-shaving” of S. aureus cells (strain Newman) in
time course experiments between the exponential and the late
stationary growth phase. Our investigation was focused on un-
expectedpost-translationalmodifications (PTM) anduncovered
an unusual PTM, hydroxymethlyation of asparagine and gluta-
mine, in some proteins expressed in S. aureus grown in an
iron-poor medium. We show evidence that this is a genuine
PTM and not a sample preparation or analytical artifact, and
we argue for the revision of its actual status, as it has been con-
sidered so far as dubious.2. Material and methods
2.1. Bacterial strains and growth conditions
Staphylococcal strain used was S. aureus Newman. Staphylo-
cocci were grown at 37 °C either in tryptic soy broth (TSB, Bec-
ton Dickinson, USA), or in Roswell Park Memorial Institute
culture medium 1640 (RPMI — Gibco, USA), without agitation.
Growth was followed by colony counting and by determining
the culture optical densities using a spectrophotometer (OD
600 nm, Ultrospec 500 pro, Amersham Biosciences). Bacterial
stocks were kept frozen at −80 °C in 20% (vol/vol) glycerol.
2.2. Preparation of bacterial cells for proteolysis of surface
proteins
Whole live cells were “trypsin-shaved” following a slightly
modified version of a recently described protocol [8]. Bacteria
were grown in 300 ml batch cultures. At various times duringPlease cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),exponential growth or stationary phase, aliquots (depending
on the cell density) were removed, immediately chilled, har-
vested by centrifugation, resuspended and washed 3× with
PBS before being resuspended in 1 ml of the same buffer. To
ensure the quantitative comparability of the proteomes ana-
lyzed from samples taken at various growth times, each sam-
ple was adjusted to the same number of cell bodies
(1×109cells/ml) as assessed by optical microscopy, using a
Neubauer cell. These samples were immediately processed
for trypsin shaving as described below.
2.3. Proteolytic digestion and sample preparation for mass
spectrometry
Bacterial bodies were adjusted to a final concentration of
1×109/ml and predigested (“shaved”) with 1 μg of porcine
trypsin (Promega, Madison, USA) for 1 h at 37 °C without agita-
tion. Treated samples were immediately chilled and bacterial
bodies were removed by centrifugation for 10 min at 4000 rpm
at 4 °C. Supernatants were filtered (0.22 μm) and freeze-dried
before being prepared for LC-MS analysis.
Pre-digested peptides from shaving were resuspended in
100 mM ammonium bicarbonate buffer, reduced with 45 μM
1,4-dithio-dl-threitol (DTT, Sigma) for 30 min at 60 °C and
alkylated with 100 mM iodoacetamide (IAA, Sigma) for
30 min in the dark. The resulting mixture was digested for
4 h with 1 μg of modified sequencing-grade porcine trypsin
(Promega, Madison, USA). The digested peptides were
desalted through Sep-Pak tC18 cartridges (Waters, Milford,
USA) as described by the manufacturer and consecutively
eluted with 1 ml of 60% and 1 ml of 30% acetonitrile (Merck,
Germany). Solution of purified peptides were pooled, dried
under vacuum, and kept at −20 °C.
2.4. Liquid chromatography-tandem mass analysis and
protein identification
Samples were analyzed on a hybrid linear trap LTQ-Orbitrap
XL mass spectrometer (Thermo Scientific, Bremen, Germany)
interfaced via a TriVersa Nanomate (Advion Biosciences, Nor-
wich, UK) to a Agilent 1100 nano HPLC system (Agilent Tech-
nologies, Waldbronn, Germany). Solvents used for the
mobile phase were 95:5 H2O:acetonitrile (v/v) with 0.1% formic
acid (A) and 5:95 H2O:acetonitrile (v/v) with 0.1% formic acid
(B).
Peptides were loaded onto a trapping microcolumn ZOR-
BAX 300SB C18 (5 mm×300 μm ID, 5 μm, Agilent) in H2O:aceto-
nitrile 97:3 (v/v)+0.1% formic acid at a flow rate of 10 μl/min.
After 5 min, they were back-flush eluted and separated on a
reversed-phase nanocolumn ZORBAX 300SB C18 column
(75 μm ID×15 cm, 3.5 μm, Agilent) at a flow rate of 300 nl/
min with a gradient from 5 to 85% acetonitrile in 0.1% formic
acid: 5 min at 0% of solvent B, from 0 to 25% of B in 35 min,
25 to 50% B in 15 min, 50 to 90% in 5 min, 90% B during
10 min, 90 to 0% in 5 min and 15 min at 0% (total time: 90 min).
For spraying, a 400 nozzle ESI Chip (Advion Biosciences)
was usedwith a voltage of 1.65 kV, and themass spectrometer
capillary transfer temperature was set at 200 °C. In data-
dependent acquisition controlled by Xcalibur 2.0 software
(Thermo Scientific), the four most intense precursor ionsw post-translational modification in Staphylococcus aureus:
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(range 350–1500 m/z, resolution 60 000 at m/z 400) were select-
ed and fragmented. MS/MS was triggered by a minimum sig-
nal threshold of 10 000 counts, carried out at relative
collision energy of 35% (CID), with isolation width of 4.0 amu.
Only precursors with a charge higher than one were selected
for CID fragmentation. Fragment ions were analyzed at low
resolution in the LTQ linear trap, or at high resolution (7500)
in the Orbitrap for some analyses. The m/z of fragmented pre-
cursors was then dynamically excluded, with a tolerance of
0.01 amu, from any selection during 120 s. For confirmatory
analyses, some samples were also reanalyzed on a LTQ-Orbi-
trap Velos instrument (Thermo Scientific, Bremen, Germany)
interfaced to an Ultimate 3000 RSLC nano HPLC system (Dio-
nex, Olten, Switzerland), using high resolution CID and HCD
MS/MS spectra acquisition. From raw files, MS/MS spectra
were exported as mgf files (Mascot Generic File, text format)
using the extract_msn.exe script from Thermo Scientific.
MS/MS spectra were analyzed using Mascot 2.3 (Matrix Sci-
ence, London, UK). Mascot was set up to search both a subset
of UniProt database (release 15.8), which contained only pro-
teins of S. aureus strain Newman (2594 sequences), and a
custom-built database containing the sequences of usual con-
taminants (enzymes, keratins, etc). Trypsin (cleavage at K, R,
not before P) was used as the enzyme definition allowing up
to 1 missed cleavage. Mascot was searched with a parent ion
tolerance of 10 ppm and a fragment ion mass tolerance of
0.50 Da, or 0.02 Da with high resolution MS/MS data. Iodoace-
tamide derivative of cysteine was specified in Mascot as a
fixed modification. Deamidation of asparagine and glutamine
and oxidation of methionine were specified as variable modi-
fications. In a second pass search, hydroxymethylation of
asparagine and glutamine was also added as variable mod-
ification, and the corresponding configuration file modified
to include the neutral loss of water in the Mascot scoring.
Scaffold (version Scaffold_3_09, Proteome Software Inc.,
Portland, OR) was used to validate MS/MS based peptide and
protein identifications, and to perform dataset alignment. Pep-
tide identifications were accepted if they could be established
at greater than 95.0% probability as specified by the Peptide
Prophet algorithm, using high mass accuracy scoring [19]. Pro-
tein identifications were accepted if they could be established
at greater than 95.0% probability and contained at least 1 identi-
fied peptide. Protein probabilities were assigned by the Protein
Prophet algorithm [20]. Proteins that contained similar peptides
and could not be differentiated based on MS/MS analysis alone
were grouped to satisfy the principle of parsimony.
2.5. Control experiment with Protein A
To determine if a potential hydroxymethylation activity was
present in the RPMI medium, Protein A standard coupled to
sepharose beads (Protein A Sepharose CL-4B, GE Healthcare)
was incubated at 37 °C overnight either in H2O or in standard
RPMI 1640 medium (Invitrogen, Carlsbad, CA). Samples were
then digested with trypsin, and the resulting peptides were
analyzed by LC-MS/MS as described above. MS/MS spectra
were searched against the UniProt database (release 2011_03)
restricted to S. aureus taxonomy and the identification results
were validated with Scaffold.Please cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),3. Results and discussion
Surface proteins (“surfaceome”) of cultured S. aureus Newman
cells were recovered by proteolysis (“trypsin-shaving”) of live
bacteria at 4 different time points between early exponential
(~2 h) and late stationary (24 h) growth phases. These growth
kinetics experiments were realized in triplicates in iron-rich
TSB or in iron-poor RPMI medium. After tryptic digestion,
the resulting peptides were analyzed by LC-MS/MS, and pro-
teins were identified using Mascot as database search soft-
ware. Based on spectral counting, we observed an increase
of various surface and membrane proteins between exponen-
tial and early stationary phases, such as immunoglobulin G
binding protein (Protein A, A6QD95), 65 kDa membrane pro-
tein (A6QIG2: OMP7_STAAE), extracellular matrix protein-
binding protein (A6QF98: EMP_STAAE), fibronectin-binding
protein A (A6QJY9). Additionally a specific increase in the
iron-regulated surface determinants IsdA (A6QG31), IsdB
(A6QG30) and IsdH (A6QHR4) were seen with the RPMI medi-
um, as expected in low iron growth conditions [12,21]. Addi-
tional results regarding kinetics of adhesins in these
experiments will be discussed elsewhere, while we focus
here on the discovery of post-translational modifications.
Looking for unexpected PTMs, we performed an error-
tolerant search on some selected data of staphylococci
grown in the RPMImedium. In this mode, Mascot searches da-
tabase entries found by a first pass classical MS/MS search
with relaxed enzyme specificity, while iterating through a
comprehensive list of chemical and post-translational modifi-
cations, together with a residue substitution matrix. As the
statistical significance of error-tolerant search results is diffi-
cult to evaluate, these must be interpreted very cautiously,
but nevertheless may allow pinpointing some potentially in-
teresting PTMs. In our case, several peptides of a few proteins
appeared to be modified with a shift of 30.011 u, which was
matched by Mascot to either hydroxymethylation of aspara-
gine (Fig. 1), or a substitution of glycine or alanine by respec-
tively a serine or threonine residue, both modifications being
isomeric and thus isobaric. As we found no indication in the
UniProt database of alanine or glycine substitution in the pro-
teins considered here, we decided to investigate the potential
presence of a hydroxymethyl modification.
Although an addition of a hydroxymethyl group to pep-
tides is already described as PTM of Asn in the RESID database
(www.ebi.ac.uk/RESID), this modification is poorly documen-
ted. We reanalyzed our data with Mascot, specifying hydroxy-
methylation of asparagine and glutamine as variable
modification. Although the hydroxymethylation of glutamine
is not documented in the RESID reference, it was included
here by analogy. With this new database search, several pep-
tides were observed with an apparent hydroxymethylation of
asparagine or glutamine residues, which motivated further
investigation. Selected samples in which putative hydroxy-
methylated peptides appeared to have the highest concentra-
tions were thus reanalyzed by LC-MS/MS, using high
resolution MS/MS for a more confident interpretation of tan-
dem mass spectra. These analyses were carried out either on
an LTQ-Orbitrap XL or LTQ-Orbitrap Velos instrument, using
data-dependent acquisition or inclusion lists.w post-translational modification in Staphylococcus aureus:
doi:10.1016/j.jprot.2011.12.014
Fig. 1 – Structure of N4-hydroxymethylasparagine according
to RESID database (AA0236, www.ebi.ac.uk/RESID). The net
mass difference relative to asparagine is +30.0106 u.
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glutamine
The first step in the characterization of hydroxymethylation
as a PTM was to determine if it was a genuine modification
or the result of an artifact, for example the combination of a
methylation and an oxidation, or a point mutation. As
shown in Fig. 2, displaying the MS/MS spectra of native and
modified peptide ADSYVPYTIAVNGTSTPILSK (from protein
OMP7), the 30.01 shift is clearly localized either on N12 or on
G13. Although a substitution of the glycine by a serine is the-
oretically possible as discussed above, it seems here to be anMascot ion score: 64
Mascot ion score: 76
A
B
Fig. 2 – Tandem mass spectra of peptide ADSYVPYTIAVNGTSTP
shift of 30.01 u at position N12 corresponds to a hydroxymethylat
7500, from peptides fragmented by CID, and annotated with the
Please cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),unlikely event as it would not explain the disappearance of
the b12 and y9 ions around the modification site in the MS/
MS spectrum of the modified peptide. Indeed, we observed
such a change in fragmentation pattern — i.e. absence of the
fragments corresponding to the modified residues — in most
of the spectra assigned to hydroxymethylated peptides,
which often made the exact localization of the modification
quite difficult. Furthermore, in all samples analyzed the
unmodified peptides with the native sequence were clearly
detected and identified with a strong signal, making the pres-
ence of mutants unlikely. An addition of a hydroxymethyl
group on the asparagine seems therefore a better explanation
for the observed shift. More importantly, no “intermediate”
methylated or oxidized form of the peptide was observed in
the MS data, which undermines the hypothesis of methylation
plus oxidation on two adjacent residues, as such a complete
double modification would be very unlikely. Interestingly we
observed only a small retention time shift of 20 s between the
unmodified and the hydroxymethylated peptide. This seems
to be compatible with the modification proposed here. On one
hand a supplementary methylene group should make the se-
quencemore hydrophobic, on the other hand themodified pep-
tide would becomemore hydrophilic because of the presence of
a free hydroxyl group, the resulting retention time shift being
probably small.ILSK (A) from protein OMP7 and its modified version (B). The
ion. Spectra were acquired on a LTQ-Orbitrap XL at resolution
software Scaffold.
w post-translational modification in Staphylococcus aureus:
doi:10.1016/j.jprot.2011.12.014
Mascot ion score: 56
Mascot ion score: 49
A
B
Fig. 3 – Tandem mass spectra of peptide DDPSQSANVLGEAQK (A) of immunoglobulin G binding protein A and its modified
version (B). The shift of 30.01 u at position Q5 corresponds to a hydroxymethylation. Spectra were acquired on a LTQ-Orbitrap
Velos at resolution 7500, from peptides fragmented by CID, and annotated with the software Scaffold.
5J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 2 ) X X X – X X XIn Fig. 3, displaying the MS/MS spectra of native and mod-
ified peptide DDPSQSANVLGEAQK (from protein A6QD95), we
show an example of a glutamine hydroxymethylation (Q5).
More strikingly than in the previous example, the modifica-
tion changed the fragmentation pattern. Fragment ions of y
series corresponding to the putative hydroxymethylated glu-
tamine and those N-terminal of themodified site were not ob-
served in the MS/MS spectrum, preventing the unambiguous
localization of the hydroxymethyl on glutamine, based on
this ions series. This phenomenon was best illustrated by
the disappearance of the base peak corresponding to frag-
ment ion y13(2+) in the spectrum of the modified peptide. Fur-
thermore, only b ions with neutral loss of H2O appeared in the
modified spectrum, while a clear b ion series was observed
with the unmodified peptide. Incidentally this b-H2O ions se-
ries allowed a clear localization of the modification on Q5,
confirming the presence of a hydroxymethylated glutamine.
When the Mascot fragment matching settings were changed
to include neutral loss of water in the scoring of the hydroxy-
methylation, the score of themodified peptide increased from
20 to 49. Similar to the first example discussed above, no “in-
termediate” methylated or oxidized form was observed in
the MS data, and the retention times of the modified andPlease cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),unmodified peptide were very close (about 7 s difference).
These data further support the idea that the mass shift ob-
served is due to a hydroxymethyl group. The data also suggest
that the modification considered is not a methoxy group (iso-
meric with hydroxymethyl), as shown by the similar retention
time and the easy loss of H2O during the fragmentation of the
peptide. Indeed, the increased neutral loss of water in the
modified peptide can be explained by the presence of a termi-
nal hydroxyl group.
Similarly, in Suppl. Fig. 1 showing the spectrum of peptide
VNVATNNPASQQVDK (from protein EMP) hydroxymethylated
on asparagine N2, only b ions with loss of H20 were observed
while the unmodified peptide produced a clear b series after
CID fragmentation. Including water neutral loss in Mascot
scoring of hydroxymethyl modification increased the ion
score from 49 to 72. Modified and native peptides almost co-
eluted, with a difference in retention time of about 10 s.
3.2. Characterization of hydroxymethylated proteins
The dataset of staphylococci grown in iron-rich RPMI medium,
including triplicate analyses of S. aureus surfaceome at 4 differ-
ent time points, was searched again with hydroxymethylationw post-translational modification in Staphylococcus aureus:
doi:10.1016/j.jprot.2011.12.014
Table 1 – Hydroxymethylated peptides identified in S. aureus Newman grown in RPMI medium. Aliquots of staphylococci were taken at various times between exponential
growth and stationary phase, based on optical density (DO) measurements. Growth experiments were carried out in triplicates. Tandem mass spectra were acquired in the
LTQ trap of a LTQ-Orbitrap XL instrument, while precursor masses were measured at high resolution in the Orbitrap. Hydroxymethylated peptides with an asterisk (*) were
confirmed by high resolution MS/MS spectra. Protein accession IDs are from UNIPROT (www.uniprot.org).
Protein description/UniProt name
(accession number)
Peptide sequence a Highest
Mascot
Ion
score
Calculated
hydroxymethylated
Peptide Mass (AMU)
T1: ~3 h
DO=0.2
T2: ~5 h
DO=0.5
T3: 6–7 h
DO=0.8
T4: 24 h
D0=1.0–1.3
Protein
region
Number of modified spectrab
Immunoglobulin G binding protein A (Protein A) DDPSQSANLLSEAK * 39 1503.7 2(2) 1(1) 2(2) B3 repeat
A6QD95_STAAE (A6QD95) DDPSQSANVLGEAQK * 53 1587.7 1(1) 2(2) 1(1) B1 repeat
MW: 57 kDa NGFIQSLKDDPSQSANLLAEAK * 53 2375.2 1(1) 1(1) 1(1) 2(2) B4 repeat
NGFIQSLKDDPSQSTNVLGEAK * 44 2377.2 4(2) 2(1) B2 repeat
NGFIQSLKDDPSQSANLLSEAK * 64 2391.2 2(2) 2(2) 2(2) 1(1) B3 repeat
NGFIQSLKDDPSQSANVLGEAQK 61 2475.2 1(1) 2(2) B1 repeat
DQQSAFYEILNMPNLNEAQR * 85 2410.1 1(1) 5(2) 5(2) 2(2) B2 repeat
EQQNAFYEILHLPNLTEEQR 22 2501.2 1(1) B5 repeat
EQQNAFYEILNMPNLNEEQR * 59 2509.2 2(2) 3(2) 2(2) 1(1) B3 repeat
EQQNAFYEILHLPNLNEEQR 29 2514.2 2(2) B4 repeat
ADNNFNKEQQNAFYEILNMPNLNEEQR 45 3312.5 1(1) 1(1) 2(2) 2(2) B3 repeat
ADAQQNNFNKDQQSAFYEILNMPNLNEAQR 33 3540.6 1(1) 2(2) B2 repeat
Sum of modified spectra (% of total spectra) 10 (6.1%) 16 (8.1%) 22 (8.5%) 15 (9.0%)
Total number of spectra (sum of triplicates) 164 197 258 167
Iron-regulated surface determinant protein B APETKPVANAVSVSNK 22 1640.9 1(1)
ISDB_STAAE (A6QG30) ATNNTYPILNQELR * 40 1675.9 2(2)
MW: 72 kDa SAITEFQNVQPTNEK 42 1734.8 1(1) 2(2) 2(2)
YMoxVMoxETTNDDYWK 36 1756.7 1(1) NEAT 2 domain
YVVYESVENNESMMDTFVK 48 2313.0 2(1) 1(1) NEAT 2 domain
Sum of modified spectra (% of total spectra) 2 (2.5%) 5 (2.2%) 5 (4.4%)
Total number of spectra (sum of triplicates) 10 79 230 113
65 kDa membrane protein SGIYTANLINSSDIK * 56 1624.8 2(2) 2(2) MAP2 repeat
OMP7_STAAE (A6QIG2) AGIYTADLINTSEIK 38 1637.9 2(2) 2(2) MAP1 repeat
MW: 66 kDa YVPYTIAVNGTSTPILSDLK * 65 2181.2 3(3) MAP4 repeat
ADSYVPYTIAVNGTSTPILSK * 99 2226.1 3(3) MAP5 repeat
Sum of modified spectra (% of total spectra) 4 (4.9%) 4 (3.5%) 6 (6.1%)
Total number of spectra (sum of triplicates) 24 81 114 99
Iron-regulated surface determinant protein A FYNANNQELATTVVNDNK * 59 2084.0 1(1) 2(2) 1(1) NEAT domain
ISDA_STAAE (A6QG31) FYNANNQELATTVVNDNKK * 51 2212.1 2(2) 2(2) NEAT domain
MW: 39 kDa Sum of modified spectra (% of total spectra) 1 (3.3%) 4 (5.1%) 3 (7.5%)
Total number of spectra (sum of triplicates) 9 30 79 40
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Glyceraldehyde 3-phosphate dehydrogenase QDVTVEQVNEAMK 25 1519.7 1(1)
A6QF81_STAAE (A6QF81) TIVFNTNHQELDGSETVVSGASCTTNSLAPVAK 44 3476.7 1(1)
MW: 36 kDa Sum of modified spectra (% of total spectra) 1 (1.7%) 1 (1.6%)
Total number of spectra (sum of triplicates) 60 63 32 43
Fructose-bisphosphate aldolase INVNTENQIASAK 63 1430.7 1(1)
A6QIW9_STAAE (A6QIW9) Sum of modified spectra (% of total spectra) 1 (4.8%)
MW: 31 kDa Total number of spectra (sum of triplicates) 21 23 7 13
Extracellular matrix protein-binding protein emp VNVATNNPASQQVDK * 53 1613.8 2(2) 2(2)
EMP_STAAE (A6QF98) Sum of modified spectra (% of total spectra) 2 (4.9%) 2 (5.7%)
MW: 38 kDa Total number of spectra (sum of triplicates) 6 16 41 35
Fibronectin binding protein A AVQAPQTAQPANIETVK 71 1794.9 1(1) 2(2) 1(1) Ligand-binding
A region
A6QJY9_STAAE (A6QJY9) Sum of modified spectra (% of total spectra) 1 (3.7%) 2 (4.3%) 1 (2.1%)
MW: 81 kDa Total number of spectra (sum of triplicates) 15 27 47 47
Leukocidin/hemolysin toxin family S subunit TISYNQQNYDTIASGK 52 1831.9 2(2)
A6QIL8_STAAE (A6QIL8) Sum of modified spectra (% of total spectra) 2 (8.3%)
MW: 40 kDa Total number of spectra (sum of triplicates) 16 22 36 24
Major cold-shock protein CspA SLEEGQAVEFEVVEGDR 36 1921.9 1(1)
A6QGV3_STAAE (A6QGV3) Sum of modified spectra (% of total spectra) 1 (12.5%)
MW: 7 kDa Total number of spectra (sum of triplicates) 8 10 5 2
Probable transglycosylase isaA LSNGNTAGATGSSAAQIMAQR 90 2035.0 1(1)
ISAA_STAAE (A6QK59) Sum of modified spectra (% of total spectra) 1 (3.4%)
MW: 24 kDa Total number of spectra (sum of triplicates) 29 25 23 11
30S ribosomal protein S16 IIEQIGTYNPTSANAPEIK 42 2088.1 1(1)
RS16_STAAE (A6QGD8) Sum of modified spectra (% of total spectra) 1 (11.1%)
MW: 10 kDa Total number of spectra (sum of triplicates) 9 7 5 6
Elongation factor Tu NGDSVAQSYDMIDNAPEEK 64 2111.9 1(1)
EFTU_STAAE (A6QEK0) Sum of modified spectra (% of total spectra) 1 (0.8%)
MW: 43 kDa Total number of spectra (sum of triplicates) 112 121 43 195
50S ribosomal protein L1 VSFTDEQLIENFNTLQDVLAK 62 2453.2 1(1)
RL1_STAAE (A6QEJ0) Sum of modified spectra (% of total spectra) 1 (4.5%)
MW: 25 kDa Total number of spectra (sum of triplicates) 17 14 9 22
Putative uncharacterized protein DGNFYQTNVDANGVNHGGSEMVQNK 44 2724.2 1(1)
A6QDB8_STAAE (A6QDB8) Sum of modified spectra (% of total spectra) 1 (6.3%)
MW: 26 kDa Total number of spectra (sum of triplicates) 14 16 19 15
aIn blue, site(s) of the modification with the highest Mascot ion score; in red, alternate sites to which were assigned other MS/MS spectra with lower Mascot score. When the sites could be clearly
localized, they are displayed in bold.
bSum of triplicates experiments. In brackets, number of replicates where the modified peptide was observed. The sum of modified spectra per protein and time point across all replicates was divided by
the corresponding total number of spectra assigned to each protein to calculate the “% of total spectra”.
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8 J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 2 ) X X X – X X Xof asparagine and glutamine as variable modification, including
neutral loss of water in Mascot scoring. As these analyses were
realized with CID fragmentation and spectra acquisition in the
LTQ part of the LC-MS system, higher sensitivity was expected
for finding hydroxymethylation, but also a higher false positive
identification of the modified peptides because of the lower res-
olution and accuracy of MS/MS spectra. We therefore applied a
stringent filtering and identification of peptideswas only accept-
ed if it could be established at greater than 95.0% probability
based on Peptide Prophet algorithm built-in Scaffold software
[19], giving a peptide FDR below 1.0%. As an additional filter, pep-
tides that were only observed in the hydroxymethylated form
(and not in unmodified form) were discarded.
Using these criteria, hydroxymethylation was observed in
35 peptides from 15 proteins in the RPMI dataset (Table 1,
Suppl. Figs. 2 and 3), which corresponded to 41 modified
sites (25 N, 16 Q), 35 of them being unambiguously localized.
Some variability in occurrence of hydroxymethylation was
observed between replicates: while a similar number of mod-
ified peptides appeared in two replicates, only 2 hydroxy-
methylated peptides (in protein OMP7) were seen in the
third replicate experiment. Because of the quite low stoichi-
ometry of the modification, in most cases below 10% based
on spectral counting, hydroxymethylated peptides were
mostly seen in abundant proteins such as immunoglobulin-
binding protein A, or when proteins were expressed at higher
abundance during growth of staphylococci, as IsdB and OMP7
at stationary phase. As notable exceptions, some proteins of
low abundance (30S ribosomal protein S16, major cold-shock
protein CspA) were also found to be modified. Altogether
only a small subset of the 321 proteins present in this dataset
contained a hydroxymethylation. The modification appeared
thus not to be randomly widespread in correlation with pro-
tein abundance, but on the contrary showed some selectivity.
More than 80% of modified sites were localized onmembrane,
secreted or cell wall associated proteins, while some abun-
dant cytoplasmic proteins found in our dataset were only
marginally modified— Elongation factor Tu (A6QEK0), Glycer-
aldehyde 3-phosphate dehydrogenase (A6QF81) (see Table 1)
— or not modified — Elongation factor G (A6QEJ9) and Pyru-
vate kinase (A6QHN2) (data not shown). Selectivity of hydro-
xymethylation is also suggested by the modification of
peptides of similar sequence from different regions in Protein
A (B repeat, predicted by homology with SPA_STAAU) [22] and
OMP7 (MAP (Eap) repeat) [23], and by the modification of pep-
tides belonging to the NEAT domain [24] in ISDA and ISDB pro-
teins (Table 1). This seems to single out hydroxymethylation
as a genuine PTM, and not as an artifact of sample prepara-
tion. Indeed, staphylococci grown in iron-rich TSB medium
were analyzed in the same conditions and after identical sam-
ple preparation and no hydroxymethylated peptides were ob-
served in any of the 381 proteins identified in this dataset. In
particular no modification appeared in immunoglobulin pro-
tein A (see example of XICs in Suppl. Figs. 4 and 5), although
it was the most abundant protein.
As a supplementary control to test for a potential hydroxy-
methylating activity in the RPMI medium itself, a sample of
Protein A standard was incubated overnight at 37 °C either in
H2O or in RPMI, digested with trypsin and analyzed by LC-
MS/MS (Suppl. Table 1). While similar sequence coverage asPlease cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),in S. aureus samples was observed, only one and two putative-
ly modified peptides, each one matched by a unique spec-
trum, were identified in the H2O and RPMI samples
respectively. Concomitantly, the unmodified versions of the
same peptides were clearly identified with respectively 35
(H2O) and 39 (RPMI) spectra matched for both peptides. Thus,
despite using a fairly large amount of material, only weak ev-
idence for hydroxymethylated peptides was found in this
standard. More importantly, no significant difference was ob-
served between samples incubated in H2O and RPMI.
3.3. Hydroxymethylation of trypsin
Although hydroxymethylation seemed to be an authentic
post-translational modification, two peptides from the diges-
tion enzyme trypsin appeared to be also modified (Suppl.
Fig. 6) in the same samples. The abundant trypsin peptide
LGEHNIDVLEGNEQFINAAK in particular was identified as
hydroxymethylated, mostly on N5, in several replicate exper-
iments at different time points of S. aureus grown in RPMI me-
dium (Suppl. Table 2). Relative to its unmodified counterpart,
the peptide showed changes in fragmentation pattern and
elution behavior similar to what observed for other hydroxy-
methylated peptides. This suggests that it is not a specific ar-
tifact of trypsin, for example due to some isobaric
combination of modifications. Indeed, such putative trypsin
modified peptides were never observed in the TSB dataset,
or in other unrelated samples from different origin analyzed
in our laboratory using the same brand of trypsin for protein
digestion. If we accept that these trypsin peptides are genuine
hydroxymethylated peptides only observed when S. aureus
was grown in RPMI medium, we could explain this surprising
result by postulating the modification of trypsin during the
pre-digestion (“shaving”) step of sample preparation. During
this step, trypsin could be exposed to some active enzyme re-
sponsible for hydroxymethylation on the S. aureus surface.
Such a localization of this activity would be compatible with
the preferential modification of membrane and surface pro-
teins observed in our data. It should be noted here that in
our experiments trypsin was not exposed to RPMI medium,
since the bacteria were washed with buffer before the shaving
procedure. This, in addition to the Protein A standard test dis-
cussed above, rules out any specific activity of the medium
itself.
3.4. Hydroxymethylation: a new post-translational
modification ?
Hydroxymethylation of asparagine is annotated in the RESID
database (http://www.ebi.ac.uk/RESID, AA0236) as dubious
(see also Unimod database: www.unimod.org, accession num-
ber 414). Indeed, its first “identification” in cyanobacteria of
the genus Anabaena was unclear and based on low resolution
MS data [25]. Furthermore, to our knowledge this modification
has not been found again in these bacteria or in any other or-
ganism. Nevertheless, our results indicate that the status of
Asn and Gln hydroxymethylation should be revised. Although
it is not possible to completely exclude that some of the mod-
ifications found in our data could be explained by the pres-
ence of unknown protein isoforms containing amino acidsw post-translational modification in Staphylococcus aureus:
doi:10.1016/j.jprot.2011.12.014
9J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 2 ) X X X – X X Xsubstitutions— such as Gly→Ser and Ala→Thr— this cannot
account for all our observations given the very diverse amino
acid composition of the detected modified peptides. The ex-
tent of hydroxymethylation in proteins like Protein A and
the variation in the presence of the modification depending
on S. aureus growth conditions support the notion of hydroxy-
methylation being a true post-translational modification. It
can appear surprising that this PTM has not been mentioned
in the literature since the first report 25 years ago. One possi-
ble reason could be that high resolution/high accuracy mass
measurements are necessary to distinguish it from other
PTMs with similar mass increase. Furthermore, hydroxy-
methylation seems to occur only in specific culture condi-
tions, at least in the case of S. aureus, and preferentially on
surface proteins. It is thus certainly easier to detect it when
specific sample preparation methods are used for surface pro-
tein enrichment before proteomics analyses. Based on our
data no sequence consensus was found, although in many
cases hydroxymethylation seemed to appear preferentially
in regions rich in asparagine or glutamine.4. Conclusions
In this study we identified hydroxymethylation in various
proteins of S. aureus and demonstrated that the status of this
modification, previously considered as dubious, should be re-
vised. We also presented evidence suggesting that it is an au-
thentic PTM and not an artifact due to sample preparation or
analytical conditions. Its structure could not be unambiguous-
ly characterized, although our data tend to rule out the iso-
meric methoxy form. Structural analysis, such as NMR,
would be necessary to confirm the structure shown in the
RESID database. Tandem MS analyses of synthetic peptides
could also allow determining more precisely the influence of
hydroxymethylation on CID fragmentation of modified pep-
tides, as discussed above, and in this way help to clarify the
structure.
The function of this PTM is for now fully unknown. As it
was mostly found on some surface proteins of S. aureus, we
can hypothesize that it has a function in the modulation of
staphylococci virulence. To further assess its function, it
would be very useful to identify the enzyme responsible for
the hydroxymethylation activity. There is currently no infor-
mation on a possible candidate, although there is some indi-
cation that this enzyme, too, could be localized on the
surface of the bacteria. In UniProt database of S. aureus New-
man proteins there are presently 2078 sequences which
have been only automatically annotated (UniProtKB/TrEMBL),
including 930 proteins noted as “putative uncharacterized
protein”. This means that there is still a large part (about
80%) of this proteome which is poorly known and could in-
deed contain an enzyme with a specific activity explaining
the modifications observed in our data.
Altogether, further work will be necessary for fully asses-
sing hydroxymethylation from both the analytical and biolog-
ical points of view. We hope that data presented here will
generate interest among microbiologists, and that this study
will contribute to expand the landscape on post-translational
modifications in bacteria.Please cite this article as: Waridel P, et al, Evidence for a ne
Hydroxymethylation of asparagine and glutamine, J Prot (2012),Supplementary materials related to this article can be
found online at doi: 10.1016/j.jprot.2011.12.014.
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Streptococcus uberis is an environmental pathogen commonly causing bovine mastitis, an infection that is
generally treated with penicillin G. No field case of true penicillin-resistant S. uberis (MIC > 16 mg/liter) has
been described yet, but isolates presenting decreased susceptibility (MIC of 0.25 to 0.5 mg/liter) to this drug
are regularly reported to our laboratory. In this study, we demonstrated that S. uberis can readily develop
penicillin resistance in laboratory-evolved mutants. The molecular mechanism of resistance (acquisition of
mutations in penicillin-binding protein 1A [PBP1A], PBP2B, and PBP2X) was generally similar to that of all
other penicillin-resistant streptococci described so far. In addition, it was also specific to S. uberis in that
independent resistant mutants carried a unique set of seven consensus mutations, of which only one (Q554E in
PBP2X) was commonly found in other streptococci. In parallel, independent isolates from bovine mastitis with
different geographical origins (France, Holland, and Switzerland) and presenting a decreased susceptibility to
penicillin were characterized. No mosaic PBPs were detected, but they all presented mutations identical to the
one found in the laboratory-evolved mutants. This indicates that penicillin resistance development in S. uberis
might follow a stringent pathway that would explain, in addition to the ecological niche of this pathogen, why
naturally occurring resistances are still rare. In addition, this study shows that there is a reservoir of mutated
PBPs in animals, which might be exchanged with other streptococci, such as Streptococcus agalactiae, that could
potentially be transmitted to humans.
Penicillin resistance has been particularly well studied for
the human pathogen Streptococcus pneumoniae (5, 15). In this
organism, resistance occurs through modifications of penicil-
lin-binding proteins (PBPs), leading to a decreased affinity for
the drug. These modifications include mutations and/or mosa-
ics in PBP2X and PBP2B, as well as in PBP1A for the highly
resistant isolates (20). Several studies also indicated that full
expression of resistance necessitates mutations both in the pbp
genes and in other genes, of which only a few have been
determined, namely, in the ciaRH, cpoA, and murMN loci (8, 9,
14). The same mechanism has also been found in viridians strep-
tococci, which are occasionally responsible for human infections
(18, 26). Very recent reports also demonstrated the implication of
PBP mutations in S. agalactiae presenting a decreased suscepti-
bility to penicillin (4, 17, 21). In contrast, the highly pathogenic
Streptococcus pyogenes, which has been widely exposed to peni-
cillin for decades, is apparently incapable of acquiring clinical
resistance in vivo (22), even though laboratory mutants presenting
decreased susceptibilities were reported (11). Thus, the capacity
to develop penicillin resistance varies among different bacteria
belonging to the same genus.
S. pneumoniae is primarily a human pathogen, while S. aga-
lactiae infects humans and sometimes animals. In contrast, S.
uberis and Streptococcus suis are primarily distributed among
cattle and pigs, respectively, in which they may be responsible
for serious and life-threatening diseases. For instance, S. uberis
is commonly responsible for clinical and subclinical bovine
mastitis, a type of infection that causes major economic loss in
the dairy industry worldwide. Recent surveys in England and in
France demonstrated that this bacterial species was implicated
in about 20% of clinical and subclinical mastitis (2, 3). In
addition, S. uberis can also be found in the environment sur-
rounding the animal.
Currently penicillin remains one of the first-line antibiotics
for prophylaxis and treatment of such pathologies. Moreover,
despite several decades of widespread use of this molecule, it
is still commonly believed that S. uberis, as well as other Strep-
tococcus spp. implicated in animal intramammary infections,
are susceptible to this drug. However, although it is true that
no high-level penicillin resistance (MIC  16 mg/liter) has yet
been described for these bacteria, isolates with intermediate
resistance (MICs ranging from 0.5 to 16 mg/liter) have been
reported (10, 24).
The present study shows that decreased susceptibilities to
penicillin can be achieved in S. uberis after repeated exposures
to increasing drug concentrations in the laboratory, despite its
phylogenetic link with S. pyogenes (27). Decreased susceptibil-
ity correlated with specific mutations in selected PBP genes.
Moreover, similar PBP mutations were also detected in clinical
isolates displaying decreased penicillin susceptibility that were
collected in France, Holland, and Switzerland. These results
highlight the reality of a reservoir of mutated PBPs in animals
and suggest that resistance development in S. uberis might
follow a quasiobligatory pathway.
* Corresponding author. Mailing address: Agence Franc¸aise de Se´-
curite´ Sanitaire des Aliments (AFSSA), Unite´ Antibiore´sistance et
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(Part of this work was presented at the 1st ASM Confer-
ence on Antimicrobial Resistance in Zoonotic Bacteria and
Food-borne Pathogens, Copenhagen, Denmark, 2008 [ab-
stract C121].)
MATERIALS AND METHODS
Microorganisms and growth conditions. S. uberis ATCC 19436 and two pen-
icillin-susceptible S. uberis strains isolated from cow mastitis cases were used as
model organisms for the selection of laboratory-cycled penicillin-resistant mu-
tants. These were compared to seven S. uberis isolates recovered from mastitis
cases in France, Holland, and Switzerland and displaying decreased penicillin
susceptibilities (MICs of 0.25 to 0.5 mg/liter). All strains were grown at 37°C
either in brain heart infusion broth (BHI) (AES, Combourg, France) without
aeration or on Columbia agar (Oxoid, Dardilly, France) supplemented with 3%
of blood. Bacterial stocks were stored at 80°C in broth supplemented with 10%
(vol/vol) of glycerol.
Antibiotics and chemicals. Penicillin G was purchased from Sigma (Saint
Quentin Fallavier, France). All other chemicals were reagent grade, commer-
cially available products.
Antibiotic susceptibility. The MICs of penicillin were determined by a previ-
ously described broth macrodilution method (1) with a final inoculum of ca. 106
CFU/ml. The MIC was defined as the lowest antibiotic concentration that in-
hibited visible bacterial growth after 24 h of incubation at 37°C.
Selection for penicillin resistance by successive cycling. Selection for penicil-
lin-resistant mutants was performed in broth cultures by exposing bacteria to
stepwise-increasing concentrations of antibiotics (7). The whole cycling experi-
ment was followed over a minimum of 50 cycles and repeated with 3 independent
isolates (strains ATCC 19436, 8749, and 9529). Individual mutants were isolated
by picking single colonies from agar plates, regrown in broth, and stored at
80°C for further study.
Identification of PBP genes in S. uberis. The DNA sequences of genes encod-
ing putative PBP1A, PBP1B, PBP2A, PBP2B, and PBP2X of S. uberis were
determined by homology searches from its nonannotated sequence, available at
http://www.sanger.ac.uk. BLAST searches were performed using the correspond-
ing amino acid sequences from S. pyogenes (accession numbers NP_269695
[PBP1A], NP_268494 PBP1B[, NP_270001 [PBP2A], and NP_269705 [PBP2X])
and S. pneumoniae (NP_359110.1 [PBP2B]).
DNA preparation and genetic strategies. Molecular techniques were carried
out by using standard methods (25) or by following instructions provided with
commercially available kits and reagents. Genomic DNA was extracted using the
Qiagen DNeasy tissue kit (Qiagen, Courtaboeuf, France). Resistance mutations
were sought in the transpeptidase domains of pbp genes and in the murMN
operon. These genes, as well as fruA and pepC, which were used as negative-
control genes, were amplified by PCR on a thermocycler (Bio-Rad, Richmond,
CA). Primers were purchased from Sigma and are presented in Table 1. Cycling
conditions consisted of 30 cycles at 94°C for 30 s, 52°C for 45 s, and 72°C for 1.5
min, followed by a 10-min delay period at 72°C after the last cycle. Amplicons
were sequenced in both directions (Genome Express, Meylan, France). Se-
quences were analyzed using the LALIGN program on the Infobiogen website
(www.fr.embnet.org).
Visualization of PBPs with Bocillin FL. First, membrane-enriched proteins
were extracted from one liter of bacterial culture in the late exponential phase of
growth (optical density at 620 nm [OD620] of ca. 0.7) as described previously (12).
The concentration of membrane proteins were determined using the Bio-Rad
protein assay (Bio-Rad Laboratories, Richmond, CA), with bovine serum albu-
min as a standard. Then, 10 g of membrane proteins were mixed with 15 M
Bocillin FL (Invitrogen) and incubated at 37°C for 45 min. The reaction was
stopped by adding 4 l of a rinsing solution (unlabeled penicillin [60 mg/ml] and
the detergent Sarkosyl [10%]), followed by 15 min of incubation at room tem-
perature before the samples were resuspended in loading buffer (1:1 ratio; 2%
sodium dodecyl sulfate [SDS], 10% glycerol, 0.1% bromophenol blue in 50 mM
Tris-HCl [pH 6.8], and 100 mM dithiothreitol) and heated at 95°C for 3 min. The
labeled PBPs were separated by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) with 6% gels and were visualized directly by fluorography using a Ty-
phoon Trio variable-mode imager (excitation at 488 nm and emission at 520
nm; GE Healthcare). Images were analyzed using the ImageQuant TL software
program (GE Healthcare). Gels were then stained with Coomassie brilliant blue
to visualize the standard and all membrane proteins.
RESULTS
S. uberis PBPs. Five PBPs were detected in silico, which were
named according to their pneumococcal homologues. The
presence of these five high-molecular-weight PBP genes was
confirmed in S. uberis by PCR, and the expression of their
protein products was assessed by gel separation of Bocillin-FL
labeled membranes (Fig. 1).
Selection for penicillin resistance. The MIC of the S. uberis
ATCC 19436 reference strain was 0.032 mg/liter. When the
strain was cycled with increasing concentrations of penicillin G,
the MIC increased from the wild-type level up to 2 mg/liter
over 30 cycles (Table 2), representing a 60-fold increase. The
2-mg/liter level constituted a plateau, since despite continuous
cycling (up to 50 cycles) the MIC did not increase any more.
According to the recommendations of either the Antibiogram
TABLE 1. Primers used for PCR amplificationa
Gene Forward sequence Reverse sequence Size (bp)
pbp1A 5-G572GCGACATCTGGATGAAAAT 5-G1289CCATTGTTCCAACATAATCA 718
pbp1B 5-C1167TTTGGCGGTTTGCTAGATG 5-G2056GATGGCGTTGGCTAGATTA 890
pbp2A 5-A1275GGGCTTGTTGGTCGTGTTA 5-C2008GGTCTTGTTAAAACCGATCC 734
pbp2B 5-C971TATGTCGGGCTTGTCTCGT 5-T1849GGCAACAGCTACTTCAGGA 879
pbp2X 5-T936GCAGATACTTTAGAAGGCTTGAA 5-G1739GAACCATTGCTACGACTGAG 804
murM 5-T27GCATTACGTCAGTGGGTTT 5-T55CAACTGATTCAGAAAAGGTTTCA 1,306
murN 5-C25GCAAACAATTAAGGAGTAAACA 5-G21CTGAAGCACTTGGTTTTTGA 1,279
fruA 5-C901CATTTGTTATTGGTGGTGGT 5-G1790CACCAGTTAAGGCAGAACC 890
pepC 5-G136CAACCGCTGATCAAGATTT 5-C998AGTCATCAGAGGCCACAAA 863
a , number of nucleotides upstream of the start codon; , number of nucleotides downstream of the stop codon.
FIG. 1. PBP profiles of S. uberis ATCC 19436 wild type and its
derivatives, presenting increasing MICs. Proteins were separated by
SDS-PAGE, and Bocillin-PBP complexes were visualized by fluorog-
raphy. Molecular mass markers are indicated at the left of the fluoro-
gram, and PBP numbers, named after their homologues in S. pneu-
moniae, are at the right. The wild type (wt) and cycled mutants with
increased penicillin MICs are indicated at the top.
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Committee of the French Society for Microbiology (CA-SFM;
sensitive, 0.25 mg/liter; resistant, 16 mg/liter) or of the
CLSI (sensitive, 0.12 mg/liter; resistant, 2 mg/liter), these
mutants are considered intermediately resistant.
The whole cycling experiment was repeated with two addi-
tional isolates tested independently. One of them had a basal
MIC of 0.016 to 0.032 mg/liter (strain 8749), and one had an
increased basal MIC of 0.128 mg/liter (strain 9529), which
would correspond to intermediate resistance according to
CLSI criteria. Interestingly, this strain already carried four
consensus resistance mutations in PBP2X and PBP2B (see
details in the next section).
In all three strains (ATCC 19436, 8749, and 9529), the MIC
increased step by step at a steady rate. The rapidity with which
the different steps were reached differed slightly between the
isolates, but the general pattern remained unchanged and re-
producible.
Resistance mutations in penicillin-resistant derivatives from a
single culture. Mutations were first sought in the transpeptidase
domains of PBP2B, -2X, and -1A of the three S. uberis cycled
isolates (ATCC 19436, 8749, and 9529). The relevance of the
detected mutations was validated by the absence of alterations
in the two control genes, fruA, which is not implicated in the
penicillin-dependent pathway, and pepC, which is located close
to PBP1A but does not belong to the same operon, both in the
wild-type strains and their resistant derivatives. Table 2 pre-
sents the mutations found in the parent strains and at MIC
levels of 0.5, 1, and 2 mg/liter. The specific locations of all PBP
mutations are schematically represented in Fig. 2.
At baseline, no sequence differences were observed between
the analyzed PBP domains of the ATCC 19436 wild-type strain
and the nonannotated genome available on the Sanger website
(www.sanger.ac.uk/Projects/S_uberis/). In this strain, the first
PBP mutations were detected at an MIC of 0.5 mg/liter, and
TABLE 2. PBP mutations in laboratory-evolved S. uberis strains
Isolate No. of cycles MIC (g/ml)
Mutations
PBP1A PBP2B PBP2X
ATCC 19436 0 0.032 —a — —
ATCC 19436 15 0.5 A227T N366I/T402I E381K/Q554E
ATCC 19436 18 1 A227T N366I/T402I E381K/D524A/Q554E
ATCC 19436 30 2 A227T/G386R N366I/T402I E381K/D524A/Q554E
8749 0 0.016 — N366I/T402I/V570A/P575S A492E
8749 16 0.5 R273H N366I/T402I E381K/Q554E
8749 28 1 A227T/G386R N366I/T402I E381K/D524A/Q554E
8749 37 2 A227T/G386R N366I/T402I E381K/D524A/Q554E
9529 0 0.128 — N366I/T402I E381K/Q554E
9529 11 0.5 R273P N366I/T402I E381K/Q554E
9529 28 1 R273P N366I/T402I E381K/Q554E
9529 39 2 A227T/G386R N366I/T402I E381K/D524A/Q554E
a —, no detected mutation.
FIG. 2. Schematic representation of the transpeptidase domains of PBP1A, PBP2B, and PBP2X. The three conserved motifs of the active site
(SXXK, SXN, and KXG) are indicated at the tops of the schemes. The mutations detailed in Table 2 are indicated at the bottoms of the schemes.
Bold characters correspond to mutations detected in all laboratory-evolved isolates.
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three PBPs were affected. First, class B PBP2X, which is a main
determinant of penicillin resistance in S. pneumoniae, carried
the E381K and Q554E mutations, which were both located close
to a conserved motif (Fig. 2). Second, class B PBP2B also
carried two substitutions (N366I and T402I) that were located in
the vicinity of conserved domains. Third, class A PBP1A al-
ready carried an A227T mutation at this early resistance step,
although it is reputed to be mutated only in pneumococci with
high-level resistance.
At the second step of resistance (MIC of 1 mg/liter), these
five mutations were conserved, and an additional one was
detected in PBP2X (D524A). At the last step (MIC of 2 mg/
liter), a second substitution in PBP1A appeared (G386R),
which was also located in the vicinity of conserved motifs (Fig.
2). Both PBP1A modifications led to the conversion of simple
hydrophobic amino acids (alanine or glycine) into a more com-
plex hydrophilic threonine or basic arginine.
This progressive accumulation of mutations paralleling the
step-by-step increase in the MIC was a feature of each strain,
and most interestingly, the same seven consensus mutations
were systematically detected in all of them at the highest level
of MIC (at 2 mg/liter). Nevertheless, slight differences oc-
curred in between, as shown by the appearance of transient
mutations that disappeared at higher resistance levels. For
example, isolate 8749 already carried two PBP2B mutations at
the basal MIC level, in addition to three other transitory al-
terations. This strain was cycled in triplicate to test whether
these transient mutations (V570A and P575S in PBP2B and
A492E in PBP2X) might be deleterious for penicillin resistance
development. Yet in all triplicates, they were always detected
both at the wild-type level and at an MIC of 0.5 mg/liter,
suggesting that whereas they are not necessary for penicillin
resistance development, they are not impeaching it either. Sim-
ilarly, isolate 9529, which had an increased MIC (0.128 mg/
liter) and already carried four mutations in PBP2B and PBP2X
at the basal level (Table 2), also displayed a mutation in
PBP1A (R273P) that disappeared after it had reached an MIC
of 2 mg/liter and developed its whole set of consensus muta-
tions.
Mutations were also sought in the murMN operon, at the
basal level and at an MIC of 2 mg/liter. In all three strains, two
mutations were detected in the murN gene in comparison to
the Sanger sequence, both at the basal level and in laboratory-
evolved mutants. Two additional substitutions in murM were
also transiently present in the noncycled ATCC 19436 strain.
However, these modifications were not linked to penicillin
resistance development, since they were already present at the
basal level.
Impact of mutations on the affinity for penicillin. The PBPs
of wild-type ATCC 19436 and the two associated mutants
presenting increasing MICs to penicillin were analyzed on Bo-
cillin-FL-labeled gels (Fig. 1). A progressive fading of all PBPs
could be observed, but the ones corresponding to nonmutated
PBP2A and -1B seemed less impacted. On the contrary, the
bands corresponding to PBP2B and -2X had already com-
pletely disappeared in the mutant presenting an MIC of 1
mg/liter.
Resistance mutations in environmental S. uberis. The
transpeptidase domains of PBP1A, -2B, and -2X of seven non-
cycled strains isolated from bovine mastitis cases and present-
ing a decreased susceptibility to penicillin (MICs of 0.25 to 05
mg/liter) were sequenced. No mosaic PBPs were identified, as
assessed by the correct PCR amplification of their transpepti-
dase domains and the absence of internal fragments presenting
highly diverging sequences compared to both the nonanno-
tated Sanger sequence and the sequences of the other isolates
tested in this study. On the other hand, all mastitis isolates
carried 2 of the consensus resistance mutations found in the
laboratory-cycled strains (Table 3). The two alterations (E381K
and Q554E) in PBP2X were systematically detected. Mutations
in PBP1A and -2B were not found in all isolates, but whenever
present, they were in conformity with the consensus (G386R in
PBP1A, N366I and T402I in PBP2B). Consequently, very similar
PBP mutations could be observed between laboratory-evolved
mutants and the natural strains with decreased penicillin sus-
ceptibility.
DISCUSSION
In this study, the capacity of S. uberis to develop penicillin
resistance was questioned, first, because S. uberis is one of the
principal causes of streptococcal mastitis; second, because pen-
icillin is widely used to treat intramammary infections in ani-
mals; and third, because field cases of S. uberis strains present-
ing decreased susceptibility to this drug were reported to our
laboratory. In addition, S. uberis is phylogenetically linked to S.
pyogenes, which is reputedly incapable of developing penicillin
resistance. The results obtained in vitro demonstrated that a
step-by-step increase in the MIC can occur for S. uberis. This
was exemplified by the 60-fold increase in the MIC that pro-
gressively developed over 30 cycles of penicillin exposure in the
TABLE 3. PBP mutations in S. uberis isolates naturally presenting decreased susceptibility to penicillin
Isolate Origin MIC (g/ml)
Mutation(s)
PBP1A PBP2B PBP2X
ALP8092 Switzerland 0.25 G386R —
a E381K/Q554E
ALP 8144 Switzerland 0.25 — — E381K/Q554E
BL246 Switzerland 0.25 — N366I/T402I E381K/Q554E
1.11 Holland 0.25 G386R T593A E381K/Q554E
20568 France 0.5 G386R N366I/T402I/V570A/P575S E381K/Q554E
20592 France 0.5 — — E381K/Q554E
20618 France 0.25 G386R — E381K/Q554E
a —, no detected mutation.
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reference strain ATCC 19436 and in the two other strains
studied.
PBP alterations have been extensively described as the ma-
jor mechanism leading to penicillin resistance in S. pneumoniae
(5). Additionally, PBP alterations were shown to be implicated
in decreased susceptibility in Streptococcus gordonii and more
recently in S. agalactiae (13, 17). Here the development of
laboratory-evolved mutants, which presented MICs that were
increasing concomitantly to the accumulation of mutations in
both class A and class B PBPs, demonstrates that S. uberis
shared the same resistance mechanism common to all strepto-
cocci. In PBP2B, two recurrent mutations were detected in the
vicinity of the SVVK and SSN domains, both generating an
isoleucine residue that might play a central role in protein
stability because of its critical importance for binding of ligands
to proteins. In PBP2X, all mutants systematically harbored
three mutations at an MIC of 2 mg/liter, among which was the
Q554E alteration. This substitution is characteristic of all pen-
icillin-resistant streptococci described so far (4, 13, 19, 21) and
was shown to be one of the major genetic determinants of
pneumococcal resistance (23). Interestingly, two PBP2X mu-
tations and two PBP2B mutations were already found in the
wild-type 9529 isolate, which displayed an MIC of 0.128 mg/
liter. Conserved mutations were also observed in PBP1A,
close—but not inside—the STMK and KTG motifs. In coher-
ence with the presence of point mutations in class B and class
A PBPs, a likely decrease in the affinity of the proteins for
penicillin was evidenced with Bocillin FL-labeled gels. Thus, all
of these mutations were probably responsible for the resistance
of the isolates, though to different extents.
All mutations were highly conserved between laboratory-
evolved mutants, apart from a few marginal alterations that
were transiently detected, as already observed in S. gordonii
(data not published) and probably reflecting the high mutabil-
ity of these PBP proteins upon selection by penicillin. Addi-
tionally, the same mutations were present in isolates from
bovine mastitis that presented decreased susceptibilities to
penicillin. More precisely, two PBP2X mutations were system-
atically found (E381K and Q554E), alone or in association with
PBP2B or PBP1A substitutions. On the contrary, no mosaic
proteins were detected in these natural isolates, since their
transpeptidase domain could be amplified by PCR and pre-
sented sequences quasi-identical to that of the wild-type ATCC
reference strain. This high conservation between mutations
from unrelated isolates (laboratory and environmental strains
from diverse origins) seems to be specific to S. uberis. Indeed,
in pneumococci, as in other Streptococcus spp., high-level
MICs of penicillin are generated by a diversity of different
patterns of mutations (6, 13, 16, 21). This specificity of S. uberis
might argue for a strong pressure of selection on very precise
regions of the protein and probably represents a quasiobliga-
tory pathway for the development of decreased susceptibility
to penicillin in this particular species. Moreover, constraint
seems particularly strong considering the fact that all the re-
sistant environmental isolates from France, Holland, and Swit-
zerland carried the same types of mutations. Such a stringent
selection mechanism, combined with the ecological niche on a
usually sterile mammary gland, which decreases the chances of
horizontal gene transfer with other species, might explain why
no S. uberis penicillin-resistant strains have been reported yet.
In addition to PBP-related mutations, a few other genes
have been implicated in penicillin resistance (8, 9, 14). Here
the murMN operon was sequenced, but the only detected al-
terations were either already present in the wild-type strain or
transient, which indicates that they were most probably not
related to resistance development. However, the fact that the
same set of mutations can be found in two successive labora-
tory-evolved mutants with different MICs (strains 8749 and
9529, MICs of 1 mg/liter and 2 mg/liter; Table 2), as well as the
existence of environmental isolates with the same pattern but
different MICs (ALP 8144 and 20592; Table 3) or with differ-
ent patterns but the same MIC (20568 and 20592), indicates
that other still-unknown genetic determinants have an impor-
tant function.
Potential genetic exchanges are undoubtedly less frequent
for bacteria living in the open environment or on the normally
sterile mammary gland than for an organism living in the oral
cavity, like S. pneumoniae, in close contact with thousands of
other species. Yet each step toward decreased susceptibility
might be a risk for the emergence of new resistant phenotypes.
Consequently, attention should be paid to any shift of popu-
lation toward progressively increased MICs.
An ultimate practical question relates to the phenotypic and
genotypic definition of resistance. In S. uberis, a simultaneous
E381K/Q554E substitution in PBP2X reliably correlated with a
penicillin MIC of 0.125 mg/liter, while partner mutations
could differ at this stage. Furthermore, a set of 7 consensus
mutations in PBP1A, -2B, and -2X was reproducibly observed
at an MIC of 2 mg/liter. Although this correlation needs to be
confirmed with larger numbers of isolates, it could provide a
genetically based marker for newly defined intermediate resis-
tance (MIC  0.125 mg/liter) and high-level resistance
(MIC  2 mg/liter), which would conform with CLSI criteria,
compared to the CA-SFM criteria (MIC  0.25 mg/liter and
MIC 16 mg/liter for intermediate and full resistance, respec-
tively). Moreover, it would also help in rationalizing the con-
ceptual differences between epidemiological cutoff values,
which are defined to differentiate a wild-type population from
a diverging one, and clinical breakpoints, which are related
primarily to the therapeutic chances of success.
In conclusion, the present work demonstrates that S. uberis
can develop decreased susceptibilities to penicillin. This devel-
opment involves mechanisms that are in part common to all
streptococci (accumulation of PBP mutations, leading to a
decreased affinity for the drug) and in part specific to S. uberis
(accumulation of highly conserved alterations). Numerous and
precise mutations related to penicillin resistance acquisition
were described, which might contribute to the pool of resis-
tance determinants exchangeable between streptococci—for
instance, between S. uberis and S. agalactiae, which are both
causative agents of intramammary infections in cattle. Yet the
use of penicillin as a first-line therapeutic choice can still be
recommended in veterinary medicine. But the use of epidemi-
ological cutoff values that would be more stringent, combined
with molecular tools, seems mandatory for the survey of the
evolution of resistance in S. uberis strains causing bovine mas-
titis and for decreasing the contribution of animals to the pool
of penicillin-resistant streptococci shared by animals and hu-
mans.
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